
<html lang="en"     class="pb-page"  data-request-id="39e2eca6-fbf7-410f-98f3-ebf4d20ba2b7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00678;issue:issue:10.1021/jmcmar.2018.61.issue-15;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase" /></meta><meta name="dc.Creator" content="Nicole  Blaquiere" /></meta><meta name="dc.Creator" content="Georgette M.  Castanedo" /></meta><meta name="dc.Creator" content="Jason D.  Burch" /></meta><meta name="dc.Creator" content="Leonid M.  Berezhkovskiy" /></meta><meta name="dc.Creator" content="Hans  Brightbill" /></meta><meta name="dc.Creator" content="Suzanne  Brown" /></meta><meta name="dc.Creator" content="Connie  Chan" /></meta><meta name="dc.Creator" content="Po-Chang  Chiang" /></meta><meta name="dc.Creator" content="James J.  Crawford" /></meta><meta name="dc.Creator" content="Teresa  Dong" /></meta><meta name="dc.Creator" content="Peter  Fan" /></meta><meta name="dc.Creator" content="Jianwen  Feng" /></meta><meta name="dc.Creator" content="Nico  Ghilardi" /></meta><meta name="dc.Creator" content="Robert  Godemann" /></meta><meta name="dc.Creator" content="Emily  Gogol" /></meta><meta name="dc.Creator" content="Alice  Grabbe" /></meta><meta name="dc.Creator" content="Alison J.  Hole" /></meta><meta name="dc.Creator" content="Baihua  Hu" /></meta><meta name="dc.Creator" content="Sarah G.  Hymowitz" /></meta><meta name="dc.Creator" content="Moulay Hicham  Alaoui Ismaili" /></meta><meta name="dc.Creator" content="Hoa  Le" /></meta><meta name="dc.Creator" content="Patrick  Lee" /></meta><meta name="dc.Creator" content="Wyne  Lee" /></meta><meta name="dc.Creator" content="Xingyu  Lin" /></meta><meta name="dc.Creator" content="Ning  Liu" /></meta><meta name="dc.Creator" content="Paul A.  McEwan" /></meta><meta name="dc.Creator" content="Brent  McKenzie" /></meta><meta name="dc.Creator" content="Hernani L.  Silvestre" /></meta><meta name="dc.Creator" content="Eric  Suto" /></meta><meta name="dc.Creator" content="Swathi  Sujatha-Bhaskar" /></meta><meta name="dc.Creator" content="Guosheng  Wu" /></meta><meta name="dc.Creator" content="Lawren C.  Wu" /></meta><meta name="dc.Creator" content="Yamin  Zhang" /></meta><meta name="dc.Creator" content="Zoe  Zhong" /></meta><meta name="dc.Creator" content="Steven T.  Staben" /></meta><meta name="dc.Description" content="NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell..." /></meta><meta name="Description" content="NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 25, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00678" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00678" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00678" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00678" /></link>
        
    
    

<title>Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00678" /></meta><meta property="og:title" content="Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0017.jpeg" /></meta><meta property="og:description" content="NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes. Compound 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00678"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00678">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00678&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00678&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00678&amp;href=/doi/10.1021/acs.jmedchem.8b00678" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6801-6813</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00633" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00694" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Nicole Blaquiere</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicole Blaquiere</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>N.B.: e-mail, <a href="/cdn-cgi/l/email-protection#a3cdcac0cccfc6c1cfc2d2d6cac6d1c6e3c4cec2cacf8dc0ccce"><span class="__cf_email__" data-cfemail="5d33343e3231383f313c2c2834382f381d3a303c3431733e3230">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicole++Blaquiere">Nicole Blaquiere</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Georgette M. Castanedo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Georgette M. Castanedo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Georgette+M.++Castanedo">Georgette M. Castanedo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason D. Burch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason D. Burch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason+D.++Burch">Jason D. Burch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leonid M. Berezhkovskiy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leonid M. Berezhkovskiy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leonid+M.++Berezhkovskiy">Leonid M. Berezhkovskiy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hans Brightbill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans Brightbill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Brightbill">Hans Brightbill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Suzanne Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suzanne Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne++Brown">Suzanne Brown</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Connie Chan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Connie Chan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Connie++Chan">Connie Chan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Po-Chang Chiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Po-Chang Chiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Po-Chang++Chiang">Po-Chang Chiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James J. Crawford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James J. Crawford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+J.++Crawford">James J. Crawford</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6408-8246" title="Orcid link">http://orcid.org/0000-0002-6408-8246</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Teresa Dong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Teresa Dong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Teresa++Dong">Teresa Dong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Fan">Peter Fan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jianwen Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianwen Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianwen++Feng">Jianwen Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nico Ghilardi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nico Ghilardi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Ghilardi">Nico Ghilardi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Godemann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Godemann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec AG,Manfred Eigen Campus, Essener Bogen, Hamburg 22419, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Godemann">Robert Godemann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emily Gogol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emily Gogol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Gogol">Emily Gogol</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alice Grabbe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alice Grabbe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec AG,Manfred Eigen Campus, Essener Bogen, Hamburg 22419, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alice++Grabbe">Alice Grabbe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alison J. Hole</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alison J. Hole</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec AG,Manfred Eigen Campus, Essener Bogen, Hamburg 22419, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alison+J.++Hole">Alison J. Hole</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Baihua Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Baihua Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Baihua++Hu">Baihua Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah G. Hymowitz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah G. Hymowitz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+G.++Hymowitz">Sarah G. Hymowitz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moulay Hicham Alaoui Ismaili</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moulay Hicham Alaoui Ismaili</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Moulay+Hicham++Alaoui+Ismaili">Moulay Hicham Alaoui Ismaili</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hoa Le</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hoa Le</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hoa++Le">Hoa Le</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Lee">Patrick Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wyne Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wyne Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wyne++Lee">Wyne Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xingyu Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xingyu Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xingyu++Lin">Xingyu Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ning Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ning Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Liu">Ning Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul A. McEwan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul A. McEwan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec AG,Manfred Eigen Campus, Essener Bogen, Hamburg 22419, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++McEwan">Paul A. McEwan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brent McKenzie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brent McKenzie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brent++McKenzie">Brent McKenzie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hernani L. Silvestre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hernani L. Silvestre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec AG,Manfred Eigen Campus, Essener Bogen, Hamburg 22419, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hernani+L.++Silvestre">Hernani L. Silvestre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Suto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Suto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Suto">Eric Suto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Swathi Sujatha-Bhaskar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Swathi Sujatha-Bhaskar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Swathi++Sujatha-Bhaskar">Swathi Sujatha-Bhaskar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guosheng Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guosheng Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guosheng++Wu">Guosheng Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lawren C. Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lawren C. Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lawren+C.++Wu">Lawren C. Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yamin Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yamin Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yamin++Zhang">Yamin Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zoe Zhong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zoe Zhong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zoe++Zhong">Zoe Zhong</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Steven T. Staben</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven T. Staben</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>S.T.S.: e-mail, <a href="/cdn-cgi/l/email-protection#760502171413185805021300131836111318135815191b"><span class="__cf_email__" data-cfemail="2f5c5b4e4d4a41015c5b4a594a416f484a414a014c4042">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven+T.++Staben">Steven T. Staben</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6137-6517" title="Orcid link">http://orcid.org/0000-0002-6137-6517</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00678&amp;href=/doi/10.1021%2Facs.jmedchem.8b00678" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6801–6813</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 25, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 April 2018</li><li><span class="item_label"><b>Published</b> online</span>25 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00678" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00678</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6801%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNicole%2BBlaquiere%252C%2BGeorgette%2BM.%2BCastanedo%252C%2BJason%2BD.%2BBurch%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D15%26contentID%3Dacs.jmedchem.8b00678%26title%3DScaffold-Hopping%2BApproach%2BTo%2BDiscover%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2BInhibitors%2Bof%2BNF-%25CE%25BAB%2BInducing%2BKinase%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6813%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00678"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3189</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00678" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;Blaquiere&quot;},{&quot;first_name&quot;:&quot;Georgette&quot;,&quot;last_name&quot;:&quot;M. Castanedo&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;D. Burch&quot;},{&quot;first_name&quot;:&quot;Leonid&quot;,&quot;last_name&quot;:&quot;M. Berezhkovskiy&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Brightbill&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Connie&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Po-Chang&quot;,&quot;last_name&quot;:&quot;Chiang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. Crawford&quot;},{&quot;first_name&quot;:&quot;Teresa&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Jianwen&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Ghilardi&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Godemann&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Gogol&quot;},{&quot;first_name&quot;:&quot;Alice&quot;,&quot;last_name&quot;:&quot;Grabbe&quot;},{&quot;first_name&quot;:&quot;Alison&quot;,&quot;last_name&quot;:&quot;J. Hole&quot;},{&quot;first_name&quot;:&quot;Baihua&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;G. Hymowitz&quot;},{&quot;first_name&quot;:&quot;Moulay&quot;,&quot;last_name&quot;:&quot;Hicham Alaoui Ismaili&quot;},{&quot;first_name&quot;:&quot;Hoa&quot;,&quot;last_name&quot;:&quot;Le&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Wyne&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Xingyu&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. McEwan&quot;},{&quot;first_name&quot;:&quot;Brent&quot;,&quot;last_name&quot;:&quot;McKenzie&quot;},{&quot;first_name&quot;:&quot;Hernani&quot;,&quot;last_name&quot;:&quot;L. Silvestre&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Suto&quot;},{&quot;first_name&quot;:&quot;Swathi&quot;,&quot;last_name&quot;:&quot;Sujatha-Bhaskar&quot;},{&quot;first_name&quot;:&quot;Guosheng&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Lawren&quot;,&quot;last_name&quot;:&quot;C. Wu&quot;},{&quot;first_name&quot;:&quot;Yamin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zoe&quot;,&quot;last_name&quot;:&quot;Zhong&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;T. Staben&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6801-6813&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00678&quot;},&quot;abstract&quot;:&quot;NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes. Compound 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00678&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00678" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00678&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00678" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00678&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00678" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00678&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00678&amp;href=/doi/10.1021/acs.jmedchem.8b00678" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00678" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00678" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00678%26sid%3Dliteratum%253Aachs%26pmid%3D29940120%26genre%3Darticle%26aulast%3DBlaquiere%26date%3D2018%26atitle%3DScaffold-Hopping%2BApproach%2BTo%2BDiscover%2BPotent%252C%2BSelective%252C%2Band%2BEfficacious%2BInhibitors%2Bof%2BNF-%25CE%25BAB%2BInducing%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D15%26spage%3D6801%26epage%3D6813%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291667" title="Vacuum">Vacuum</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/jmcmar.2018.61.issue-15/20180809/jmcmar.2018.61.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes. Compound <b>4f</b> is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NF-κB inducing kinase (NIK) is a key regulator of noncanonical NF-κB signaling.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> NIK is a “non-RD” (non-arginine-aspartate) kinase,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and activation of NIK downstream of TNF receptor superfamily members (such as BAFF, CD40, and TWEAK) is achieved by regulation of NIK’s stability. In the absence of pathway stimulation, co-binding of NIK, TRAF2/3, and cIAP lead to cIAP-mediated ubiquitination and proteasomal degradation of NIK.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Upon stimulation, TNF receptor superfamily members are thought to bind the TRAF2/3–cIAP complex, decreasing the proximity of NIK to cIAP and thus improving the stability of NIK. Accumulated and constitutively active NIK phosphorylates and activates IKKα, and downstream events lead to p100 processing, nuclear translocation of p52, and increased transcription of NF-κB target genes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Several TNF family superfamily members have been implicated in systemic lupus erythematosus (SLE) pathophysiology, most notably BAFF,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> CD40, and TWEAK.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> We hypothesize that inhibiting the kinase function of NIK would target common downstream pathways of these implicated tumor necrosis factor receptor superfamily (TNFRSF) receptors and potentially provide superior efficacy in SLE compared to targeting individual TNFRSF receptors with biologic approaches.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Several efforts have been disclosed detailing small molecule inhibitors of NIK,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> but few have proven to generate appropriately potent and selective chemical tools to prosecute the relevance of NIK activity in autoinflammatory diseases. We recently reported a structure-based design effort leading to a series of type 1.5 inhibitors of NIK possessing a benzoxepin core structure and pendant propargyl alcohol (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, compounds <b>1</b>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> While large improvements in potency and kinase selectivity were obtained, these compounds were insufficient for robust in vivo evaluation of NIK pharmacology. Here we describe a scaffold-hopping approach<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> directed at further improvements in cell potency, kinase selectivity, and in vivo PK properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Proposed excision of oxepin ring of <b>1</b> to 2-(3-amido)pyrazolylpyridines <b>2</b>. (b) Crystal structure of benzoxazepin <b>1a</b> (blue) in murine NIK (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y">6G4Y</a>). Solvent accessible surface is indicated in gray. Key intermolecular distances are indicated with gray lines/text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A minimalist approach was taken to chemically simplify and identify new vectors of substitution within the benzoxepin series. Our previous studies indicated the benzoxepin oxygen atom was not required for NIK potency and could be replaced with a bridged bicyclic carbon core, yielding improved selectivity over several kinases including phosphatidylinositol 3-kinase (PI3K).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We also reported some substituents on the five-membered aromatic heterocycle afforded improved kinase selectivity without much consequence to NIK affinity. With this in mind, we hypothesized that removal of the oxepin ring would be tolerated, simplifying the synthetic accessibility of compounds with substitution on the heterocyclic core (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). A crystal structure of representative benzoxazepin <b>1a</b> in murine NIK<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> is shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y">6G4Y</a>). The core positions a primary amide to accept and donate hydrogen bonds to hinge residues Leu474 and Glu472, as well as directs the propargyl alcohol substituent past the gatekeeper Met471 to engage critical residues common for type 1.5 inhibitors (αC-helix Glu442 and DFG-motif Phe537).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In order to maintain these key interactions, as well as reinforce optimal binding conformation created by the constrained rigidity of the oxepin, we first designed 1-(2-pyridyl)-3-amidopyrazoles exemplified by compounds <b>2</b>. We anticipated a desirable torsional preference of the primary amide and biaryl C–N bond based on an intramolecular hydrogen bond and electron pair repulsion, respectively. This design was also anticipated to allow rapid access to multiple analogs using simple S<sub>N</sub>Ar chemistry (vide infra). We chose 3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one substitution at the 4-position of the pyridine given reliably high lipophilic ligand efficiency (LLE)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> analogs created in the benzoxepin series.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Biochemical activity and LLE values for initial ring-opened derivatives are displayed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The ability of compounds to inhibit recombinant NIK protein was determined by measuring inhibition of the native rate of substrate-independent hydrolysis of ATP to ADP (“NIK ADP FP”).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Cellular activity was determined through inhibition of the expression of the NF-κB response element-regulated firefly luciferase reporter in HEK-293 cells (dox-inducible NIK, “NF-κB reporter”).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As we have demonstrated previously, large shifts between inhibition in biochemical and cell based assays emphasize the need for exquisitely potent inhibitors. We believe this to be partially due to NIK’s low <i>K</i><sub>m</sub> for ATP (∼7 μM).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Unsubstituted pyrazole <b>2a</b> is a moderately potent inhibitor in the biochemical assay (<i>K</i><sub>i</sub> of 28 nM) and expectedly does not influence the NF-κB reporter assay at concentrations up to 20 μM. This compound, however, does have a desirable LLE (6.9) based on a low measured log <i>D</i><sup>pH 7.4</sup> (0.61). We hypothesized increasing the log <i>D</i> of the compound with nonpolar substitution off the pyrazole would increase the inhibitory potency by aiding desolvation of the compound. The addition of small lipophilic substituents to the 5-position of the pyrazole ring such as compound <b>2c</b> did indeed improve cell potency to the single-digit μM range, as did the addition of an unsubstituted amino group (<b>2b</b>). We hypothesized the amine in <b>2b</b> could form an intramolecular hydrogen bond with the pyridine nitrogen, providing stabilization of the low energy binding conformation. Cellular activity of this analog, however, was modest. Fused bicyclic systems exemplified by compounds <b>2d</b>–<b>f</b> proved stronger inhibitors of NIK activity. In particular, indazoles such as <b>2e</b> and <b>2f</b> afforded impressive potency gains. Indazole <b>2e</b> (<i>K</i><sub>i</sub> = 0.08 ± 0.05 nM; cellular IC<sub>50</sub> = 33 ± 9 nM) is >250-fold more active than pyrazole <b>2a</b>, maintains a desirable overall lipophilicity (log <i>D</i><sup>pH 7.4</sup> = 1.9), and improves LLE substantially (8.2 vs 6.9, respectively).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical and Cellular Inhibition Data for Initial Ring-Opened Analogs<a class="ref internalNav" href="#t1fn1" aria-label="e">e</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup><sup>a</sup></sup><p class="last">Inhibition of NIK-catalyzed hydrolysis of ATP to ADP (FP = fluorescence polarization).</p></div><div class="footnote" id="t1fn3"><sup><sup>b</sup></sup><p class="last">Inhibition of expression of NF-κB response element-regulated firefly luciferase reporter gene in HEK293 cells.</p></div><div class="footnote" id="t1fn4"><sup><sup>c</sup></sup><p class="last">log <i>D</i> measured using a high-throughput microscale shake flask and liquid chromatography–tandem mass spectrometry approach.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></p></div><div class="footnote" id="t1fn5"><sup><sup>d</sup></sup><p class="last">Lipophilic ligand efficiency (LLE) was calculated utilizing measured log <i>D</i> values via the following equation: [NIK ADP-FP p<i>K</i><sub>i</sub>] – [log <i>D</i><sup>pH7.4</sup>].</p></div><div class="footnote" id="t1fn1"><sup><sup>e</sup></sup><p class="last">N.R.: not reported. Data are represented as the mean ± standard deviation of the average for the number (<i>n</i>) of experiments conducted.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>2d</b>–<b>f</b> were tested for single point inhibition of select additional kinases at a concentration of 100 nM, >100× the biochemical <i>K</i><sub>i</sub> for NIK. These compounds were determined to have high selectivity for NIK; only one or two kinases (KHS1 and PKD1) were inhibited at >50% (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a, tabulated data in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">Supporting Information</a>). A co-crystal structure of <b>2f</b> bound to murine NIK confirmed our proposed binding mode of this series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z">6G4Z</a>). As designed, we observed that <b>2f</b> (blue sticks) aligns well with benzoxazepin <b>1a</b> (magenta wireframe); the primary amide lies in proximity of the hinge to interact with residues Leu474 and Glu472, and the propargyl alcohol maintains critical H-bonding distances with the DFG motif and αC-helix glutamate. From this structure it is also clear the ligand occupies an area of the active site (between the lower hinge and P-loop) that was otherwise difficult to access with the benzoxepin series. Interestingly, the observed dihedral angle between aryl rings of the small molecule when bound to murine NIK (mNIK) is ∼19° out of plane, in opposition to the ∼0° dihedral angle observed with benzoxazepins such as <b>1a</b>. We hypothesized that the increased rotational freedom around this bond may allow for more optimal space filling and hydrogen bonding interactions of the primary amide and propargyl alcohol, accounting for some of the observed inhibitory potency.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Inhibition of kinase activity at a single concentration (100 nM) across a range of kinases tested at Invitrogen (red, >80% inhibition; yellow, 50–80%; green, <50%). (b) X-ray cocrystal structure of <b>2f</b> (blue) in mNIK (gray) including an overlay of benzoxazepin <b>1a</b> (magenta wire-frame) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z">6G4Z</a>). Solvent accessible surface is indicated in gray. Key intermolecular distances are indicated with gray lines/text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>2d</b>–<b>f</b> were incubated with human liver microsomes (HLM) and human hepatocytes (HH) to evaluate their metabolic stability (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>2d</b> was particularly stable in HLM, with a predicted hepatic clearance of 1.6 mL min<sup>–1</sup> kg<sup>–1</sup>. The other two molecules were found to be moderately stable in HLM, with predicted hepatic clearance between 30% and 50% liver blood flow. In contrast, all three compounds were rapidly metabolized in HH (predicted hepatic clearance of >14 mL min<sup>–1</sup> kg<sup>–1</sup>, >70% liver blood flow) suggesting additional phase II metabolism pathways may be operative. Metabolites were analyzed after 3 h incubation of <b>2f</b> with human hepatocytes. This experiment revealed that a major metabolite resulted from glutathione (GSH) addition to the parent molecule. We hypothesized 1,6 addition of glutathione to the electron-deficient alkyne may be possible given the electron-withdrawing nature of the 4-pyridyl (schematic in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This glutathione conjugation was not observed in the benzoxepin series of NIK inhibitors. The other major route of metabolism was hydrolysis of the primary amide, presumably catalyzed by the action of hydrolases present in the hepatocyte prep.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Human liver microsome (HLM) and human hepatocyte (HH) predicted hepatic clearance.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (b) Qualitative representation of metabolism pathways observed in HH after 3 h incubation with 5 μM <b>2f</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next synthesized and tested analogs similar to <b>2e</b>,<b>f</b> where the central pyridine ring was replaced with a 1,3-disubstituted benzene and alternative 6,5 aromatic heterocycles (compounds <b>3</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We anticipated these two changes would minimize the electrophilicity of the alkyne and potentially modulate the rate of primary amide hydrolysis. Importantly, the central pyridyl nitrogen did not appear to be crucial for activity as many analogs containing 6,5 heterocyclic systems were potent in both the biochemical and cell-based assays (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Among changes investigated, one not tolerated was in azaindole <b>3a</b>, possibly owing to steric clash of the C–H bond with the methionine gatekeeper and/or to effects on the conformation of the hinge-binding primary amide. Pyrazolopyridines <b>3b</b>,<b>c</b> were potent and moderately stable in HLM as well as HH, with small substituents such as methoxy having minimal effects on these parameters. Indazole <b>3d</b> maintained similar potency compared to compound <b>2e</b> with the pyridyl central ring. This, in combination with an observed biaryl torsion of ∼19° for <b>2f</b> shown previously when bound to mNIK, implies that our initial concerns around controlling the dihedral angle to match the benzoxazepin series were not well-founded.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical and Cellular Potency and Metabolic Stability Data for Select Analogs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for assay details.</p></div></div><div></div></div><div class="NLM_p">Imidazopyridines were designed as indazole replacements, maintaining the necessary nitrogen placement to control the conformation of the primary amide. Imidazopyridine <b>3f</b> was significantly less potent than indazole comparator <b>3d</b> (NF-κB IC<sub>50</sub> = 500 ± 64 nM vs 29 ± 9 nM, respectively). However, this compound had promising in vitro stability, with a predicted hepatic clearance of 2.5 mL min<sup>–1</sup> kg<sup>–1</sup> determined in HH. The alternative imidazopyridine isomer, however, was significantly more potent. With NIK <i>K</i><sub>i</sub> = 0.05 nM and NF-κB IC<sub>50</sub> = 4.7 ± 2.7 nM, <b>3i</b> was the most potent compound from this set. Unfortunately, despite favorable lipophilicity (log <i>D</i><sup>pH7.4</sup> < 3), all compounds including this imidazopyridine isomer were labile in HLM and HH.</div><div class="NLM_p">Compound <b>3d</b> was selected for further profiling due to its favorable potency profile and moderate clearance in HLM and HH. Metabolites were analyzed after 3 h incubation with HH.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> GSH conjugation to the parent molecule was greatly reduced, which we anticipate to be a result of a less electron withdrawing central phenyl ring. However, the total rate of clearance of <b>3d</b> (HH CL<sub>hep</sub> = 13 mL min<sup>–1</sup> kg<sup>–1</sup>) remained a concern. The major metabolite observed from this study was amide hydrolysis.</div><div class="NLM_p">We next put effort toward a further reduction in clearance and increased potency by expansion of the five-membered heteroaromatic ring. We hypothesized the enzymatic hydrolysis of the primary amide could be altered by modifying the adjacent electronic, steric, and/or polar environment. In addition, ligand-based overlays predicted expansion of the five-membered heteroarene would move this key primary amide in more optimal H-bonding distance to the hinge. Data for these analogs (compounds <b>4</b>) are presented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Replacement of the core with a simple phenyl ring was not well-tolerated (<b>4a</b>, NIK <i>K</i><sub>i</sub> = 68 nM, LLE = 5.6) suggesting nonoptimal low energy torsions at the biaryl and/or amide C–C bonds. Inclusion of 2,5-subsituted pyrazine and 2,4-substituted pyrimidine in analogs <b>4b</b> and <b>4c</b> resulted in single-digit nM values in the NIK biochemical assay; however these did not have the desired level of potency in the cell-based NF-κB reporter assay. The isomeric 2,4-substituted pyrimidine and 2-amidopyridines <b>4d</b>–<b>f</b> had improved overall profiles.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Data for Compounds <b>4</b> with Six-Membered R<sup>1</sup> Substitution<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">See <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for assay details.</p></div></div><div></div></div><div class="NLM_p">Analogs with these substructures consistently inhibited NIK in the biochemical assay with <i>K</i><sub>i</sub> values of <1 nM. Among these, 4-methoxy-2-amidopyridine <b>4f</b> had the best cell-based activity (NF-κB reporter IC<sub>50</sub> = 34 ± 6 nM). Notably, predicted hepatic clearance of <b>4f</b> from in vitro HLM and HH experiments was improved relative to above indazole <b>3d</b>. Additional potency was achievable within this subseries, albeit at the cost of kinase selectivity. Quinazoline <b>4g</b> and 3-amino-2-amidopyridine <b>4h</b> were particularly potent in the NF-κB reporter assay (IC<sub>50</sub> = 10 ± 5 nM and 16 ± 5 nM, respectively). However, these inhibitors lost significant selectivity against the kinome.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>4f</b> possessed the combination of cell-based potency and improved liver microsome stability to profile further for progression to in vivo studies.</div><div class="NLM_p">Additional data for compound <b>4f</b> are dislpayed in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Consistent with expectations for a NIK inhibitor, <b>4f</b> was shown to inhibit nuclear translocation of p52 (RelB) (IC<sub>50</sub> = 70 nM). Importantly, nuclear translocation of canonical NF-κB marker RelA was not influenced up to 20 μM test concentration, suggesting high selectivity for inhibition of noncanonical NF-κB signaling.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Kinase selectivity was very high as <b>4f</b> inhibited only KHS1 > 50% in a 228 panel of kinases tested at 0.100 μM (>400-fold NIK <i>K</i><sub>i</sub>; see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">Supporting Information</a>). Moderate to good hepatic clearance was predicted across species based on incubation with liver microsomes and hepatocytes. This molecule had a high measured kinetic solubility (139 μM) and moderate passive permeability as determined against a Madin–Darby canine kidney line (MDCK, <i>P</i><sub>app</sub>(A–B = 7.3 × 10<sup>–6</sup> cm/s) which predicted high bioavailability upon oral dosing. In a metabolite identification experiment, amide hydrolysis was substantially reduced for <b>4f</b> relative to compound <b>3d</b> and GSH conjugation was not observed.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Due to these favorable in vitro properties, <b>4f</b> was further profiled in pharmacokinetic studies. In vivo clearance values generally correlated well with predicted clearance in the microsomal and hepatocyte assays (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Moderate to excellent bioavailability was observed across species.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Profile of Compound <b>4f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0016.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>4f</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NIK ADP-FP K<sub>i</sub> (nM)/LLE</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.17 (<i>n</i> = 2)/7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NFκB-LUC IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">0.034 ± 6 (<i>n</i> = 7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HeLa p52/HeLa RelA (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.070 ± 0.048 (<i>n</i> = 5)/>20 (<i>n</i> = 8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW/log <i>D</i>/TPSA</td><td class="colsep0 rowsep0" align="left">365/1.9/105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM CL<sub>hep</sub> (H/R/M/D/C)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.5/21/53/16/19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hep CL<sub>hep</sub> (H/R/M/D/C)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.8/18/38/21/17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Kinetic solubility (μM)</td><td class="colsep0 rowsep0" align="left">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK (A to B)/(B to A)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">7.30/10.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma protein binding % (H/R/M)</td><td class="colsep0 rowsep0" align="left">84.9/90.1/95.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">Supporting Information</a> for experimental details.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Units of mL min<sup>–1</sup> kg<sup>–1</sup>.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Units of 10<sup>–6</sup> cm/s</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo PK Data for <b>4f</b> across Multiple Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">SD rat</th><th class="colsep0 rowsep0" align="center">CD-1 mouse</th><th class="colsep0 rowsep0" align="center">beagle</th><th class="colsep0 rowsep0" align="center">cynomologous monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intravenous Cl<sub>p</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.35</td><td class="colsep0 rowsep0" align="left">1.58</td><td class="colsep0 rowsep0" align="left">0.778</td><td class="colsep0 rowsep0" align="left">1.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">formulation</td><td class="colsep0 rowsep0" align="left">susp in corn oil</td><td class="colsep0 rowsep0" align="left">susp in MCT</td><td class="colsep0 rowsep0" align="left">susp in MCT</td><td class="colsep0 rowsep0" align="left">susp in MCT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Dosed orally at 5 mg/kg.</p></div></div></div><div class="NLM_p">We also examined the pharmacology of compound <b>4f</b> in isolated mouse and human primary B-cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). As expected, compound <b>4f</b> inhibits BAFF stimulated B cell survival in mouse B cells in a concentration dependent manner (IC<sub>50</sub> = 373 nM). Human B cell proliferation was similarly affected.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4f</b> inhibits BAFF-induced B cell (mouse) survival in vitro. Splenic mouse B cells were cultured with mouse rBAFF for 4 days. B cell survival was measured by Cell Titer Glo (Promega). Mean and standard deviation of three biological replicates are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dose-dependent inhibition of B cell survival was also observed in vivo (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). C57BL/6 mice were treated twice daily for 7 days with orally administered <b>4f</b> or with three injections of recombinant BAFF receptor fusion protein (Br3-mIgG2a) over the course of the 7-day experiment as a positive control. Compound <b>4f</b> serum levels at the highest doses met our goal of exceeding the in vitro determined IC<sub>90</sub> concentration, suggesting that complete or near-complete target coverage had been reached. We hypothesize that the nonlinearity of exposure relative to dose between 100 and 200 mg/kg is a result of saturation of clearance mechanisms. Marginal zone B cells, which are highly dependent on BAFF signaling for their survival, were greatly reduced by compound <b>4f</b> treatment. Marginal zone B cells (B220<sup>+</sup> CD21<sup>high</sup> CD23<sup>low</sup>) were monitored by flow cytometry. At the highest dose, where IC<sub>90</sub> coverage was maintained, NIK inhibition and BAFF blockade reduced marginal zone B cells with similar effect.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>4f</b> inhibits BAFF signaling in vivo. (A, B) NIK inhibition reduces marginal zone B cell (B220+ CD5– CD21high CD23low) frequency (A) and number (B). (C) Terminal free plasma concentration of compound <b>4f</b>. IC<sub>50</sub>, IC<sub>70</sub>, and IC<sub>90</sub> levels were determined based on in vitro mouse B cell survival assay results (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Data are represented as the mean ± standard deviation of 4–5 mice per group. Statistics are with unpaired <i>t</i> test with Welch’s correction (GraphPad Prism software): (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01, (∗∗∗) <i>p</i> < 0.001, (∗∗∗∗) <i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Key propargyl alcohol (<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one (<b>8</b>) was synthesized following the route depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Readily available 4-amino-2-hydroxybutanoic acid (<b>5</b>) was Boc-protected, converted to the methyl ester, and <i>N</i>-alkylated to deliver <b>6</b> in 40% overall yield. Oxidation with Dess–Martin periodinane (DMP) followed by treatment with ethynylmagnesium bromide delivered precursor <b>7</b>. Removal of the Boc protecting group under acidic conditions followed by cyclization under basic conditions gave racemic <b>8</b> which was resolved via chiral SFC (20% mass yield, 40% of theoretical).</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>R</i>)-3-Ethynyl-3-hydroxy-1-methylpyrrolidin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Boc<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 0°C to rt; (b) HOBT, EDCI, methanol 0 °C to rt; (c) TBSCl, imidazole, CH<sub>2</sub>Cl<sub>2,</sub> 0 °C to rt; (d) MeI, NaH, DMF, 0 °C to rt; (e) TBAF, THF, 0 °C to rt (40% yield over 5 steps); (f) DMP (1.4 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C – rt (87% yield); (g) ethynylmagnesium bromide (0.5 M in THF), THF, −70 °C (76% yield); (h) TFA, CH<sub>2</sub>Cl<sub>2</sub> followed by Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (i) Chiral SFC, CHIRALPAK IC, 20% yield over two steps.</p></p></figure><div class="NLM_p">Compounds in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were generally prepared by S<sub>N</sub>Ar reaction with 2-chloro-4-iodopyridine. Example routes are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Pyrazole-3-carboxylates <b>9a</b> and <b>9b</b> were reacted with 2-chloro-4-iodopyridine to give 2-pyrazolopyridines <b>10</b>. Amidation with ammonium chloride in the presence of HATU preceded Sonogashira coupling with (<i>R</i>)-<b>8</b> to give <b>2c</b> and <b>2d</b> in good yield. Indazole-3-carboxylates <b>11</b> were transformed to <b>2e</b> and <b>2f</b> through a similar three-step process.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>2c</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 2-Chloro-4-iodopyridine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (b) NH<sub>4</sub>Cl, HATU, DIPEA, THF, rt; (c) compound (<i>R</i>)-<b>8</b> (2–3 equiv), CuI (0.05 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.05–0.1 equiv), TEA, DMF, MeCN, 80°C [90% yield of <b>2c</b>, 66% yield of <b>2d</b>, 67% yield of <b>2e</b>, 37% yield of <b>2f</b>].</p></p></figure><div class="NLM_p">Indazoles <b>3d</b> and <b>3e</b> were prepared by Chan–Lam <i>N</i>-arylation with 3-halophenylboronic acids, followed by copper-free Sonogashira coupling with (<i>R</i>)-<b>8</b> and amidation with saturated ammonia in methanol (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Intermediate <b>18</b> proved useful for the preparation of many analogs presented in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, including <b>4b</b> and <b>4f</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Treatment of 3-iodophenylboronic acid with potassium hydrogen fluoride delivered potassium trifluoroborate <b>17</b>. Sonogashira reaction with (<i>R</i>)-<b>8</b> proceeded to give 90% isolated yield of key intermediate <b>18</b>. Compound <b>4b</b> was prepared by Suzuki coupling of intermediate <b>18</b> with methyl-2-chloro-6-carboxypyrazine (<b>19</b>) followed by conversion of the ester to primary amide by action of saturated ammonia in methanol. Compound <b>4f</b> was similarly prepared by Suzuki coupling of <b>18</b> with <b>21</b> (50% yield).</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>3d</b> and <b>3e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 3-Bromophenylboronic acid, Cu(OAc)<sub>2</sub>, pyridine, THF, oxygen atmosphere, 50–90 °C (43% of <b>14a</b>, 14% of <b>14b</b>); (b) compound (<i>R</i>)-<b>8</b> (2 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.3 equiv), TEA, DMSO, microwave at 90 °C (74% of <b>15a</b>, 60% of <b>15b</b>); (c) NH<sub>3</sub>, MeOH, 40 °C (40% of <b>3d</b>, 47% of <b>3e</b>).</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>4b</b> and <b>4f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) KHF<sub>2</sub>, water, rt; (b) compound (<i>R</i>)-<b>8</b> (1.10 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv), CuI (0.1 equiv) TEA, DMF, 40 °C (90%); (c) compound <b>18</b> (1–2 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub>, water, 90 °C (52% yield of <b>20</b>, 57% yield of <b>4f</b>); (d) NH<sub>3</sub>, methanol, 40 °C (50% yield of <b>4b</b>).</p></p></figure><div class="NLM_p last">The syntheses and characterization of all additional exemplified compounds have been reported elsewhere.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary we described a structure-guided scaffold-hopping campaign resulting in the discovery and evaluation of several new classes of NIK inhibitors. We found that removal of the oxepin ring from our previously disclosed benzoxepin class was well-tolerated and increased synthetic access to potent and selective compounds with expanded structural diversity. Nonoxidative metabolism (GSH addition and amide hydrolysis) was minimized through careful modification of neighboring functionality, substantially decreasing in vitro clearance. Compound <b>4f</b> was identified as a highly potent and selective NIK inhibitor with suitable properties for advanced ADME and pharmacology experiments. This compound inhibits BAFF induced B cell survival in vitro and splenic marginal zone B cells in a dose/concentration-dependent manner. Additional pharmacology for compounds <b>3d</b> and <b>4f</b> are reported elsewhere.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry. General Methods</h3><div class="NLM_p last">All commercially available reagents and solvents were used as received. Reactions using air or moisture sensitive reagents were performed under an atmosphere of nitrogen using freshly opened solvents. Reaction progress was monitored by TLC or LC–MS. Flash column chromatography was performed with Isco CombiFlash Companion systems using prepacked silica gel columns (40–60 μm particle size RediSep or 20–40 μm spherical silica gel RediSep Gold columns or similar columns from other vendors). Preparative reverse phase HPLC purifications were typically performed using a Phenomenex Gemini-NX C-18 (3 cm × 5 cm; 5 μm) stationary phase, with 0.1% aqueous formic acid in acetonitrile or 0.1% aqueous ammonium hydroxide in acetonitrile gradients as the mobile phase (typically 5–85% acetonitrile over 10 min) with a flow rate of 60 mL/min. NMR spectra were measured on Bruker 300, 400, or 500 MHz spectrometer, and chemical shifts were reported in ppm downfield from TMS using residual nondeuterated solvent as internal standards (CHCl<sub>3</sub>, 7.26 ppm; DMSO, 2.50 ppm; MeOH, 3.31 ppm). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. The purity of final compounds was verified by LC–MS (3 min run) and <sup>1</sup>H NMR (Bruker 300, 400, or 500 MHz spectrometer) to be ≥95% in all cases. The syntheses and characterization of all listed compounds have been reported elsewhere.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 5-Cyclopropyl-1-[4-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]-2-pyridyl]pyrazole-3-carboxamide (<b>2c</b>)</h3><div class="NLM_p"><i>Step 1.</i> 5-Cyclopropyl-1-(4-iodo-2-pyridyl)pyrazole-3-carboxylic acid (240 mg, 0.676 mmol) and HATU (393 mg, 1.014 mmol, 1.5 equiv) were weighed out and transferred to a vial to which DMF (2.7 mL) and DIPEA (0.6 mL, 3.379 mmol, 5 equiv) were subsequently added. Ammonium chloride (253 mg, 4.731 mmol, 7 equiv) was added to the reaction mixture, and the reaction was stirred at room temperature for 1 h. Reaction conversion was monitored by LC–MS. Upon completion, the reaction was cooled and the crude product was extracted with saturated ammonium chloride and ethyl acetate. Purification by flash chromatography afforded 100 mg (42% yield) of 5-cyclopropyl-1-(4-iodo-2-pyridyl)pyrazole-3-carboxamide.</div><div class="NLM_p last"><i>Step 2.</i> 5-Cyclopropyl-1-(4-iodo-2-pyridyl)pyrazole-3-carboxamide (70 mg, 0.198 mmol) was transferred to a sealed tube and brought up in DMF (0.6 mL) and triethylamine (0.6 mL). The solution was degassed with nitrogen, and copper(I) iodide (1.9 mg, 0.010 mmol, 0.05 equiv) and bis(triphenylphosphine)palladium(II) chloride (6.9 mg, 0.010 mmol, 0.05 equiv) were added. (3<i>R</i>)-3-Ethynyl-3-hydroxy-1-methylpyrrolidin-2-one was added, and the reaction mixture was heated for 1 h at 80 °C and monitored by LC–MS for consumption of starting material. Upon completion, the reaction was cooled and the crude product was extracted with saturated ammonium chloride and DCM whereupon the organic layer was dried with sodium sulfate, filtered, and concentrated to dryness. The crude product was purified by reverse phase HPLC to afford 65 mg of the title compound (90% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.54 (dd, <i>J</i> = 5.2, 0.9 Hz, 1H), 7.98–7.94 (m, 1H), 7.78 (s, 1H), 7.44 (dd, <i>J</i> = 5.1, 1.4 Hz, 1H), 7.31 (s, 1H), 6.64 (s, 1H), 6.48 (s, 1H), 3.41–3.35 (m, 2H), 2.81 (s, 3H), 2.49–2.42 (m, 1H), 2.27–2.17 (m, 1H), 1.12 (t, <i>J</i> = 7.3 Hz, 1H), 1.01–0.94 (m, 2H), 0.77–0.69 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 170.69, 163.25, 153.39, 149.76, 148.90, 148.00, 132.97, 124.59, 118.92, 104.91, 95.88, 81.51, 70.46, 46.13, 45.00, 36.22, 30.38, 9.39, 8.71. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>O<sub>3</sub>N<sub>5</sub> (M + H)<sup>+</sup> 366.1561, found 366.1551.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1-[4-[2-[(3<i>R</i>)-3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]-2-pyridyl]-4,5,6,7-tetrahydroindazole-3-carboxamide (<b>2d</b>)</h3><div class="NLM_p last">A solution of 1-(4-iodo-2-pyridyl)-4,5,6,7-tetrahydroindazole-3-carboxylic acid (<b>10b</b>, 70 mg, 0.19 mmol) in tetrahydrofuran (1.2 mL) was treated with ammonium chloride (6.0 equiv, 61 mg, 1.1 mmol) and <i>N,N</i>-diisopropylethylamine (6.0 equiv, 0.20 mL, 1.1 mmol) followed by HATU (2.0 equiv, 146 mg, 0.38 mmol) . The reaction was stirred at room temperature overnight. A solution of saturated sodium bicarbonate was added, and the mixture was extracted 3 times with dichloromethane. The organic layers were combined, dried with sodium sulfate, and concentrated under vacuum. The crude material was purified by flash chromatography (Silicycle HP, 1–10% methanol in dichloromethane) to afford a light yellow solid. 1-(4-Iodo-2-pyridyl)-4,5,6,7-tetrahydroindazole-3-carboxamide was reacted with (3<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one ((<i>R</i>)-<b>8</b> to give 44 mg of the title compound (<b>2d</b>, 66%). M + H = 380.0; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.54–8.40 (m, 1H), 8.06 (d, <i>J</i> = 1.3 Hz, 1H), 7.76 (br s, 1H), 7.34 (dd, <i>J</i> = 5.3, 1.4 Hz, 1H), 7.23 (br s, 1H), 6.62 (s, 1H), 3.43–3.34 (m, 2H), 3.10 (t, <i>J</i> = 6.0 Hz, 2H), 2.81 (s, 3H), 2.70 (t, <i>J</i> = 5.8 Hz, 2H), 2.48–2.41 (m, 1H), 2.28–2.15 (m, 1H), 1.83–1.59 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 170.71, 164.37, 153.44, 148.79, 144.53, 141.93, 132.87, 123.73, 120.44, 116.73, 95.60, 81.67, 70.45, 45.00, 36.24, 30.38, 25.63, 22.68, 22.43, 21.86. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>O<sub>3</sub>N<sub>5</sub> (M + H)<sup>+</sup> 380.1717, found 380.1711.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-[4-[2-[(3<i>R</i>)-3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]-2-pyridyl]indazole-3-carboxamide (<b>2e</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of crude 1-(4-iodo-2-pyridyl)indazole-3-carboxylic acid (1.0 equiv, 0.56 mmol, 205 mg) in THF (3.6 mL) were added ammonium chloride (6.0 equiv, 181 mg, 3.37 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (6.0 equiv, 0.59 mL, 3.37 mmol) followed by HATU (2.0 equiv, 431 mg, 1.12 mmol). The reaction was stirred at room temperature overnight whereupon a saturated bicarbonate solution was added and the mixture was extracted with dichloromethane (3×). The organic layers were combined, dried over sodium sulfate, concentrated, and purified by flash chromatography (EtOAc in heptanes) to afford 124 mg (61%) of 1-(4-iodo-2-pyridyl)indazole-3-carboxamide as a white solid.</div><div class="NLM_p last"><i>Step 2.</i> A solution of 1-(4-iodo-2-pyridyl)indazole-3-carboxamide (1.0 equiv, 60 mg, 0.17 mmol) in diisopropylamine (18.6 equiv, 0.43 mL, 3.06 mmol) and <i>N</i>,<i>N</i>-dimethylformamide (0.2 mL) was sparged with nitrogen gas. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.05 equiv, 5.90 mg, 0.008 mmol) and copper(I) iodide (0.05 equiv, 1.5 mg, 0.008 mmol) were added under inert atmosphere, followed by (<i>R</i>)-<b>8</b> (1.2 equiv, 27.5 mg, 0.20 mmol). The reaction was heated to 80 °C for 1 h, then cooled to room temperature. The reaction mixture was then diluted with dichloromethane, filtered over Celite, and purified by reverse-phase HPLC to afford 41.2 mg (67%) of the titled compound as a white solid. M + H = 376.0; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.83–8.75 (m, 1H), 8.63–8.58 (m, 1H), 8.35–8.24 (m, 3H), 7.68–7.57 (m, 2H), 7.43 (ddd, <i>J</i> = 8.0, 7.1, 0.9 Hz, 1H), 7.38 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 6.65 (s, 1H), 3.45–3.35 (m, 2H), 2.83 (s, 3H), 2.54–2.46 (m, 1H), 2.24 (dt, <i>J</i> = 12.9, 7.1 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 170.14, 163.13, 153.45, 148.46, 140.52, 139.40, 132.43, 128.47, 124.07, 123.96, 122.74, 122.23, 115.11, 115.09, 95.06, 81.22, 69.91, 44.45, 35.72, 29.82. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>O<sub>3</sub>N<sub>5</sub> (M + H)<sup>+</sup> 376.1404, found 376.1397.</div></div><div id="sec5_1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 5-Fluoro-1-[4-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]-2-pyridyl]indazole-3-carboxamide (<b>2f</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of crude 5-fluoro-1-(4-iodo-2-pyridyl)indazole-3-carboxylic acid (1.0 equiv, 1.11 mmol, 425 mg) in THF (7.2 mL) were added ammonium chloride (6.0 equiv, 358 mg, 6.7 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (6.0 equiv, 1.16 mL, 6.7 mmol) followed by HATU (2.0 equiv, 852 mg, 2.22 mmol). The reaction was stirred at room temperature overnight whereupon a saturated bicarbonate solution was added and the mixture was extracted 3 times with dichloromethane. The organic layers were combined with the filtered aqueous phase, dried over sodium sulfate, concentrated, and recrystallized from dichloromethane to afford 424 mg (quantitative yield) of 5-fluoro-1-(4-iodo-2-pyridyl)indazole-3-carboxamide as a white solid. This was used in the next step without further purification.</div><div class="NLM_p last"><i>Step 2.</i> A solution of 5-fluoro-1-(4-iodo-2-pyridyl)indazole-3-carboxamide (1.0 equiv, 120 mg, 0.28 mmol) in triethylamine (0.73 mL) and <i>N</i>,<i>N</i>-dimethylformamide (0.37 mL) was sparged with nitrogen gas. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.05 equiv, 10.1 mg, 0.014 mmol) and copper(I) iodide (0.05 equiv, 2.7 mg, 0.014 mmol) were added under inert atmosphere, followed by (<i>R</i>)-<b>8</b> (1.2 equiv, 47.2 mg, 0.34 mmol). The reaction was heated to 80 °C for 1 h, then cooled to room temperature. The reaction mixture was diluted with dichloromethane, filtered over Celite, and purified by reverse-phase HPLC to afford 41.2 mg (37.1%) of the titled compound as a colorless solid. M + H = 394.0; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.81 (dd, <i>J</i> = 9.4, 4.5 Hz, 1H), 8.61 (dd, <i>J</i> = 5.1, 0.7 Hz, 1H), 8.34 (br s, 1H), 8.27 (d, <i>J</i> = 1.1 Hz, 1H), 7.94 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 7.67 (br s, 1H), 7.54 (td, <i>J</i> = 9.2, 2.6 Hz, 1H), 7.40 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 6.65 (s, 1H), 3.45–3.34 (m, 2H), 2.82 (s, 3H), 2.53–2.45 (m, 1H), 2.24 (dt, <i>J</i> = 13.5, 7.1 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.69, 163.42, 159.27 (d, <i>J</i> = 240.3 Hz), 153.70, 149.02, 140.68 (d, <i>J</i> = 5.8 Hz), 136.97, 133.12, 125.08 (d, <i>J</i> = 10.4 Hz), 123.59, 118.20 (d, <i>J</i> = 26.5 Hz), 117.57 (d, <i>J</i> = 9.1 Hz), 115.52, 106.90 (d, <i>J</i> = 24.2 Hz), 95.75, 81.72, 70.49, 45.02, 36.28, 30.39. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>O<sub>3</sub>N<sub>5</sub>F (M + H)<sup>+</sup> 394.1310 found 394.1301.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>R</i>)-1-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-1<i>H</i>-indazole-3-carboxamide (<b>3d</b>)</h3><div class="NLM_p last">A solution of methyl 1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15a</b>, 130 mg, 0.33 mmol) in methanol (saturated with ammonia, 20 mL) was stirred overnight at 40 °C. The resulting mixture was concentrated under vacuum. The crude product was purified by preparative HPLC with the following conditions: column, Xselect C18 19 mm × 150 mm; mobile phase, water with 0.05% NH<sub>3</sub> and MeCN (20.0% MeCN up to 35.0% in 8 min); detector, 254/220 nm. This resulted in 49.6 mg (40%) of 1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxamide (<b>3d</b>) as a white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 375 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.93 (s, 1H), 7.87–7.81 (m, 2H), 7.64–7.53 (m, 3H), 7.39 (t, <i>J</i> = 7.5 Hz, 1H), 3.51–3.45 (m, 2H), 2.94 (s, 3H), 2.65–2.57 (m, 1H), 2.38–2.28 (m, 1H). 171.15, 163.99, 140.30, 140.00, 139.76, 130.76, 130.69, 128.54, 125.99, 123.98, 123.86, 123.78, 123.42, 123.01, 111.46, 91.48, 83.46, 70.39, 45.00, 36.44, 30.36. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>19</sub>O<sub>3</sub>N<sub>4</sub> (M + H)<sup>+</sup> 375.1452 found 375.1446.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>R</i>)-5-Fluoro-1-(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-1<i>H</i>-indazole-3-carboxamide (<b>3e</b>)</h3><div class="NLM_p last">5-Fluoro-1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15b</b>, 35 mg, 0.09 mmol) in methanol (4 mL, saturated with ammonia) was stirred overnight at 40 °C. The resulting solution was concentrated under vacuum. The residue was purified by flash column chromatography, dichloromethane/methanol (50:1), to afford 15.7 mg (47%) of 5-fluoro-1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxamide (<b>3e</b>) as a white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 393 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00–7.93 (m, 2H), 7.89–7.83 (m, 2H), 7.66–7.58 (m, 2H), 7.41–7.37 (m, 1H), 3.52–3.46 (m, 2H), 2.95 (s, 3H), 2.65–2.59 (m, 1H), 2.38–2.31 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.56, 163.15, 158.41 (d, <i>J</i> = 239.2 Hz), 139.43 (d, <i>J</i> = 5.8 Hz), 138.95, 136.56, 130.47, 130.16, 125.49, 123.82 (d, <i>J</i> = 11.7 Hz), 123.25, 122.91, 117.26 (d, <i>J</i> = 27.0 Hz), 112.98 (d, <i>J</i> = 9.7 Hz), 106.27 (d, <i>J</i> = 24.4 Hz), 90.99, 82.80, 69.81, 44.43, 35.87, 29.79. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>18</sub>O<sub>3</sub>N<sub>4</sub> F(M + H)<sup>+</sup> 393.1357 found 393.1351.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>R</i>)-6-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)pyrazine-2-carboxamide (<b>4b</b>)</h3><div class="NLM_p last">A stirred solution of methyl 6-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)pyrazine-2-carboxylate (<b>20</b>, 106 mg, 0.30 mmol) in methanol (10 mL) was treated with saturated ammonia (>20 equiv) in methanol (10 mL). The resulting solution was stirred for 2 h at 40 °C and then concentrated under vacuum. The residue was purified by prep-HPLC with the following conditions (prep-HPLC-019): column, XBridge Prep C18 OBD column, 19 mm × 100 mm, 5 μm, 13 nm; mobile phase, water with 10 mmol of NH<sub>4</sub>HCO<sub>3</sub> and MeCN (30.0% MeCN up to 60.0% in 6 min); detector, UV 254/220 nm. This resulted in 50.4 mg (50%) of 6-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)pyrazine-2-carboxamide (<b>4b</b>) as a white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 337 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.35 (s, 1H), 9.22 (s, 1H), 8.40 (s, 1H), 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 7.64–7.55 (m, 2H), 3.54–3.48 (m, 2H), 2.96 (s, 3H), 2.66–2.60 (m, 1H), 2.38–2.31(m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.23, 165.61, 149.25, 144.77, 144.76, 142.61, 135.97, 133.75, 130.41, 129.87, 128.20, 123.18, 90.97, 84.06, 70.40, 45.00, 36.56, 30.36. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>17</sub>O<sub>3</sub>N<sub>4</sub> (M + H)<sup>+</sup> 337.1295 found 337.1291</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-6-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-4-methoxypicolinamide (<b>4f</b>)</h3><div class="NLM_p last">A 500 mL flask under inert atmosphere of nitrogen was charged with ethanol (300 mL), water (50 mL), 6-bromo-4-methoxypyridine-2-carboxamide (<b>21</b>, 14.4 g, 62.325 mmol), potassium (<i>S</i>)-trifluoro(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3yl)ethynyl)phenyl)borate (<b>18</b>, 20 g, 63 mmol, 1 equiv), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (4.37 g, 6.3 mmol, 0.10 equiv), sodium carbonate (13.2 g, 125 mmol, 2.0 equiv). The resulting solution was stirred overnight at 90 °C. The solids were removed by filtration and discarded. The resulting solution was concentrated under vacuum. The residue was purified by flash column chromatography, ethyl acetate/petroleum ether (100/1). The crude product was purified by reverse-phase column with the following conditions: column, XBridge Prep C18 OBD column, 50 mm × 200 mm, 25 μm, ∼35 nm; mobile phase, water with 10 mmol of NH<sub>4</sub>HCO<sub>3</sub> and MeCN (20.0% MeCN up to 40.0% in 30 min); detector, UV 254/220 nm. This resulted in 12.965 g (57%) of 6-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-4-methoxypyridine-2-carboxamide (<b>4f</b>) as an off-white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 366 [M + H]<sup>+</sup>.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (s, 1H), 8.30(s, 1H), 7.68 (s, 1H), 7.57–7.56 (m, 3H), 3.98 (s, 3H), 3.41 (m, 2H), 2.83 (s, 3H), 2.52–2.50 (m, 1H), 2.30–2.21 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.28, 168.04, 166.31, 156.34, 152.68, 138.64, 132.97, 130.22, 129.53, 128.21, 122.78, 109.09, 107.48, 90.59, 84.35, 70.40, 56.37, 45.01, 36.54, 30.35. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>O<sub>4</sub>N<sub>3</sub> (M + H)<sup>+</sup> 366.1448 found 366.1444.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of (<i>R</i>)-<b>8</b>: Methyl 4-((<i>tert</i>-Butoxycarbonyl)(methyl)amino)-2-hydroxybutanoate (<b>6</b>)</h3><div class="NLM_p"><i>Step 1.</i> A 100 L round-bottom flask was charged with a solution of 4-amino-2-hydroxybutanoic acid (<b>5</b>, 7 kg, 59 mol) and water (36 L). Potassium carbonate (25 kg, 3 equiv) was added followed by the addition of a solution of di-<i>tert</i>-butyl dicarbonate (14.5 kg, 1.1 equiv) in dioxane (23 mL) dropwise with stirring at 0–10 °C. The resulting solution was stirred overnight at 20–25 °C. The reaction mixture was washed with 10 L of ether (2×). The pH value of the aqueous phase was adjusted to 4–5 with 6 N hydrogen chloride, and the resulting solution was extracted with 15 L of ethyl acetate (4×). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated under vacuum to afford 7 kg (54%) of crude 4-[[(<i>tert</i>-butoxy)carbonyl]amino]-2-hydroxybutanoic acid as a yellow oil. This material was used in the subsequent step without purification. LC–MS (ES, <i>m</i>/<i>z</i>): 218 (M – 1).</div><div class="NLM_p"><i>Step 2.</i> A solution of 4-[[(<i>tert-</i>butoxy)carbonyl]amino]-2-hydroxybutanoic acid (7 kg, 32 mol, 1.00 equiv) in methanol (60 L) was treated with HOBT (6.5 kg, 1.5 equiv) and EDCI (9.2 kg, 1.5 equiv) followed by the addition of DIPEA (8.3 kg, 2.0 equiv) dropwise with stirring at 0–10 °C. The reaction mixture was allowed to warm to room temperature to stir for 2 h. The resulting mixture was then concentrated under vacuum to remove the methanol. The resultant residue was dissolved in 40 L of ethyl acetate, washed with water (20 L, 3×) and the organic layer was dried over anhydrous sodium sulfate and concentrated to afford 6 kg (81%) of crude methyl 4-[[(<i>tert</i>-butoxy)carbonyl]amino]-2-hydroxybutanoate as a yellow oil that was used in the next step without purification. LC–MS (ES, <i>m</i>/<i>z</i>): 234 (M + 1); 134 (M – 100 + 1).</div><div class="NLM_p"><i>Step 3.</i> A solution of methyl 4-[[(<i>tert</i>-butoxy)carbonyl]amino]-2-hydroxybutanoate (6 kg, 26 mol) in dichloromethane (45 L) was treated with imidazole (3.5 kg, 2.0 equiv), followed by a solution of <i>tert</i>-butyldimethylsilyl chloride (7.7 kg, 2.0 equiv) in dichloromethane (8 L) dropwise with stirring at 0–10 °C. The reaction mixture was warmed to room temperature to stir overnight. The resultant suspension was filtered and the filtrate concentrated under vacuum. The residue was purified by flash column chromatography, eluting with ethyl acetate/petroleum ether (1:50), to afford 8.5 kg (95%) of methyl 4-[[(<i>tert</i>-butoxy)carbonyl]amino]-2-[(<i>tert</i>-butyldimethylsilyl)oxy]butanoate as a yellow oil. LC–MS (ES, <i>m</i>/<i>z</i>): 348 (M + 1); 248 (M – 100 + 1).</div><div class="NLM_p"><i>Step 4.</i> The following reaction was run in 5 equivalent batches: A solution of methyl 4-[[(<i>tert</i>-butoxy)carbonyl]amino]-2-[(<i>tert</i>-butyldimethylsilyl)oxy]butanoate (1.2 kg, 3.5 mol, 1.0 equiv) in <i>N</i>,<i>N</i>-dimethylformamide (5 L) was treated with MeI (4.5 kg, 9.2 equiv), followed by portionwise addition of sodium hydride (300 g, 2.2 equiv, 60%) at 0–10 °C. The reaction mixture was allowed to warm to room temperature to stir for 8 h. The resulting solution was diluted with 20 L of H<sub>2</sub>O and extracted with ethyl acetate (10 L, 3×). The combined organic layers (from 5 batched reactions) were concentrated under vacuum to give 16 kg (crude) of methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-[(<i>tert</i>-butyldimethylsilyl)oxy]butanoate as a brown oil. LC–MS (ES, <i>m</i>/<i>z</i>): 362(M + 1); 262 (M – 100 + 1).</div><div class="NLM_p last"><i>Step 5.</i> A solution of crude methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-[(<i>tert</i>-butyldimethylsilyl)oxy]butanoate (16 kg, 35 mol) in tetrahydrofuran (50 L) was treated with TBAF (12.6 kg, 1.40 equiv) in tetrahydrofuran (10 L) slowly while stirring at 0–10 °C. The reaction mixture was allowed to warm to room temperature to stir for 2 h. The mixture was diluted with 60 L of water and extracted with ethyl acetate (30 L, 3×). The organics were combined and concentrated under vacuum. The residue was purified on a silica gel column eluting with ethyl acetate/petroleum ether (1:20) to afford 5.9 kg (98%) of methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-hydroxybutanoate (<b>6</b>) as a yellow oil [40% yield over 5 steps]. LC–MS (ES, <i>m</i>/<i>z</i>): 248 (M + 1); 148 (M – 100 + 1).</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl 2-(2-((<i>tert</i>-Butoxycarbonyl)(methyl)amino)ethyl)-2-hydroxybut-3-ynoate (<b>7</b>)</h3><div class="NLM_p"><i>Step 1.</i> A solution of methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-hydroxybutanoate (<b>6</b>, 5.9 kg, 24 mol) in dichloromethane (60 L) was treated with Dess–Martin reagent (14.2 kg, 1.4 equiv), portionwise, at 0–10 °C. The reaction mixture was allowed to warm to room temperature to stir 2 h. The mixture was diluted with 50 L of saturated NaHCO<sub>3</sub> and extracted with dichloromethane (25 L, 3×). The combined organics were concentrated under vacuum. The resultant residue was purified by flash column chromatography, eluting with ethyl acetate/petroleum ether (1/5), to afford 5.1 kg (87%) of methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-oxobutanoate as a yellow oil. LC–MS (ES, <i>m</i>/<i>z</i>): 246 (M + 1); 146 (M – 100 + 1).</div><div class="NLM_p last"><i>Step 2.</i> A solution of methyl 4-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]-2-oxobutanoate (144 g, 587 mmol) in tetrahydrofuran (5 L) was cooled to −70 °C. Bromo(ethynyl)magnesium (0.5 M in THF, 1.2 L, 1.0 equiv) was added slowly. The resulting solution was stirred at −70 °C for 20 min. The reaction mixture was then diluted with 5 L of saturated NH<sub>4</sub>Cl and extracted with ethyl acetate (5 L, 2×). The combined organics were concentrated under vacuum and the residue was purified by flash column chromatography, ethyl acetate/petroleum ether (1/5) to give methyl 2-(2-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]ethyl)-2-hydroxybut-3-ynoate as a brown oil (<b>7</b>, 76% yield). LC–MS (ES, <i>m</i>/<i>z</i>): 272 (M + 1); 172 (M – 100 + 1).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-3-Ethynyl-3-hydroxy-1-methylpyrrolidin-2-one (<b>8</b>)</h3><div class="NLM_p last">A solution of methyl 2-(2-[[(<i>tert</i>-butoxy)carbonyl](methyl)amino]ethyl)-2-hydroxybut-3-ynoate (<b>7</b>, 600 g, 2.2 mol) in dichloromethane (5 L) was treated with trifluoroacetic acid (0.9 L). The reaction mixture was stirred at room temperature for 2 h, concentrated under vacuum and the resultant residue dissolved in dichloromethane (5 L). Triethylamine (2.2 kg, 10 equiv) was added slowly while maintaining the reaction mixture at 0–10 °C. The mixture was warmed to room temperature to stir overnight. This reaction was batched 7 times, and the combined crude mixtures were purified by flash column chromatography, ethyl acetate/petroleum ether (1/1). The racemic <b>8</b> (450 g) was separated by chiral prep-SFC with the following conditions (prep SFC 350): column, CHIRALPAK IC SFC, 5 cm × 25 cm, 5 μm; mobile phase, CO<sub>2</sub> (65%), isopropyl acetate (0.2% DEA) (35%); detector, UV 220 nm, flow rate (g/min) 160; injection volume (mg, mL) 150 mg, 3.5 mL; column temperature, 35 °C to give 165.3 g (20%) of (3<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one ((<i>R</i>)-<b>8</b>) as a light brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, ppm): δ 3.6 (s, 1H); 3.48–3.31 (m, 2 H); 2.93 (s, 3H); 2.58–2.51 (m, 2H); 2.34–2.24 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.20, 84.48, 76.00, 69.72, 44.83, 36.34, 30.25.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-Cyclopropyl-1-(4-iodopyridin-2-yl)-1<i>H</i>-pyrazole-3-carboxylic Acid (<b>10a</b>)</h3><div class="NLM_p last">Similar as described for the synthesis of <b>10b</b>, 5-cyclopropyl-1<i>H</i>-pyrazole-3-carboxylic acid (<b>9a</b>, 200 mg) was reacted with 2-fluoro-4-iodopyridine to give 240 mg crude 5-cyclopropyl-1-(4-iodo-2-pyridyl)pyrazole-3-carboxylic acid (<b>10a</b>). The crude acid <b>10a</b> was used directly in the subsequent reaction.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-Iodopyridin-2-yl)-4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylic Acid (<b>10b</b>)</h3><div class="NLM_p last">A solution of 4,5,6,7-tetrahydro-1<i>H</i>-indazole-3-carboxylic acid (<b>9b</b>, 50 mg, 0.30 mmol) and cesium carbonate (3.0 equiv, 294 mg, 0.90 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (0.60 mL) was added 2-fluoro-4-iodopyridine (1.1 equiv, 74 mg, 0.33 mmol). The reaction mixture was heated to 100 °C and stirred at this temperature for 2 h. The reaction mixture was then cooled to room temperature and acidified to pH = 1 with 10% aqueous HCl solution. The solution was extracted twice with dichloromethane. The organic layers were combined, dried with sodium sulfate, and concentrated under vacuum. The crude acid <b>10b</b> was used directly in the subsequent reaction.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-Iodo-2-pyridyl)indazole-3-carboxylic Acid (<b>12a</b>)</h3><div class="NLM_p last">To a solution of methyl 1<i>H</i>-indazole-3-carboxylate (1.0 equiv, 100 mg, 0.57 mmol) and cesium carbonate (2.0 equiv, 370 mg, 1.14 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (1.1 mL) was added 2-fluoro-4-iodopyridine (1.1 equiv, 139 mg, 0.62 mmol). The reaction was heated to 100 °C for 3 h whereupon the reaction mixture was then acidified to pH 1 with 10% HCl and extracted with dichloromethane (3×). The organic layers were combined, dried over sodium sulfate, and concentrated to afford 205 mg of crude 1-(4-iodo-2-pyridyl)indazole-3-carboxylic acid which was used in the next step without purification.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-Fluoro-1-(4-iodo-2-pyridyl)indazole-3-carboxylic Acid (<b>12b</b>)</h3><div class="NLM_p last">To a solution of 5-fluoro-1<i>H</i>-indazole-3-carboxylic acid (1.0 equiv, 200 mg, 1.1 mmol) and cesium carbonate (3.0 equiv, 1090 mg, 3.33 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (2.2 mL) was added 2-fluoro-4-iodopyridine (1.1 equiv, 272 mg, 1.22 mmol). The reaction was heated to 100 °C and then cooled to room temperature. The solution was acidified to pH 1 with 10% HCl and extracted with dichloromethane 3 times. The organic layers were combined, dried over sodium sulfate, and concentrated to afford 425 mg (quantitative yield) of crude 5-fluoro-1-(4-iodo-2-pyridyl)indazole-3-carboxylic acid which was used in the next step without purification.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 1-(3-Bromophenyl)-1<i>H</i>-indazole-3-carboxylate (<b>14a</b>)</h3><div class="NLM_p last">In a 20 mL sealed tube purged and maintained with an atmosphere of oxygen, a suspension of methyl 1<i>H</i>-indazole-3-carboxylate (<b>13a</b>, 500 mg, 2.8 mmol), (3-bromophenyl)boronic acid (852 mg, 4.2 mmol, 1.5 equiv), and copper(II) acetate (155 mg, 0.85 mmol, 0.3 equiv) in <i>N</i>,<i>N</i>-dimethylformamide (5.7 mL) and pyridine (0.7 mL) was heated for 2 h at 90 °C. The resulting mixture was concentrated under vacuum and diluted with 10 mL of water. The mixture was extracted with ethyl acetate (90 mL), and the organic layers were combined and dried over anhydrous sodium sulfate. The residue was purified flash column chromatography, ethyl acetate/petroleum ether (1:20), to give 400 mg (43%) of methyl 1-(3-bromophenyl)-1<i>H</i>-indazole-3-carboxylate (<b>14a</b>) as a white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 331, 333 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 1-(3-Bromophenyl)-5-fluoro-1<i>H</i>-indazole-3-carboxylate (<b>14b</b>)</h3><div class="NLM_p last">A suspension of 5-fluoro-1<i>H</i>-indazole-3-carboxylate (<b>13b</b>, 200 mg, 1.0 mmol), (3-bromophenyl)boronic acid (311 mg, 1.6 mmol, 1.5 equiv), copper(II) acetate (56.3 mg, 0.31 mmol, 0.30 equiv), and pyridine (0.5 mL) in tetrahydrofuran (2 mL) was stirred under an oxygen atmosphere at 50 °C for 2 h. The precipitate was removed by filtration and the filtrate concentrated under vacuum. The residue was purified on a silica gel column eluting with ethyl acetate/petroleum ether (1:50) to give 50 mg (14%) of methyl 1-(3-bromophenyl)-5-fluoro-1<i>H</i>-indazole-3-carboxylate (<b>14b</b>) as an off-white solid. LC–MS (ES, <i>m</i>/<i>z</i>): 349 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl (<i>R</i>)-1-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15a</b>)</h3><div class="NLM_p last">In a 5 mL sealed tube purged and maintained with an atmosphere of nitrogen, a suspension of methyl 1-(3-bromophenyl)-1<i>H</i>-indazole-3-carboxylate (<b>14a</b>, 150 mg, 0.45 mmol), (3<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one ((<i>R</i>)-<b>8</b>) (126 mg, 0.91 mmol, 2.0 equiv), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (96 mg, 0.14 mmol, 0.30 equiv) in triethylamine (1 mL), and dimethyl sulfoxide (1 mL) was irradiated with microwave radiation for 1.5 h at 90 °C. The reaction was quenched by addition of 10 mL of saturated brine and extracted with ethyl acetate (90 mL). The organic layers were combined, washed with 20 mL of saturated brine, and dried over anhydrous sodium sulfate. Concentration under vacuum left a residue that was purified by a flash column chromatography, ethyl acetate/petroleum ether (1:1), to give 130 mg (74%) of methyl 1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15a</b>) as a yellow solid. LC–MS (ES, <i>m</i>/<i>z</i>): 390 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Methyl (<i>R</i>)-5-Fluoro-1-(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15b</b>)</h3><div class="NLM_p last">In a microwave vial purged and maintained with an inert atmosphere of nitrogen, a solution of methyl 1-(3-bromophenyl)-5-fluoro-1<i>H</i>-indazole-3-carboxylate (<b>14b</b>, 50 mg, 0.14 mmol), (3<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one ((<i>R</i>)-<b>8</b>) (39.5 mg, 0.28 mmol, 2.0 equiv), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (30 mg, 0.04 mmol, 0.3 equiv) in dimethylsulfoxide (1 mL) and triethylamine (1 mL) was heated with microwave radiation for 30 min at 90 °C. After completion, the mixture was diluted with ethyl acetate and the organic layer was washed with water then brine. The organic layer was dried over anhydrous sodium sulfate and concentrated under vacuum. The resultant residue was purified by flash column chromatography, ethyl acetate/petroleum ether (2:1), to afford 35 mg (60%) of methyl 5-fluoro-1-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)-1<i>H</i>-indazole-3-carboxylate (<b>15b</b>) as yellow oil. LC–MS (ES, <i>m</i>/<i>z</i>): 408 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Potassium (<i>S</i>)-Trifluoro(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3yl)ethynyl)phenyl)borate (<b>18</b>)</h3><div class="NLM_p"><i>Step 1.</i> The following reaction was run in two equal batches: A solution of KHF<sub>2</sub> (66.8 g, 855 mmol, 4.0 equiv) in water (212 mL) was added over 5 min to a solution of 3-iodophenylboronic acid (<b>16</b>, 53 g, 213 mmol) in MeOH (424 mL). The gel/suspension was stirred at room temperature for 2 h. The combined reactions were concentrated to remove methanol and placed in the fridge (2 °C) for 18 h. The solid was collected by filtration and washed with cold water (2 × 300 mL), hexanes (3 × 100 mL) and the solid dried under vacuum for 2 days to give a total of 141 g of potassium trifluoro-(3-iodophenyl)boranide (<b>17</b>) as a white solid; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.62 (s, 2H), 7.39 (d, <i>J</i> = 7.1 Hz, 1H), 7.30 (d, <i>J</i> = 7.1 Hz, 1H), 6.92 (t, <i>J</i> = 7.5 Hz, 1H).</div><div class="NLM_p last"><i>Step 2.</i> The following reaction was run in two equal batches: A suspension of potassium trifluoro-(3-iodophenyl)boranide (<b>17</b>, 29.75 g, 96 mmol), (<i>R</i>)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one ((<i>R</i>)-<b>8</b>) (14.7 g, 106 mmol, 1.1 equiv), and CuI (2.01 g, 10.6 mmol, 0.11 equiv) in DMF (147 mL) was treated with Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (7.4 g, 10.6 mmol, 0.11 equiv). The reaction mixture was sparged with nitrogen for 5 min. Triethylamine was then added (74 mL, 528 mmol, 5.5 equiv). The light brown solution was heated at 40 °C for 1.5 h. The mixture was concentrated and azeotroped with heptanes (2 × 250 mL). Water was added (350 mL) and stirred for 15 min, the precipitate was filtered, washed with water (2 × 50 mL) and the filtrate was concentrated. The mixture was azeotroped with acetone (2 × 250 mL) and dichloromethane (2 × 250 mL). Trituration with DCM (500 mL) for 1 h delivered a solid that was filtered, washed with dichloromethane (2 × 100 mL), and dried under vacuum for 18 h. The combined reactions gave 55.1 g (90%) of potassium (<i>S</i>)-trifluoro(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3yl)ethynyl)phenyl)borate (<b>18</b>) as a pale orange solid. LC–MS (ES, <i>m</i>/<i>z</i>): 280 [M – K]<sup>−</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.35 (bs, 1H), 7.32–7.28 (m, 1H), 7. 12–7.06 (m, 2H), 6.35 (s, 1H), 2.82–2.78 (m, 2H), 2.39 (td, <i>J</i> = 5.4 and 7.1 Hz, 1H), 2.14 (td, <i>J</i> = 5.2 and 7.5 Hz, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.19, 134.86, 131.79, 127.96, 126.41, 119.58, 87.77, 85.74, 69.81, 44.48, 36.26, 29.84. C-3 aryl carbon not observed. HRMS (ESI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>13</sub>O<sub>3</sub>N<sub>4</sub>B(boronic acid)<sup>+</sup> 260.1075 found 260.1081.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl (<i>R</i>)-6-(3-((3-Hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)phenyl)pyrazine-2-carboxylate (<b>20</b>)</h3><div class="NLM_p last">A solution of methyl 6-chloropyrazine-2-carboxylate (<b>19</b>, 100 mg, 0.58 mmol), potassium (<i>S</i>)-trifluoro(3-((3-hydroxy-1-methyl-2-oxopyrrolidin-3yl)ethynyl)phenyl)borate (<b>18</b>, 375 mg, 1.2 mmol, 2.0 equiv), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (41 mg, 0.06 mmol, 0.10 equiv), sodium carbonate (124 mg, 1.2 mmol, 2.0 equiv) in ethanol (10 mL) and water (1 mL) was sparged with nitrogen and then irradiated with microwave radiation for 1 h at 90 °C. The resulting mixture was concentrated under vacuum and then purified by flash column chromatography, dichloromethane/MeOH (20/1), to afford 106 mg (52%) of methyl 5-(3-[2-[(3<i>R</i>)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl)pyrazine-2-carboxylate (<b>20</b>) as a yellow solid. LC–MS (ES, <i>m</i>/<i>z</i>): 352 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00678" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00678" class="ext-link">10.1021/acs.jmedchem.8b00678</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Biochemical and cellular assay conditions, metabolic stability assay conditions, kinase selectivity data, crystallography details, pharmacokinetic study conditions, metabolite identification assays, and human B cell survival data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf">jm8b00678_si_001.pdf (567.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_002.csv">jm8b00678_si_002.csv (2.47 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Protein Data Bank codes are the following: <b>1a</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y">6G4Y</a>; <b>2f</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z">6G4Z</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00678" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole Blaquiere</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#107e79737f7c75727c7161657975627550777d71797c3e737f7d"><span class="__cf_email__" data-cfemail="cba5a2a8a4a7aea9a7aababea2aeb9ae8baca6aaa2a7e5a8a4a6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven T. Staben</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6137-6517" title="Orcid link">http://orcid.org/0000-0002-6137-6517</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91e2e5f0f3f4ffbfe2e5f4e7f4ffd1f6f4fff4bff2fefc"><span class="__cf_email__" data-cfemail="3a494e5b585f5414494e5f4c5f547a5d5f545f14595557">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgette M. Castanedo</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason D. Burch</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonid M. Berezhkovskiy</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Brightbill</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne Brown</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Connie Chan</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Po-Chang Chiang</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. Crawford</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6408-8246" title="Orcid link">http://orcid.org/0000-0002-6408-8246</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teresa Dong</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Fan</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianwen Feng</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Ghilardi</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Godemann</span> - <span class="hlFld-Affiliation affiliation">Evotec
AG,Manfred Eigen Campus,
Essener Bogen, Hamburg 22419, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Gogol</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alice Grabbe</span> - <span class="hlFld-Affiliation affiliation">Evotec
AG,Manfred Eigen Campus,
Essener Bogen, Hamburg 22419, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alison J. Hole</span> - <span class="hlFld-Affiliation affiliation">Evotec
AG,Manfred Eigen Campus,
Essener Bogen, Hamburg 22419, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baihua Hu</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah G. Hymowitz</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moulay Hicham Alaoui Ismaili</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hoa Le</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Lee</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wyne Lee</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingyu Lin</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Liu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. McEwan</span> - <span class="hlFld-Affiliation affiliation">Evotec
AG,Manfred Eigen Campus,
Essener Bogen, Hamburg 22419, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brent McKenzie</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hernani L. Silvestre</span> - <span class="hlFld-Affiliation affiliation">Evotec
AG,Manfred Eigen Campus,
Essener Bogen, Hamburg 22419, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Suto</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Swathi Sujatha-Bhaskar</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guosheng Wu</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawren C. Wu</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yamin Zhang</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoe Zhong</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3211-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Seth Harris from the structural biology group, as well as the Genentech analytical and purification groups, particularly Yanzhou Liu for NMR assistance.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">NIK</td><td class="NLM_def"><p class="first last">NF-κB inducing kinase</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">BAFF</td><td class="NLM_def"><p class="first last">B cell activating factor</p></td></tr><tr><td class="NLM_term">LTβR</td><td class="NLM_def"><p class="first last">lymphotoxin β receptor</p></td></tr><tr><td class="NLM_term">CD40</td><td class="NLM_def"><p class="first last">cluster of differentiation 40</p></td></tr><tr><td class="NLM_term">TWEAK</td><td class="NLM_def"><p class="first last">TNF-like weak inducer of apoptosis</p></td></tr><tr><td class="NLM_term">TRAF</td><td class="NLM_def"><p class="first last">TNF receptor-associated factor 2</p></td></tr><tr><td class="NLM_term">cIAP</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">TNFRSF</td><td class="NLM_def"><p class="first last">tumor necrosis factor receptor superfamily</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">ADP</td><td class="NLM_def"><p class="first last">adenosine diphosphate</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">KHS1</td><td class="NLM_def"><p class="first last">killer of heat sensitive</p></td></tr><tr><td class="NLM_term">mNIK</td><td class="NLM_def"><p class="first last">murine NIK</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HH</td><td class="NLM_def"><p class="first last">human hepatocyte</p></td></tr><tr><td class="NLM_term">CL<sub>hep</sub></td><td class="NLM_def"><p class="first last">hepatic clearance</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">mL</td><td class="NLM_def"><p class="first last">milliliter</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">kg</td><td class="NLM_def"><p class="first last">kilogram</p></td></tr><tr><td class="NLM_term">LM</td><td class="NLM_def"><p class="first last">liver microsome</p></td></tr><tr><td class="NLM_term">Hep</td><td class="NLM_def"><p class="first last">hepatocyte</p></td></tr><tr><td class="NLM_term">Kin</td><td class="NLM_def"><p class="first last">kinetic</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">cm</td><td class="NLM_def"><p class="first last">centimeter</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague Dawley</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">medium chain triglyceride</p></td></tr><tr><td class="NLM_term">DMP</td><td class="NLM_def"><p class="first last">Dess–Martin periodinane</p></td></tr><tr><td class="NLM_term">HOBT</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">TBSCl</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">adsorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">MHz</td><td class="NLM_def"><p class="first last">megahertz</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 18 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="note"><p class="first last">For leading references see the following:</p></div><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.+C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0lhqxduy-qidIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, A.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase: a key regulator in the immune system and in cancer</span>. <i>Cytokine Growth Factor Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.cytogfr.2010.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.cytogfr.2010.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=20685151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGjsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=213-226&author=Y.+M.+Thuauthor=A.+Richmond&title=NF-%CE%BAB+inducing+kinase%3A+a+key+regulator+in+the+immune+system+and+in+cancer&doi=10.1016%2Fj.cytogfr.2010.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase: A key regulator in the immune system and in cancer</span></div><div class="casAuthors">Thu, Yee Mon; Richmond, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-226</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NF-κB inducing kinase (NIK) is a kinase that activates the canonical and non-canonical NF-κB pathways to control transcriptional expression of certain proteins such as cytokines, chemokines and NF-κB signaling mols.  Many advances have been made in understanding the mol. mechanisms by which the stability of NIK is regulated to affect downstream signaling.  Genetic mouse models suggest that NIK plays an essential role in the regulation of the immune system as well as in the bone microenvironment.  Increasing evidence links NIK to the tumorigenesis of hematol. cancers, such as multiple myeloma, and solid tumors, such as pancreatic carcinoma and melanoma.  Understanding the mechanism by which NIK is de-regulated will potentially provide therapeutic options for certain diseases such as autoimmunity and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMtga85N1_7LVg90H21EOLACvtfcHk0lhqxduy-qidIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGjsbbL&md5=5a8cebc7e8423336295544bcc4aab2d8</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2010.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2010.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DY.%2BM.%26aulast%3DRichmond%26aufirst%3DA.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%253A%2520a%2520key%2520regulator%2520in%2520the%2520immune%2520system%2520and%2520in%2520cancer%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2010%26volume%3D21%26spage%3D213%26epage%3D226%26doi%3D10.1016%2Fj.cytogfr.2010.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cildir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-κB signaling in health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.molmed.2016.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=414-429&author=G.+Cildirauthor=K.+C.+Lowauthor=V.+Tergaonkar&title=Noncanonical+NF-%CE%BAB+signaling+in+health+and+disease&doi=10.1016%2Fj.molmed.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DCildir%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DK.%2BC.%26aulast%3DTergaonkar%26aufirst%3DV.%26atitle%3DNoncanonical%2520NF-%25CE%25BAB%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D414%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Regulation and function of NF-kappaB transcription factors in the immune system</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1146%2Fannurev.immunol.021908.132641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=19302050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=693-733&author=S.+Vallabhapurapuauthor=M.+Karin&title=Regulation+and+function+of+NF-kappaB+transcription+factors+in+the+immune+system&doi=10.1146%2Fannurev.immunol.021908.132641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of NF-κB transcription factors in the immune system</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">693-733</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The mammalian Rel/NF-κB family of transcription factors, including RelA, c-Rel, RelB, NF-κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100), plays a central role in the immune system by regulating several processes ranging from the development and survival of lymphocytes and lymphoid organs to the control of immune responses and malignant transformation.  The 5 members of the NF-κB family are normally kept inactive in the cytoplasm by interaction with inhibitors called IκBs or the unprocessed forms of NF-κB1 and NF-κB2.  A wide variety of signals emanating from antigen receptors, pattern-recognition receptors, receptors for the members of TNF and IL-1 cytokine families, and others induce differential activation of NF-κB heterodimers.  Although work over the past two decades has shed significant light on the regulation of NF-κB transcription factors and their functions, much progress has been made in the past two years revealing new insights into the regulation and functions of NF-κB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbeMOsSfPT7Vg90H21EOLACvtfcHk0lhqxduy-qidIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7o%253D&md5=9353fabd1673c6191220ef4acaf95c32</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132641%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRegulation%2520and%2520function%2520of%2520NF-kappaB%2520transcription%2520factors%2520in%2520the%2520immune%2520system%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D693%26epage%3D733%26doi%3D10.1146%2Fannurev.immunol.021908.132641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">The noncanonical NF-kappaB pathway</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">125</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2011.01088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1111%2Fj.1600-065X.2011.01088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22435551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyku73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=125&author=S.+C.+Sun&title=The+noncanonical+NF-kappaB+pathway&doi=10.1111%2Fj.1600-065X.2011.01088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">The noncanonical NF-κB pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-140, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The noncanonical nuclear factor-κB (NF-κB) signaling pathway mediates activation of the p52/RelB NF-κB complex and, thereby, regulates specific immunol. processes.  This NF-κB pathway relies on the inducible processing of NF-κB2 precursor protein, p100, as opposed to the degrdn. of IκBα in the canonical NF-κB pathway.  A central signaling component of the noncanonical NF-κB pathway is NF-κB-inducing kinase (NIK), which functions together with a downstream kinase, IKKα (inhibitor of NF-κB kinase α), to induce phosphorylation-dependent ubiquitination and processing of p100.  Under normal conditions, NIK is targeted for continuous degrdn. by a tumor necrosis factor (TNF) receptor-assocd. factor-3 (TRAF3)-dependent E3 ubiquitin ligase.  In response to signals mediated by a subset of TNF receptor superfamily members, NIK becomes stabilized as a result of TRAF3 degrdn., leading to the activation of noncanonical NF-κB.  This review discusses both the historical perspectives and the recent progress in the regulation and biol. function of the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqjkgMTubiLVg90H21EOLACvtfcHk0lgitBL1SJAvZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyku73K&md5=f857e411ec0f648f6d6171a984dcc394</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01088.x%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DThe%2520noncanonical%2520NF-kappaB%2520pathway%26jtitle%3DImmunol%2520Rev.%26date%3D2012%26volume%3D246%26spage%3D125%26doi%3D10.1111%2Fj.1600-065X.2011.01088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichardt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2011.01059.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1111%2Fj.1600-065X.2011.01059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22017430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFagsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2011&pages=44-54&author=B.+Razaniauthor=A.+D.+Reichardtauthor=G.+Cheng&title=Non-canonical+NF-kappaB+signaling+activation+and+regulation%3A+principles+and+perspectives&doi=10.1111%2Fj.1600-065X.2011.01059.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1fR"><div class="casContent"><span class="casTitleNuber">1f</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling activation and regulation: principles and perspectives</span></div><div class="casAuthors">Razani, Bahram; Reichardt, Anna Devi; Cheng, Genhong</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Nuclear-factor κB (NF-κB) transcription factors are activated by a wide variety of stimuli in diverse cell types and control key aspects of immune function and development.  Receptor-mediated activation of NF-κB appears to occur through two distinct signaling pathways termed as the canonical and non-canonical NF-κB pathways.  Although much work has demonstrated the physiol. importance of non-canonical NF-κB signaling to immunity and its involvement in diverse pathologies, such as cancers and autoimmune disease, the architecture and regulation of the pathway is only beginning to be understood.  The non-canonical pathway appears to be activated by a select set of receptors within the tumor necrosis factor superfamily, and we discuss the mol. mechanisms that connect ligation of these receptors to pathway activation.  It has become increasingly clear that the key regulatory step of the pathway involves modulation of the post-translational degrdn. of NF-κB-inducing kinase (NIK), the central activating kinase of non-canonical NF-κB signaling.  How NIK post-translational stability is controlled before and after receptor ligation is an important aspect of understanding non-canonical NF-κB signaling.  Furthermore, how release of NF-κB dimers downstream of the pathway's activation is actually connected to its identified physiol. and pathol. roles is a key remaining question in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjtZ3BYUJjrVg90H21EOLACvtfcHk0lgitBL1SJAvZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFagsL%252FK&md5=b4b7e40a5437602ea0a61aaa5577e1f3</span></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01059.x%26sid%3Dliteratum%253Aachs%26aulast%3DRazani%26aufirst%3DB.%26aulast%3DReichardt%26aufirst%3DA.%2BD.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DNon-canonical%2520NF-kappaB%2520signaling%2520activation%2520and%2520regulation%253A%2520principles%2520and%2520perspectives%26jtitle%3DImmunol%2520Rev.%26date%3D2011%26volume%3D244%26spage%3D44%26epage%3D54%26doi%3D10.1111%2Fj.1600-065X.2011.01059.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. J.</span></span> <span> </span><span class="NLM_article-title">Active and inactive protein kinases: structural basis for regulation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81092-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2FS0092-8674%2800%2981092-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=8612268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADyaK28XisFejs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=149-158&author=L.+N.+Johnsonauthor=M.+E.+M.+Nobleauthor=D.+J.+Owen&title=Active+and+inactive+protein+kinases%3A+structural+basis+for+regulation&doi=10.1016%2FS0092-8674%2800%2981092-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Active and inactive protein kinases: structural basis for regulation</span></div><div class="casAuthors">Johnson, Louise N.; Noble, Martin E. M.; Owen, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-58</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 37 refs., examg. structural information available for active and inactive forms of various protein kinases and relating the information to regulation of enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyGfpacKLdrVg90H21EOLACvtfcHk0lgitBL1SJAvZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFejs7o%253D&md5=aa92e06eb2c5f80208a2f2ff5243e2a6</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981092-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981092-2%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BJ.%26atitle%3DActive%2520and%2520inactive%2520protein%2520kinases%253A%2520structural%2520basis%2520for%2520regulation%26jtitle%3DCell%26date%3D1996%26volume%3D85%26spage%3D149%26epage%3D158%26doi%3D10.1016%2FS0092-8674%2800%2981092-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Krupa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span> <span> </span><span class="NLM_article-title">Structural modes of stablilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1039</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.jmb.2004.04.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2004&pages=1025-1039&author=A.+Krupaauthor=G.+Preethiauthor=N.+Srinivasan&title=Structural+modes+of+stablilization+of+permissive+phosphorylation+sites+in+protein+kinases%3A+distinct+strategies+in+Ser%2FThr+and+Tyr+kinases&doi=10.1016%2Fj.jmb.2004.04.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKrupa%26aufirst%3DA.%26aulast%3DPreethi%26aufirst%3DG.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DStructural%2520modes%2520of%2520stablilization%2520of%2520permissive%2520phosphorylation%2520sites%2520in%2520protein%2520kinases%253A%2520distinct%2520strategies%2520in%2520Ser%252FThr%2520and%2520Tyr%2520kinases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D339%26spage%3D1025%26epage%3D1039%26doi%3D10.1016%2Fj.jmb.2004.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harhaj, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">26243</span>– <span class="NLM_lpage">26250</span>, <span class="refDoi"> DOI: 10.1074/jbc.M403286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1074%2Fjbc.M403286200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=26243-26250&author=G.+Liaoauthor=M.+Zhangauthor=E.+W.+Harhajauthor=S.+C.+Sun&title=Regulation+of+the+NF-kappaB-inducing+kinase+by+tumor+necrosis+factor+receptor-associated+factor+3-induced+degradation&doi=10.1074%2Fjbc.M403286200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403286200%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHarhaj%26aufirst%3DE.%2BW.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520the%2520NF-kappaB-inducing%2520kinase%2520by%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520factor%25203-induced%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D26243%26epage%3D26250%26doi%3D10.1074%2Fjbc.M403286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignali, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1038/ni.1678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fni.1678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=18997792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1364-1370&author=S.+Vallabhapurapuauthor=A.+Matsuzawaauthor=W.+Zhangauthor=P.+H.+Tsengauthor=J.+J.+Keatsauthor=H.+Wangauthor=D.+A.+Vignaliauthor=P.+L.+Bergsagelauthor=M.+Karin&title=Nonredundant+and+complementary+functions+of+TRAF2+and+TRAF3+in+a+ubiquitination+cascade+that+activates+NIK-dependent+alternative+NF-kappaB+signaling&doi=10.1038%2Fni.1678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Keats, Jonathan J.; Wang, Haopeng; Vignali, Dario A. A.; Bergsagel, P. Leif; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1364-1370</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB-inducing kinase (NIK) for ubiquitin-dependent degrdn., thus preventing processing of the NF-κB2 precursor protein p100 to release p52.  However, the resp. functions of TRAF2 and TRAF3 in NIK degrdn. and activation of alternative NF-κB signaling have remained elusive.  We now show that CD40 or BAFF receptor activation result in TRAF3 degrdn. in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity.  Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2.  Degrdn. of TRAF3 prevented assocn. of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-κB2-p100 processing.  Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohqDvmlMG8NrVg90H21EOLACvtfcHk0lj4hBV_BfKcMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K&md5=37793636ab6dd59cfc73a923b5f22702</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fni.1678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1678%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTseng%26aufirst%3DP.%2BH.%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DVignali%26aufirst%3DD.%2BA.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNonredundant%2520and%2520complementary%2520functions%2520of%2520TRAF2%2520and%2520TRAF3%2520in%2520a%2520ubiquitination%2520cascade%2520that%2520activates%2520NIK-dependent%2520alternative%2520NF-kappaB%2520signaling%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1364%26epage%3D1370%26doi%3D10.1038%2Fni.1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarnegar, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1378</span>, <span class="refDoi"> DOI: 10.1038/ni.1676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fni.1676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=18997794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1371-1378&author=B.+J.+Zarnegarauthor=Y.+Wangauthor=D.+J.+Mahoneyauthor=P.+W.+Dempseyauthor=H.+H.+Cheungauthor=J.+Heauthor=T.+Shibaauthor=X.+Yangauthor=W.+C.+Yehauthor=T.+W.+Makauthor=R.+G.+Kornelukauthor=G.+Cheng&title=Noncanonical+NF-kappaB+activation+requires+coordinated+assembly+of+a+regulatory+complex+of+the+adaptors+cIAP1%2C+cIAP2%2C+TRAF2+and+TRAF3+and+the+kinase+NIK&doi=10.1038%2Fni.1676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK</span></div><div class="casAuthors">Zarnegar, Brian J.; Wang, Yaya; Mahoney, Douglas J.; Dempsey, Paul W.; Cheung, Herman H.; He, Jeannie; Shiba, Travis; Yang, Xiaolu; Yeh, Wen-chen; Mak, Tak W.; Korneluk, Robert G.; Cheng, Genhong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1371-1378</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent studies suggest that nuclear factor κB-inducing kinase (NIK) is suppressed via constitutive proteasome-mediated degrdn. regulated by TRAF2, TRAF3 and cIAP1 or cIAP2.  Here the authors demonstrated that the degrdn. of NIK occurs upon assembly of a regulatory complex via TRAF3 recruitment of NIK and TRAF2 recruitment of cIAP1 and cIAP2.  In contrast to TRAF2 and TRAF3, cIAP1 and cIAP2 seem to play redundant roles in the degrdn. of NIK, as inhibition of both cIAPs was required for noncanonical NF-κB activation and increased survival and proliferation of primary B lymphocytes.  Furthermore, the lethality of TRAF3 deficiency in mice could be rescued by a single NIK gene, highlighting the importance of tightly regulated NIK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLV9SGYvOx7Vg90H21EOLACvtfcHk0lj4hBV_BfKcMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsbrM&md5=66f315dca2be3608590b5d8bb9801f85</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fni.1676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1676%26sid%3Dliteratum%253Aachs%26aulast%3DZarnegar%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMahoney%26aufirst%3DD.%2BJ.%26aulast%3DDempsey%26aufirst%3DP.%2BW.%26aulast%3DCheung%26aufirst%3DH.%2BH.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYeh%26aufirst%3DW.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DNoncanonical%2520NF-kappaB%2520activation%2520requires%2520coordinated%2520assembly%2520of%2520a%2520regulatory%2520complex%2520of%2520the%2520adaptors%2520cIAP1%252C%2520cIAP2%252C%2520TRAF2%2520and%2520TRAF3%2520and%2520the%2520kinase%2520NIK%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1371%26epage%3D1378%26doi%3D10.1038%2Fni.1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation and TNFα-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=W.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-%CE%BAB+activation+and+TNF%CE%B1-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DW.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-%25CE%25BAB%2520activation%2520and%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.cell.2007.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Senftleben, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krähn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonizzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1126/science.1062677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1126%2Fscience.1062677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=11520989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1495-1499&author=U.+Senftlebenauthor=Y.+Caoauthor=G.+Xiaoauthor=F.+R.+Gretenauthor=G.+Kr%C3%A4hnauthor=G.+Bonizziauthor=Y.+Chenauthor=Y.+Huauthor=A.+Fongauthor=S.-C.+Sunauthor=M.+Karin&title=Activation+by+IKK%CE%B1+of+a+second%2C+evolutionary+conserved%2C+NF-%CE%BAB+signaling+pathway&doi=10.1126%2Fscience.1062677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span></div><div class="casAuthors">Senftleben, Uwe; Cao, Yixue; Xiao, Gutian; Greten, Florian R.; Kraehn, Gertraud; Bonizzi, Giuseppina; Chen, Yi; Hu, Yinling; Fong, Abraham; Sun, Shao-Cong; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5534</span>),
    <span class="NLM_cas:pages">1495-1499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In mammals, the canonical nuclear factor κB (NF-κB) signaling pathway activated in response to infections is based on degrdn. of IκB inhibitors.  This pathway depends on the IκB kinase (IKK), which contains two catalytic subunits, IKKα and IKKβ.  IKKβ is essential for inducible IκB phosphorylation and degrdn., whereas IKKα is not.  Here the authors show that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-κB2 (p100) precursor.  IKKα preferentially phosphorylates NF-κB2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-κB-inducing kinase (NIK).  IKKα is therefore a pivotal component of a second NF-κB activation pathway based on regulated NF-κB2 processing rather than IκB degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL1TLJXkDAYrVg90H21EOLACvtfcHk0liUfIPKm3DCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D&md5=fbd1395649a813a75e82a154543a7396</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062677%26sid%3Dliteratum%253Aachs%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKr%25C3%25A4hn%26aufirst%3DG.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DActivation%2520by%2520IKK%25CE%25B1%2520of%2520a%2520second%252C%2520evolutionary%2520conserved%252C%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1495%26epage%3D1499%26doi%3D10.1126%2Fscience.1062677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.+C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0liUfIPKm3DCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roschke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fessler, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimberly, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.4049%2Fjimmunol.166.1.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=6-10&author=J.+Zhangauthor=V.+Roschkeauthor=K.+P.+Bakerauthor=Z.+Wangauthor=G.+S.+Alarc%C3%B3nauthor=B.+J.+Fesslerauthor=H.+Bastianauthor=R.+P.+Kimberlyauthor=T.+Zhou&title=Cutting+edge%3A+a+role+for+B+lymphocyte+stimulator+in+systemic+lupus+erythematosus&doi=10.4049%2Fjimmunol.166.1.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoschke%26aufirst%3DV.%26aulast%3DBaker%26aufirst%3DK.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DG.%2BS.%26aulast%3DFessler%26aufirst%3DB.%2BJ.%26aulast%3DBastian%26aufirst%3DH.%26aulast%3DKimberly%26aufirst%3DR.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DCutting%2520edge%253A%2520a%2520role%2520for%2520B%2520lymphocyte%2520stimulator%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26spage%3D6%26epage%3D10%26doi%3D10.4049%2Fjimmunol.166.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheema, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roschke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilbert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stohl, W.</span></span> <span> </span><span class="NLM_article-title">Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=11407690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1319&author=G.+S.+Cheemaauthor=V.+Roschkeauthor=D.+M.+Hilbertauthor=W.+Stohl&title=Elevated+serum+B+lymphocyte+stimulator+levels+in+patients+with+systemic+immune-based+rheumatic+diseases&doi=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases</span></div><div class="casAuthors">Cheema, Gurtej S.; Roschke, Viktor; Hilbert, David M.; Stohl, William</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1313-1319</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective. to det. whether serum levels of B lymphocyte stimulator (BLyS) are elevated in patients with systemic immune-based rheumatic diseases and correlate with serum Ig levels and/or autoantibody titers.  Methods. Sera from 185 patients with various systemic immune-based rheumatic diseases (95 with systemic lupus erythematosus [SLE], 67 with rheumatoid arthritis [RA], 23 with other diagnoses) were assayed for BLyS and Ig.  In 7 patients who required arthrocentesis of a swollen knee, coincident serum and synovial fluid samples were assayed for BLyS.  Medical charts were retrospectively reviewed for elevated autoantibody titers and proteinuria within a 1-mo period before or after collection of sera for BLyS and Ig detn.  Sera concurrently collected from 48 normal healthy subjects served as controls.  Results. Serum BLyS levels were elevated in 38 of 185 patients (21%) and correlated significantly with serum IgG levels.  Serum BLyS levels did not correlate with the patients' age, sex, race, or medications, but correlated pos. with anti-double-stranded DNA antibody titers among SLE patients and with rheumatoid factor titers among seropos. RA patients.  In contrast, serum BLyS levels correlated inversely with nephrotic-range proteinuria among SLE patients.  In every case tested, BLyS levels in clin. inflamed synovial fluids were greater than those in simultaneously obtained sera.  Conclusion. BLyS may be an important factor in driving polyclonal hypergammaglobulinemia and elevated autoantibody titers in patients with systemic immune-based rheumatic diseases.  Local prodn. of BLyS in the joints may contribute to joint pathol.  Patients with elevated serum BLyS levels may be ideal candidates for therapeutic targeting of BLyS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryThicWY4tN7Vg90H21EOLACvtfcHk0liUfIPKm3DCEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFQ%253D&md5=6a72a4e2531f86c693797c6225a4099b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200106%252944%253A6%253C1313%253A%253AAID-ART223%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DCheema%26aufirst%3DG.%2BS.%26aulast%3DRoschke%26aufirst%3DV.%26aulast%3DHilbert%26aufirst%3DD.%2BM.%26aulast%3DStohl%26aufirst%3DW.%26atitle%3DElevated%2520serum%2520B%2520lymphocyte%2520stimulator%2520levels%2520in%2520patients%2520with%2520systemic%2520immune-based%2520rheumatic%2520diseases%26jtitle%3DArthritis%2520Rheum.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1319%26doi%3D10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madireddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span> <span> </span><span class="NLM_article-title">TNF superfamily in inflammatory disease: translating basic insights</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.it.2011.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.it.2011.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22169337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1yitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=144-152&author=M.+Croftauthor=W.+Duanauthor=H.+Choiauthor=S.+Y.+Eunauthor=S.+Madireddiauthor=A.+Mehta&title=TNF+superfamily+in+inflammatory+disease%3A+translating+basic+insights&doi=10.1016%2Fj.it.2011.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TNF superfamily in inflammatory disease: translating basic insights</span></div><div class="casAuthors">Croft, Michael; Duan, Wei; Choi, Heonsik; Eun, So-Young; Madireddi, Shravan; Mehta, Amit</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tumor necrosis factor (TNF) and TNF receptor superfamilies (TNFSF and TNFRSF) consist of approx. 50 membrane and sol. proteins that can modulate cellular function.  Most of these mols. are expressed by or can target cells of the immune system, and they have a wide range of actions including promoting cellular differentiation, survival, and prodn. of inflammatory cytokines and chemokines.  Emerging data show that TNFSF ligand-receptor signaling pathways are active in inflammatory and autoimmune disease.  Furthermore, several genetic polymorphisms in TNFSF and TNFRSF assoc. with susceptibility to developing disease.  Here, we examine recent data regarding the potential of these mols. as targets for therapy of autoimmune and inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRh8nycH5RH7Vg90H21EOLACvtfcHk0lizuwPTrspY_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1yitLo%253D&md5=2695b879fef1f6d4b20286e9c4274db9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2011.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2011.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCroft%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DEun%26aufirst%3DS.%2BY.%26aulast%3DMadireddi%26aufirst%3DS.%26aulast%3DMehta%26aufirst%3DA.%26atitle%3DTNF%2520superfamily%2520in%2520inflammatory%2520disease%253A%2520translating%2520basic%2520insights%26jtitle%3DTrends%2520Immunol.%26date%3D2012%26volume%3D33%26spage%3D144%26epage%3D152%26doi%3D10.1016%2Fj.it.2011.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Looney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anolik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, I.</span></span> <span> </span><span class="NLM_article-title">A perspective on B-cell-targeting therapy for SLE</span>. <i>Mod. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.3109/s10165-009-0213-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.3109%2Fs10165-009-0213-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=19669389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FovFGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1-10&author=R.+J.+Looneyauthor=J.+Anolikauthor=I.+Sanz&title=A+perspective+on+B-cell-targeting+therapy+for+SLE&doi=10.3109%2Fs10165-009-0213-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on B-cell-targeting therapy for SLE</span></div><div class="casAuthors">Looney R John; Anolik Jennifer; Sanz Inaki</div><div class="citationInfo"><span class="NLM_cas:title">Modern rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In recent years, large controlled trials have tested several new agents for systemic lupus erythematosus (SLE).  Unfortunately, none of these trials has met its primary outcome.  This does not mean progress has not been made.  In fact, a great deal has been learned about doing clinical trials in lupus and about the biological and clinical effects of the drugs being tested.  Many of these drugs were designed to target B cells directly, e.g., rituximab, belimumab, epratuzumab, and transmembrane activator and calcium modulator and cyclophilin ligand interactor-immunoglobulin (TACI-Ig).  The enthusiasm for targeting B cells derives from substantial evidence showing the critical role of B cells in murine models of SLE, as well promising results from multiple open trials with rituximab, a chimeric anti-CD20 monoclonal antibody that specifically depletes B cells (Martin and Chan in Immunity 20(5):517-527, 2004; Sobel et al. in J Exp Med 173:1441-1449, 1991; Silverman and Weisman in Arthritis Rheum 48:1484-1492, 2003; Silverman in Arthritis Rheum 52(4):1342, 2005; Shlomchik et al. in Nat Rev Immunol 1:147-153, 2001; Looney et al. in Arthritis Rheum 50:2580-2589, 2004; Lu et al. in Arthritis Rheum 61(4):482-487, 2009; Saito et al. in Lupus 12(10):798-800, 2003; van Vollenhoven et al. in Scand J Rheumatol 33(6):423-427, 2004; Sfikakis et al.  Arthritis Rheum 52(2):501-513, 2005).  Why have the controlled trials of B-cell-targeting therapies failed to demonstrate efficacy? Were there flaws in design or execution of these trials? Or, were promising animal studies and open trials misleading, as so often happens? This perspective discusses the current state of B-cell-targeting therapies for human lupus and the future development of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFLEl7jX-CDAwxfk_AGB-EfW6udTcc2eYKJHPoG3liC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FovFGlsg%253D%253D&md5=c9b565d7d1d494c0931f0ae1c25a2d08</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3109%2Fs10165-009-0213-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-009-0213-x%26sid%3Dliteratum%253Aachs%26aulast%3DLooney%26aufirst%3DR.%2BJ.%26aulast%3DAnolik%26aufirst%3DJ.%26aulast%3DSanz%26aufirst%3DI.%26atitle%3DA%2520perspective%2520on%2520B-cell-targeting%2520therapy%2520for%2520SLE%26jtitle%3DMod.%2520Rheumatol.%26date%3D2010%26volume%3D20%26spage%3D1%26epage%3D10%26doi%3D10.3109%2Fs10165-009-0213-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mortier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remouchamps, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4515</span>– <span class="NLM_lpage">4520</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2010.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4515-4520&author=J.+Mortierauthor=B.+Masereelauthor=C.+Remouchampsauthor=C.+Ganeffauthor=J.+Pietteauthor=R.+Frederick&title=NF-%CE%BAB+inducing+kinase+%28NIK%29+inhibitors%3A+Identification+of+new+scaffolds+using+virtual+screening&doi=10.1016%2Fj.bmcl.2010.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DMortier%26aufirst%3DJ.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DRemouchamps%26aufirst%3DC.%26aulast%3DGaneff%26aufirst%3DC.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DR.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%253A%2520Identification%2520of%2520new%2520scaffolds%2520using%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4515%26epage%3D4520%26doi%3D10.1016%2Fj.bmcl.2010.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span>; <span class="NLM_string-name">Sagara, T.</span>; <span class="NLM_string-name">Fan, W.</span>; <span class="NLM_string-name">Haxell, T. F. N.</span>; <span class="NLM_string-name">Jenks, M. G.</span>; <span class="NLM_string-name">Malaska, M. J.</span>; <span class="NLM_string-name">Moore, J. A.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Pandi, B.</span>; <span class="NLM_string-name">Peel, M. R.</span>; <span class="NLM_string-name">Steward, K. M.</span></span> <span> </span><span class="NLM_article-title">Novel 6-Azaindole Aminopyrimidine Derivatives Having NIK Inhibitory Activity</span>. <span class="NLM_patent">WO2010042337</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Goto&author=T.+Sagara&author=W.+Fan&author=T.+F.+N.+Haxell&author=M.+G.+Jenks&author=M.+J.+Malaska&author=J.+A.+Moore&author=G.+Ouvry&author=B.+Pandi&author=M.+R.+Peel&author=K.+M.+Steward&title=Novel+6-Azaindole+Aminopyrimidine+Derivatives+Having+NIK+Inhibitory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DY.%26atitle%3DNovel%25206-Azaindole%2520Aminopyrimidine%2520Derivatives%2520Having%2520NIK%2520Inhibitory%2520Activity%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstein, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2013.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1238-1244&author=K.+Liauthor=L.+R.+McGeeauthor=B.+Fisherauthor=A.+Sudomauthor=J.+Liuauthor=S.+M.+Rubensteinauthor=M.+K.+Anwerauthor=T.+D.+Cushingauthor=Y.+Shinauthor=M.+Ayresauthor=F.+Leeauthor=J.+Eksterowiczauthor=P.+Faulderauthor=B.+Waszkowyczauthor=O.+Plotnikovaauthor=E.+Farrellyauthor=S.-H.+Xiaoauthor=G.+Chenauthor=Z.+Wang&title=Inhibiting+NF-%CE%BAB-inducing+kinase+%28NIK%29%3A+Discovery%2C+structure-based+design%2C+synthesis%2C+structure-activity+relationship%2C+and+co-crystal+structures&doi=10.1016%2Fj.bmcl.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRubenstein%26aufirst%3DS.%2BM.%26aulast%3DAnwer%26aufirst%3DM.%2BK.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DF.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DInhibiting%2520NF-%25CE%25BAB-inducing%2520kinase%2520%2528NIK%2529%253A%2520Discovery%252C%2520structure-based%2520design%252C%2520synthesis%252C%2520structure-activity%2520relationship%252C%2520and%2520co-crystal%2520structures%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1238%26epage%3D1244%26doi%3D10.1016%2Fj.bmcl.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span>; <span class="NLM_string-name">Cushing, T. D.</span>; <span class="NLM_string-name">Fisher, B.</span>; <span class="NLM_string-name">He, X.</span>; <span class="NLM_string-name">Li, K.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">McGee, L. R.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Faulder, P.</span>; <span class="NLM_string-name">Seganish, J. L.</span>; <span class="NLM_string-name">Shin, Y.</span>; <span class="NLM_string-name">Wang, Z.</span>; <span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols as Kinase Inhibitors</span>. <span class="NLM_patent">WO2009158011</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Chen&author=T.+D.+Cushing&author=B.+Fisher&author=X.+He&author=K.+Li&author=Z.+Li&author=L.+R.+McGee&author=V.+Pattaropong&author=P.+Faulder&author=J.+L.+Seganish&author=Y.+Shin&author=Z.+Wang&author=W.+Liu&title=Alkynyl+Alcohols+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26atitle%3DAlkynyl%2520Alcohols%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of tricyclic NF-κB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.-F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-based+design+of+tricyclic+NF-%CE%BAB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)</span></div><div class="casAuthors">Castanedo, Georgette M.; Blaquiere, Nicole; Beresini, Maureen; Bravo, Brandon; Brightbill, Hans; Chen, Jacob; Cui, Hai-Feng; Eigenbrot, Charles; Everett, Christine; Feng, Jianwen; Godemann, Robert; Gogol, Emily; Hymowitz, Sarah; Johnson, Adam; Kayagaki, Nobuhiko; Kohli, Pawan Bir; Knuppel, Kathleen; Kraemer, Joachim; Kruger, Susan; Loke, Pui; McEwan, Paul; Montalbetti, Christian; Roberts, David A.; Smith, Myron; Steinbacher, Stefan; Sujatha-Bhaskar, Swathi; Takahashi, Ryan; Wang, Xiaolu; Wu, Lawren C.; Zhang, Yamin; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a structure-guided optimization of a novel series of NF-κB inducing kinase (NIK) inhibitors.  Starting from a modestly potent, low mol. wt. lead, activity was improved by designing a type I1/2 binding mode that accessed a back pocket past the methionine-471 gatekeeper.  Divergent binding modes in NIK and PI3K were used to dampen PI3K-inhibition while maintaining NIK inhibition within these series.  Potent compds. were discovered that selectively inhibit the nuclear translocation of NF-kB2 (p52/REL-B) but not canonical NF-kB1 (REL-A/p50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-sPXJiSfLVg90H21EOLACvtfcHk0lh8ddw9oU4uRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK&md5=316b70f51a5b800ba810082d0b3862da</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.-F.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-based%2520design%2520of%2520tricyclic%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in scaffold hopping</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01437</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01437" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1238&author=Y.+Huauthor=D.+Stumpfeauthor=J.+Bajorath&title=Recent+advances+in+scaffold+hopping&doi=10.1021%2Facs.jmedchem.6b01437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Scaffold Hopping</span></div><div class="casAuthors">Hu, Ye; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1238-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Scaffold hopping refers to the computer-aided search for active compds. contg. different core structures, which is a topic of high interest in medicinal chem.  Herein foundations and caveats of scaffold hopping approaches are discussed and recent methodol. developments analyzed.  Despite the conceptual prevalence of pharmacophore methods for scaffold hopping, a variety of computational approaches have been successfully applied.  In recent years, scaffold hopping calcns. are increasingly carried out at the level of scaffolds rather than compds., and scaffold queries increasingly from chem. structures.  In addn., relationships between compds., scaffolds, and biol. activities are beginning to be globally explored, beyond individual applications.  Going forward, computational scaffold hopping is thought to benefit from the consideration of new scaffold concepts and the development of methods capable of guiding search calcns. toward scaffolds that are likely to represent potent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreklFOuNfjw7Vg90H21EOLACvtfcHk0lig7lxkcqaBdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSks7%252FM&md5=a845ab13a7af0e397eedc94f7adcf870</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01437%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520scaffold%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1238%26doi%3D10.1021%2Facs.jmedchem.6b01437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span> <i>Scaffold Hopping in Medicinal Chemistry</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2F9783527665143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=N.+Brown&title=Scaffold+Hopping+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2F9783527665143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527665143%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%26btitle%3DScaffold%2520Hopping%2520in%2520Medicinal%2520Chemistry%26pub%3DWiley-VCH%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.str.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22921830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1704-1714&author=G.+de%0ALeon-Boenigauthor=K.+K.+Bowmanauthor=J.+A.+Fengauthor=T.+Crawfordauthor=C.+Everettauthor=Y.+Frankeauthor=A.+Ohauthor=M.+Stanleyauthor=S.+T.+Stabenauthor=M.+A.+Starovasnikauthor=H.+J.+A.+Wallweberauthor=J.+Wuauthor=L.+C.+Wuauthor=A.+R.+Johnsonauthor=S.+G.+Hymowitz&title=The+crystal+structure+of+the+catalytic+domain+of+the+NF-%CE%BAB+inducing+kinase+reveals+a+narrow+but+flexible+active+site&doi=10.1016%2Fj.str.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site</span></div><div class="casAuthors">de Leon-Boenig, Gladys; Bowman, Krista K.; Feng, Jianwen A.; Crawford, Terry; Everett, Christine; Franke, Yvonne; Oh, Angela; Stanley, Mark; Staben, Steven T.; Starovasnik, Melissa A.; Wallweber, Heidi J. A.; Wu, Jiansheng; Wu, Lawren C.; Johnson, Adam R.; Hymowitz, Sarah G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The NF-κB inducing kinase (NIP) regulates the non-canonical NF-κB pathway downstream of important clin. targets including BAFF, RANKL, and LTβ.  Despite numerous genetic studies assocg. dysregulation of this pathway with autoimmune diseases and hematol. cancers, detailed mol. characterization of this central signaling node has been lacking.  We undertook a systematic cloning and expression effort to generate sol., well-behaved proteins encompassing the kinase domains of human and murine NIK.  Structures of the apo NIK kinase domain from both species reveal an active-like conformation in the absence of phosphorylation.  ATP consumption and peptide phosphorylation assays confirm that phosphorylation of NIK does not increase enzymic activity.  Structures of murine NIK bound to inhibitors possessing two different chemotypes reveal conformational flexibility in the gatekeeper residue controlling access to a hydrophobic pocket.  Finally, a single amino acid difference affects the ability of some inhibitors to bind murine and human NIK with the same affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkN2Wi64mVzLVg90H21EOLACvtfcHk0lig7lxkcqaBdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P&md5=3f7d5bbd95066eb9d660ba810aba6e54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Boenig%26aufirst%3DG.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520reveals%2520a%2520narrow%2520but%2520flexible%2520active%2520site%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1704%26epage%3D1714%26doi%3D10.1016%2Fj.str.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angiolini, M.</span></span> <span> </span><span class="NLM_article-title">Through the ‘gatekeeper door’: Exploiting the active kinase conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2681</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/jm901443h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%98gatekeeper+door%E2%80%99%3A+Exploiting+the+active+kinase+conformation&doi=10.1021%2Fjm901443h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%2598gatekeeper%2520door%25E2%2580%2599%253A%2520Exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2681%26epage%3D2694%26doi%3D10.1021%2Fjm901443h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Angiolini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.4155%2Ffmc.10.294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21446845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=309-337&author=M.+Angiolini&title=Targeting+the+DFG-in+kinase+conformation%3A+a+new+trend+emerging+from+a+patent+analysis&doi=10.4155%2Ffmc.10.294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis</span></div><div class="casAuthors">Angiolini, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-337</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Aberrant kinase signaling leads to a multitude of disease states.  The clin. and com. success of agents typified by imatinib or dasatinib in the treatment of hematol. malignancies has further validated kinase inhibition as a useful clin. strategy.  This increased interest in kinases as therapeutic targets is evidenced by the rapidly increasing no. of patent applications and peer-reviewed articles.  This article discusses recent Patent that describe small mols. targeting the DFG-in active kinase conformation, by the so-called type I1/21/2'' inhibitor, against a small set of clin. relevant targets such as B-Raf, p38αα, Jak2 and EphB4.  Preclin. and clin. data are also highlighted for the most promising new mol. entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGWPNwqVr3XrVg90H21EOLACvtfcHk0lig7lxkcqaBdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVCltb8%253D&md5=7c6cbe986141be40b6ae2109170fc41b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.294%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520DFG-in%2520kinase%2520conformation%253A%2520a%2520new%2520trend%2520emerging%2520from%2520a%2520patent%2520analysis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D309%26epage%3D337%26doi%3D10.4155%2Ffmc.10.294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.phrs.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=26529477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKksL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2016&pages=26-48&author=R.+Roskoski&title=Classification+of+small+molecule+protein+kinase+inhibitors+based+upon+the+structures+of+their+drug-enzyme+complexes&doi=10.1016%2Fj.phrs.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes</span></div><div class="casAuthors">Roskoski, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-48</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Because dysregulation and mutations of protein kinases play causal roles in human disease, this family of enzymes has become one of the most important drug targets over the past two decades.  The X-ray crystal structures of 21 of the 27 FDA-approved small mol. inhibitors bound to their target protein kinases are depicted in this paper.  The structure of the enzyme-bound antagonist complex is used in the classification of these inhibitors.  Type I inhibitors bind to the active protein kinase conformation (DFG-Asp in, αC-helix in).  Type I1/2 inhibitors bind to a DFG-Asp in inactive conformation while Type II inhibitors bind to a DFG-Asp out inactive conformation.  Type I, I1/2, and type II inhibitors occupy part of the adenine binding pocket and form hydrogen bonds with the hinge region connecting the small and large lobes of the enzyme.  Type III inhibitors bind next to the ATP-binding pocket and type IV inhibitors do not bind to the ATP or peptide substrate binding sites.  Type III and IV inhibitors are allosteric in nature.  Type V inhibitors bind to two different regions of the protein kinase domain and are therefore bivalent inhibitors.  The type I-V inhibitors are reversible.  In contrast, type VI inhibitors bind covalently to their target enzyme.  Type I, I1/2, and II inhibitors are divided into A and B subtypes.  The type A inhibitors bind in the front cleft, the back cleft, and near the gatekeeper residue, all of which occur within the region sepg. the small and large lobes of the protein kinase.  The type B inhibitors bind in the front cleft and gate area but do not extend into the back cleft.  An anal. of the limited available data indicates that type A inhibitors have a long residence time (minutes to hours) while the type B inhibitors have a short residence time (seconds to minutes).  The catalytic spine includes residues from the small and large lobes and interacts with the adenine ring of ATP.  Nearly all of the approved protein kinase inhibitors occupy the adenine-binding pocket; thus it is not surprising that these inhibitors interact with nearby catalytic spine (CS) residues.  Moreover, a significant no. of approved drugs also interact with regulatory spine (RS) residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0COwqC0CabVg90H21EOLACvtfcHk0lhv8EuKikb5EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKksL%252FN&md5=e6b45c8644e322f30f898e763780c64b</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DClassification%2520of%2520small%2520molecule%2520protein%2520kinase%2520inhibitors%2520based%2520upon%2520the%2520structures%2520of%2520their%2520drug-enzyme%2520complexes%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D103%26spage%3D26%26epage%3D48%26doi%3D10.1016%2Fj.phrs.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">LLE = lipophilic ligand efficiency = p<i>K</i><sub>i</sub> – log <i>D</i>.</p></div><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhv8EuKikb5EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+expectations+in+molecular+optimizations%3A+Strengths+and+limitations+of+commonly+used+composite+parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0lhv8EuKikb5EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520expectations%2520in%2520molecular%2520optimizations%253A%2520Strengths%2520and%2520limitations%2520of%2520commonly%2520used%2520composite%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Fragment screening: an introduction</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1039/b610069b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1039%2Fb610069b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCks7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=429-446&author=A.+R.+Leachauthor=M.+M.+Hannauthor=J.+N.+Burrowsauthor=E.+J.+Griffen&title=Fragment+screening%3A+an+introduction&doi=10.1039%2Fb610069b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening: an introduction</span></div><div class="casAuthors">Leach, Andrew R.; Hann, Michael M.; Burrows, Jeremy N.; Griffen, Ed J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">429-446</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpttvt8xGGyL7Vg90H21EOLACvtfcHk0lg6i2qVce0BgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCks7vE&md5=66d60d107405d7e87e90f5d2d29355ed</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1039%2Fb610069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610069b%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DFragment%2520screening%253A%2520an%2520introduction%26jtitle%3DMol.%2520BioSyst.%26date%3D2006%26volume%3D2%26spage%3D429%26epage%3D446%26doi%3D10.1039%2Fb610069b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span> For a related mechanism,
see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degnan, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span> <span> </span><span class="NLM_article-title">Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.061879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1124%2Fdmd.114.061879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=25633841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFSjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=578-589&author=X.+Zhuoauthor=X.+S.+Huangauthor=A.+P.+Degnanauthor=L.+B.+Snyderauthor=F.+Yangauthor=H.+Huangauthor=Y.+Z.+Shuauthor=B.+M.+Johnson&title=Identification+of+glutathione+conjugates+of+acetylene-containing+positive+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+5&doi=10.1124%2Fdmd.114.061879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Zhuo, Xiaoliang; Huang, Xiaohua Stella; Degnan, Andrew P.; Snyder, Lawrence B.; Yang, Fukang; Huang, Hong; Shu, Yue-Zhong; Johnson, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">578-589</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A recent medicinal chem. campaign to identify pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) led to the discovery of potent compds. featuring an oxazolidinone structural core flanked by biaryl acetylene and haloaryl moieties.  However, biotransformation studies of some of these mGluR5 PAMs demonstrated the formation of glutathione (GSH) conjugates.  The conjugates in question were formed independently of NADPH as the main products in liver microsomes and liver cytosol (rat and human) and exhibited masses that were 307 u greater than their resp. substrates, indicating the involvement of a reductive step in the formation of these metabolites.  To further characterize the relevant metabolic sequences, GSH conjugates of (4R,5R)-5-(3-fluorophenyl)-4-(5-(pyrazin-2-ylethynyl)pyridin-3-yl)oxazolidin-2-one and (4R,5R)-5-(4-fluorophenyl)-4-(6-((3-fluoropyridin-2-yl)ethynyl) pyridin-2-yl)oxazolidin-2-one were biosynthesized and isolated.  Subsequent anal. by NMR showed that GSH had reacted with the acetylene carbon atoms of these mGluR5 PAMs, suggesting a conjugate addn. mechanism and implicating cytosolic and microsomal GSH S-transferases (GSTs) in catalysis.  Interestingly, five closely related mGluR5 PAMs were not similarly prone to the formation of GSH conjugates in vitro.  These compds. also featured acetylenes, but were flanked by either Ph or cyclohexyl rings, which indicated that the formation of GSH conjugates was influenced by proximal functional groups that modulated the electron d. of the triple bond and/or differences in enzyme-substrate specificity.  These results informed an ongoing drug-discovery effort to identify mGluR5 PAMs with drug-like properties and a low risk of reactivity with endogenous thiols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHBHWhrex97Vg90H21EOLACvtfcHk0lg6i2qVce0BgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFSjsbY%253D&md5=fca55e910eac73eebdf2e67242b13718</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.061879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.061879%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%2BS.%26aulast%3DDegnan%26aufirst%3DA.%2BP.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DShu%26aufirst%3DY.%2BZ.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26atitle%3DIdentification%2520of%2520glutathione%2520conjugates%2520of%2520acetylene-containing%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D578%26epage%3D589%26doi%3D10.1124%2Fdmd.114.061879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laizure, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herring, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witbrodt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. B.</span></span> <span> </span><span class="NLM_article-title">The role of human carboxylesterases in drug metabolism: Have we overlooked their importance?</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1002/phar.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2Fphar.1194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=23386599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVOltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=210-222&author=S.+C.+Laizureauthor=V.+Herringauthor=Z.+Huauthor=K.+Witbrodtauthor=R.+B.+Parker&title=The+role+of+human+carboxylesterases+in+drug+metabolism%3A+Have+we+overlooked+their+importance%3F&doi=10.1002%2Fphar.1194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of human carboxylesterases in drug metabolism: have we overlooked their importance?</span></div><div class="casAuthors">Laizure, S. Casey; Herring, Vanessa; Hu, Zheyi; Witbrodt, Kevin; Parker, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-222</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Carboxylesterases are a multigene family of mammalian enzymes widely distributed throughout the body that catalyze the hydrolysis of esters, amides, thioesters, and carbamates.  In humans, two carboxylesterases, hCE1 and hCE2, are important mediators of drug metab.  Both are expressed in the liver, but hCE1 greatly exceeds hCE2.  In the intestine, only hCE2 is present and highly expressed.  The most common drug substrates of these enzymes are ester prodrugs specifically designed to enhance oral bioavailability by hydrolysis to the active carboxylic acid after absorption from the gastrointestinal tract.  Carboxylesterases also play an important role in the hydrolysis of some drugs to inactive metabolites.  It has been widely believed that drugs undergoing hydrolysis by hCE1 and hCE2 are not subject to clin. significant alterations in their disposition, but evidence exists that genetic polymorphisms, drug-drug interactions, drug-disease interactions and other factors are important determinants of the variability in the therapeutic response to carboxylesterase-substrate drugs.  The implications for drug therapy are far-reaching, as substrate drugs include numerous examples from widely prescribed therapeutic classes.  Representative drugs include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, antiplatelet drugs, statins, antivirals, and central nervous system agents.  As research interest increases in the carboxylesterases, evidence is accumulating of their important role in drug metab. and, therefore, the outcomes of pharmacotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Icv81r0ebVg90H21EOLACvtfcHk0lg6i2qVce0BgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVOltrs%253D&md5=6a68263c68e92bba8bbcb64e0e30ae92</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fphar.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1194%26sid%3Dliteratum%253Aachs%26aulast%3DLaizure%26aufirst%3DS.%2BC.%26aulast%3DHerring%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWitbrodt%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DR.%2BB.%26atitle%3DThe%2520role%2520of%2520human%2520carboxylesterases%2520in%2520drug%2520metabolism%253A%2520Have%2520we%2520overlooked%2520their%2520importance%253F%26jtitle%3DPharmacotherapy%26date%3D2013%26volume%3D33%26spage%3D210%26epage%3D222%26doi%3D10.1002%2Fphar.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span>; <span class="NLM_string-name">Mayer, J.
M.</span></span> <span> </span><span class="NLM_article-title">Hydrolysis in Drug and Prodrug Metabolism: Chemistry</span>.  <i>Biochemistry and Enzymology</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+Testa&author=J.%0AM.+Mayer&title=Biochemistry+and+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DHydrolysis%2520in%2520Drug%2520and%2520Prodrug%2520Metabolism%253A%2520Chemistry%26btitle%3DBiochemistry%2520and%2520Enzymology%26pub%3DWiley-VCH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J. P.</span>; <span class="NLM_string-name">Trager, W.</span></span> <i>Drug Metabolism: Chemical and Enzymatic Aspects</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.3109%2F9780849375965" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+P.+Uetrecht&author=W.+Trager&title=Drug+Metabolism%3A+Chemical+and+Enzymatic+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.3109%2F9780849375965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.3109%252F9780849375965%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26btitle%3DDrug%2520Metabolism%253A%2520Chemical%2520and%2520Enzymatic%2520Aspects%26pub%3DInforma%2520Healthcare%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taketani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterase in the liver and small intestine of experimental animals and human</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2007.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.lfs.2007.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=924-932&author=M.+Taketaniauthor=M.+Shiiauthor=K.+Ohuraauthor=S.+Ninomiyaauthor=T.+Imai&title=Carboxylesterase+in+the+liver+and+small+intestine+of+experimental+animals+and+human&doi=10.1016%2Fj.lfs.2007.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2007.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2007.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DNinomiya%26aufirst%3DS.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DCarboxylesterase%2520in%2520the%2520liver%2520and%2520small%2520intestine%2520of%2520experimental%2520animals%2520and%2520human%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D924%26epage%3D932%26doi%3D10.1016%2Fj.lfs.2007.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Burch, J.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Staben, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2015025025</span>, Feb 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Blaquiere&author=J.+Burch&author=G.+M.+Castanedo&author=J.+A.+Feng&author=B.+Hu&author=S.+Staben&author=G.+Wu&author=P.-W.+Yuen&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Burch, J.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>, <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Staben, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2015025026</span>, Feb 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Blaquiere&author=J.+Burch&author=G.+M.+Castanedo&author=J.+A.+Feng&author=B.+Hu&author=X.+Lin&author=S.+Staben&author=G.+Wu&author=P.-W.+Yuen&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>; <span class="NLM_string-name">Crawford, J. J.</span>; <span class="NLM_string-name">Lee, W.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Wu, G.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2016135163</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Blaquiere&author=G.+M.+Castanedo&author=J.+A.+Feng&author=J.+J.+Crawford&author=W.+Lee&author=X.+Lin&author=B.+Hu&author=G.+Wu&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bents, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaochico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">179</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02672-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fs41467-017-02672-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=29330524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=179&author=H.+D.+Brightbillauthor=E.+Sutoauthor=N.+Blaquiereauthor=N.+Ramamoorthiauthor=S.+Sujatha-Bhaskarauthor=E.+B.+Gogolauthor=G.+M.+Castanedoauthor=B.+T.+Jacksonauthor=Y.+C.+Kwonauthor=S.+Hallerauthor=J.+Leschauthor=K.+Bentsauthor=C.+Everettauthor=P.+Bir+Kohliauthor=S.+Lingeauthor=L.+Christianauthor=K.+Barrettauthor=A.+Jaochicoauthor=L.+M.+Berezhkovskiyauthor=P.+W.+Fanauthor=Z.+Modrusanauthor=K.+Velizauthor=M.+J.+Townsendauthor=J.+DeVossauthor=A.+R.+Johnsonauthor=R.+Godemannauthor=W.+P.+Leeauthor=C.+D.+Austinauthor=B.+S.+McKenzieauthor=J.+A.+Hackneyauthor=J.+J.+Crawfordauthor=S.+T.+Stabenauthor=M.+H.+Alaoui+Ismailiauthor=L.+C.+Wuauthor=N.+Ghilardi&title=NF-%CE%BAB+inducing+kinase+is+a+therapeutic+target+for+systemic+lupus+erythematosus&doi=10.1038%2Fs41467-017-02672-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span></div><div class="casAuthors">Brightbill Hans D; Sujatha-Bhaskar Swathi; Gogol Emily B; Jackson Benjamin T; Christian Laura; Wu Lawren C; Ghilardi Nico; Suto Eric; Kwon Youngsu C; Lesch Justin; DeVoss Jason; Lee Wyne P; McKenzie Brent S; Blaquiere Nicole; Castanedo Georgette M; Crawford James J; Staben Steven T; Ramamoorthi Nandhini; Townsend Michael J; Haller Susan; Austin Cary D; Bents Karin; Linge Sandra; Godemann Robert; Everett Christine; Kohli Pawan Bir; Barrett Kathy; Johnson Adam R; Alaoui Ismaili Moulay H; Jaochico Allan; Berezhkovskiy Leonid M; Fan Peter W; Modrusan Zora; Veliz Kelli; Hackney Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NF-κB-inducing kinase (NIK) mediates non-canonical NF-κB signaling downstream of multiple TNF family members, including BAFF, TWEAK, CD40, and OX40, which are implicated in the pathogenesis of systemic lupus erythematosus (SLE).  Here, we show that experimental lupus in NZB/W F1 mice can be treated with a highly selective and potent NIK small molecule inhibitor.  Both in vitro as well as in vivo, NIK inhibition recapitulates the pharmacological effects of BAFF blockade, which is clinically efficacious in SLE.  Furthermore, NIK inhibition also affects T cell parameters in the spleen and proinflammatory gene expression in the kidney, which may be attributable to inhibition of OX40 and TWEAK signaling, respectively.  As a consequence, NIK inhibition results in improved survival, reduced renal pathology, and lower proteinuria scores.  Collectively, our data suggest that NIK inhibition is a potential therapeutic approach for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSowPmlnIWxaqcneEtCi92fW6udTcc2eYIJArC-pXISrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D&md5=41a91514e1f4e8b2b44912ba6d6a4788</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02672-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02672-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrightbill%26aufirst%3DH.%2BD.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DRamamoorthi%26aufirst%3DN.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DGogol%26aufirst%3DE.%2BB.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BT.%26aulast%3DKwon%26aufirst%3DY.%2BC.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DBents%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DChristian%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DJaochico%26aufirst%3DA.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DFan%26aufirst%3DP.%2BW.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DVeliz%26aufirst%3DK.%26aulast%3DTownsend%26aufirst%3DM.%2BJ.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DAustin%26aufirst%3DC.%2BD.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DHackney%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DGhilardi%26aufirst%3DN.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%2520is%2520a%2520therapeutic%2520target%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D179%26doi%3D10.1038%2Fs41467-017-02672-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e','cit1f'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b','cit13c'],'ref14':[],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Islam Al-Khawaldeh, Mohammed J. Al Yasiri, Gregory G. Aldred, Christine Basmadjian, Cinzia Bordoni, Suzannah J. Harnor, Amy B. Heptinstall, Stephen J. Hobson, Claire E. Jennings, Shaimaa Khalifa, Honorine Lebraud, Mathew P. Martin, Duncan C. Miller, Harry J. Shrives, João V. de Souza, Hannah L. Stewart, Max Temple, Huw D. Thomas, Jane Totobenazara, Julie A. Tucker, Susan J. Tudhope, Lan Z. Wang, Agnieszka K. Bronowska, Céline Cano, Jane A. Endicott, Bernard T. Golding, Ian R. Hardcastle, Ian Hickson, Stephen R. Wedge, Elaine Willmore, Martin E. M. Noble, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Waring</span>. </span><span class="cited-content_cbyCitation_article-title">An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10001-10018. <a href="https://doi.org/10.1021/acs.jmedchem.0c01249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252BAlkynylpyrimidine-Based%252BCovalent%252BInhibitor%252BThat%252BTargets%252Ba%252BUnique%252BCysteine%252Bin%252BNF-%2525CE%2525BAB-Inducing%252BKinase%26aulast%3DAl-Khawaldeh%26aufirst%3DIslam%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17022021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D10001%26epage%3D10018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuqin Zhu, Yuxiang Ma, Weidong Zu, Jianing Song, Hua Wang, You Zhong, Hongmei Li, Yanmin Zhang, Qianqian Gao, Bo Kong, Junyu Xu, Fei Jiang, Xinren Wang, Shuwen Li, Chenhe Liu, Haichun Liu, Tao Lu, <span class="NLM_string-name hlFld-ContribAuthor">Yadong Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of N-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives as Novel, Potent, and Selective NF-κB Inducing Kinase (NIK) Inhibitors for the Treatment of Psoriasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 6748-6773. <a href="https://doi.org/10.1021/acs.jmedchem.0c00055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BN-Phenyl-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-amine%252BDerivatives%252Bas%252BNovel%25252C%252BPotent%25252C%252Band%252BSelective%252BNF-%2525CE%2525BAB%252BInducing%252BKinase%252B%252528NIK%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BPsoriasis%26aulast%3DZhu%26aufirst%3DYuqin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12012020%26date%3D16062020%26date%3D01062020%26volume%3D63%26issue%3D13%26spage%3D6748%26epage%3D6773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiqiang Li, Xinzhi Li, Ming-Bo Su, Li-Xin Gao, Yu-Bo Zhou, Bingchuan Yuan, Xilin Lyu, Ziqin Yan, Chujiao Hu, Hao Zhang, Cheng Luo, Zheng Chen, Jia Li, <span class="NLM_string-name hlFld-ContribAuthor">Yujun Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4388-4407. <a href="https://doi.org/10.1021/acs.jmedchem.0c00396" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00396%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BNF-%2525CE%2525BAB-Inducing%252BKinase%252B%252528NIK%252529%252BInhibitor%252BThat%252BHas%252BAnti-inflammatory%252BEffects%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DLi%26aufirst%3DZhiqiang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07032020%26date%3D07042020%26date%3D27032020%26volume%3D63%26issue%3D8%26spage%3D4388%26epage%3D4407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Cheng</span>, <span class="hlFld-ContribAuthor ">Xuexin  Feng</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Li</span>, <span class="hlFld-ContribAuthor ">Feilong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jin-Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 552-565. <a href="https://doi.org/10.1039/D0MD00361A" title="DOI URL">https://doi.org/10.1039/D0MD00361A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00361A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00361A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPharmacological%252Binhibition%252Bof%252BNF-%2525CE%2525BAB-inducing%252Bkinase%252B%252528NIK%252529%252Bwith%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252Bhuman%252Bdiseases%26aulast%3DCheng%26aufirst%3DJing%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D552%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Ge  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127862. <a href="https://doi.org/10.1016/j.bmcl.2021.127862" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127862%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BI%252529%25253A%252BKinase%252Binhibitors%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D38%26spage%3D127862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Daohong  Liao</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Landry</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of an Azabicyclo[3.1.0]hexanone-Containing Inhibitor of NF-κΒ Inducing Kinase via Catalytic C–H Activation. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2020,</strong> <em>52 </em>
                                    (22)
                                     , 3420-3426. <a href="https://doi.org/10.1055/s-0040-1707279" title="DOI URL">https://doi.org/10.1055/s-0040-1707279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1707279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1707279%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DSynthesis%252Bof%252Ban%252BAzabicyclo%25255B3.1.0%25255Dhexanone-Containing%252BInhibitor%252Bof%252BNF-%2525CE%2525BA%2525CE%252592%252BInducing%252BKinase%252Bvia%252BCatalytic%252BC%2525E2%252580%252593H%252BActivation%26aulast%3DCrawford%26aufirst%3DJames%2BJ.%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D22%26spage%3D3420%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn M.  Pflug</span>, <span class="hlFld-ContribAuthor ">Raquel  Sitcheran</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (22)
                                     , 8470. <a href="https://doi.org/10.3390/ijms21228470" title="DOI URL">https://doi.org/10.3390/ijms21228470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21228470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21228470%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BNF-%2525CE%2525BAB-Inducing%252BKinase%252B%252528NIK%252529%252Bin%252BImmunity%25252C%252BInflammation%25252C%252Band%252BCancer%26aulast%3DPflug%26aufirst%3DKathryn%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D22%26spage%3D8470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ada Hang-Heng  Wong</span>, <span class="hlFld-ContribAuthor ">Eun Myoung  Shin</span>, <span class="hlFld-ContribAuthor ">Vinay  Tergaonkar</span>, <span class="hlFld-ContribAuthor ">Wee-Joo  Chng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NF-κB Signaling for Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2203. <a href="https://doi.org/10.3390/cancers12082203" title="DOI URL">https://doi.org/10.3390/cancers12082203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082203%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BNF-%2525CE%2525BAB%252BSignaling%252Bfor%252BMultiple%252BMyeloma%26aulast%3DWong%26aufirst%3DAda%2BHang-Heng%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Sun</span>, <span class="hlFld-ContribAuthor ">Zhong-Fei  Gao</span>, <span class="hlFld-ContribAuthor ">Wei-Bin  Yan</span>, <span class="hlFld-ContribAuthor ">Bin-Rong  Yao</span>, <span class="hlFld-ContribAuthor ">Wen-Yu  Xin</span>, <span class="hlFld-ContribAuthor ">Chun-Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Qing-Guo  Meng</span>, <span class="hlFld-ContribAuthor ">Gui-Ge  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112366. <a href="https://doi.org/10.1016/j.ejmech.2020.112366" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112366%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BNF-%2525D0%2525BAB%252Binhibitor%252Bbased%252Bon%252Bscaffold%252Bhopping%25253A%252B1%25252C4%25252C5%25252C6%25252C7%25252C8-hexahydropyrido%25255B4%25252C3-d%25255Dpyrimidine%26aulast%3DSun%26aufirst%3DYue%26date%3D2020%26volume%3D198%26spage%3D112366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>, <span class="hlFld-ContribAuthor ">Herman Van  Vlijmen</span>, <span class="hlFld-ContribAuthor ">Olivier  Querolle</span>, <span class="hlFld-ContribAuthor ">Ian  Stansfield</span>, <span class="hlFld-ContribAuthor ">Lieven  Meerpoel</span>, <span class="hlFld-ContribAuthor ">Matthias  Versele</span>, <span class="hlFld-ContribAuthor ">George  Hynd</span>, <span class="hlFld-ContribAuthor ">Ricardo  Attar</span>. </span><span class="cited-content_cbyCitation_article-title">FEP+ calculations predict a stereochemical SAR switch for first-in-class indoline NIK inhibitors for multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Future Drug Discovery</span><span> <strong>2020,</strong> <em>2 </em>
                                    (3)
                                     , FDD43. <a href="https://doi.org/10.4155/fdd-2020-0004" title="DOI URL">https://doi.org/10.4155/fdd-2020-0004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fdd-2020-0004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffdd-2020-0004%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Drug%2520Discovery%26atitle%3DFEP%25252B%252Bcalculations%252Bpredict%252Ba%252Bstereochemical%252BSAR%252Bswitch%252Bfor%252Bfirst-in-class%252Bindoline%252BNIK%252Binhibitors%252Bfor%252Bmultiple%252Bmyeloma%26aulast%3DJacoby%26aufirst%3DEdgar%26date%3D2020%26volume%3D2%26issue%3D3%26spage%3DFDD43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Meng  Sun</span>, <span class="hlFld-ContribAuthor ">Jin-Jing  Qin</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Tan</span>, <span class="hlFld-ContribAuthor ">Wen-Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent strategy for the chemoselective synthesis of N-Arylbenzimidazoles and N-Arylindazoles from arylamino oximes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (8)
                                     , 130945. <a href="https://doi.org/10.1016/j.tet.2020.130945" title="DOI URL">https://doi.org/10.1016/j.tet.2020.130945</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.130945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.130945%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDivergent%252Bstrategy%252Bfor%252Bthe%252Bchemoselective%252Bsynthesis%252Bof%252BN-Arylbenzimidazoles%252Band%252BN-Arylindazoles%252Bfrom%252Barylamino%252Boximes%26aulast%3DLi%26aufirst%3DZhen-Hua%26date%3D2020%26volume%3D76%26issue%3D8%26spage%3D130945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanxun  Wang</span>, <span class="hlFld-ContribAuthor ">Zisen  Gao</span>, <span class="hlFld-ContribAuthor ">Peilu  Song</span>, <span class="hlFld-ContribAuthor ">Baichun  Hu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2019,</strong> <em>21 </em>
                                    (43)
                                     , 24147-24164. <a href="https://doi.org/10.1039/C9CP04353E" title="DOI URL">https://doi.org/10.1039/C9CP04353E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CP04353E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CP04353E%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Band%252BQM%25252FMM%252Bcalculation%252Breveal%252Bthe%252Bselectivity%252Bmechanism%252Bof%252Btype%252BI%252B1%25252F2%252Bkinase%252Binhibitors%25253A%252Bthe%252Beffect%252Bof%252Bintramolecular%252BH-bonds%252Band%252Bconformational%252Brestriction%252Bfor%252Bimproved%252Bselectivity%26aulast%3DWang%26aufirst%3DHanxun%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D43%26spage%3D24147%26epage%3D24164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiao‐Bing  Mei</span>, <span class="hlFld-ContribAuthor ">You‐You  Yan</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Xiao‐Wu  Dong</span>, <span class="hlFld-ContribAuthor ">Neng‐Ming  Lin</span>, <span class="hlFld-ContribAuthor ">Yu‐Bo  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of new NIK inhibitors by discriminatory analysis‐based molecular docking and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (7)
                                     , 1800374. <a href="https://doi.org/10.1002/ardp.201800374" title="DOI URL">https://doi.org/10.1002/ardp.201800374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800374%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIdentification%252Bof%252Bnew%252BNIK%252Binhibitors%252Bby%252Bdiscriminatory%252Banalysis%2525E2%252580%252590based%252Bmolecular%252Bdocking%252Band%252Bbiological%252Bevaluation%26aulast%3DCheng%26aufirst%3DGang%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D7%26spage%3D1800374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Xuwen  Wang</span>, <span class="hlFld-ContribAuthor ">Tailong  Lei</span>, <span class="hlFld-ContribAuthor ">Ercheng  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Huidong  Yu</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I1/2 NIK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00345" title="DOI URL">https://doi.org/10.3389/fphar.2019.00345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00345%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DImportance%252Bof%252BIncorporating%252BProtein%252BFlexibility%252Bin%252BMolecule%252BModeling%25253A%252BA%252BTheoretical%252BStudy%252Bon%252BType%252BI1%25252F2%252BNIK%252BInhibitors%26aulast%3DShen%26aufirst%3DChao%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lara  Valiño-Rivas</span>, <span class="hlFld-ContribAuthor ">Juan José  Vaquero</span>, <span class="hlFld-ContribAuthor ">David  Sucunza</span>, <span class="hlFld-ContribAuthor ">Sara  Gutierrez</span>, <span class="hlFld-ContribAuthor ">Ana B.  Sanz</span>, <span class="hlFld-ContribAuthor ">Manuel  Fresno</span>, <span class="hlFld-ContribAuthor ">Alberto  Ortiz</span>, <span class="hlFld-ContribAuthor ">Maria Dolores  Sanchez-Niño</span>. </span><span class="cited-content_cbyCitation_article-title">NIK as a Druggable Mediator of Tissue Injury. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2019,</strong> <em>25 </em>
                                    (4)
                                     , 341-360. <a href="https://doi.org/10.1016/j.molmed.2019.02.005" title="DOI URL">https://doi.org/10.1016/j.molmed.2019.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2019.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2019.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DNIK%252Bas%252Ba%252BDruggable%252BMediator%252Bof%252BTissue%252BInjury%26aulast%3DVali%25C3%25B1o-Rivas%26aufirst%3DLara%26date%3D2019%26volume%3D25%26issue%3D4%26spage%3D341%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Gu</span>, <span class="hlFld-ContribAuthor ">Beibei  Wang</span>, <span class="hlFld-ContribAuthor ">Wenhai  Huang</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen  Ma</span>, <span class="hlFld-ContribAuthor ">Shenxin  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhengrong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 808-817. <a href="https://doi.org/10.1080/14756366.2019.1587417" title="DOI URL">https://doi.org/10.1080/14756366.2019.1587417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1587417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1587417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bcoumarin%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bbioavailable%252BBRD4%252Binhibitors%252Bbased%252Bon%252Bscaffold%252Bhopping%26aulast%3DZhang%26aufirst%3DZhimin%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D808%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Paul</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>, <span class="hlFld-ContribAuthor ">Christopher  Pepper</span>, <span class="hlFld-ContribAuthor ">Simon  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 176. <a href="https://doi.org/10.3390/cells7100176" title="DOI URL">https://doi.org/10.3390/cells7100176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells7100176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells7100176%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DInhibitory-%2525CE%2525BAB%252BKinase%252B%252528IKK%252529%252B%2525CE%2525B1%252Band%252BNuclear%252BFactor-%2525CE%2525BAB%252B%252528NF%2525CE%2525BAB%252529-Inducing%252BKinase%252B%252528NIK%252529%252Bas%252BAnti-Cancer%252BDrug%252BTargets%26aulast%3DPaul%26aufirst%3DAndrew%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Proposed excision of oxepin ring of <b>1</b> to 2-(3-amido)pyrazolylpyridines <b>2</b>. (b) Crystal structure of benzoxazepin <b>1a</b> (blue) in murine NIK (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y">6G4Y</a>). Solvent accessible surface is indicated in gray. Key intermolecular distances are indicated with gray lines/text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Inhibition of kinase activity at a single concentration (100 nM) across a range of kinases tested at Invitrogen (red, >80% inhibition; yellow, 50–80%; green, <50%). (b) X-ray cocrystal structure of <b>2f</b> (blue) in mNIK (gray) including an overlay of benzoxazepin <b>1a</b> (magenta wire-frame) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z">6G4Z</a>). Solvent accessible surface is indicated in gray. Key intermolecular distances are indicated with gray lines/text.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Human liver microsome (HLM) and human hepatocyte (HH) predicted hepatic clearance.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (b) Qualitative representation of metabolism pathways observed in HH after 3 h incubation with 5 μM <b>2f</b>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>4f</b> inhibits BAFF-induced B cell (mouse) survival in vitro. Splenic mouse B cells were cultured with mouse rBAFF for 4 days. B cell survival was measured by Cell Titer Glo (Promega). Mean and standard deviation of three biological replicates are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>4f</b> inhibits BAFF signaling in vivo. (A, B) NIK inhibition reduces marginal zone B cell (B220+ CD5– CD21high CD23low) frequency (A) and number (B). (C) Terminal free plasma concentration of compound <b>4f</b>. IC<sub>50</sub>, IC<sub>70</sub>, and IC<sub>90</sub> levels were determined based on in vitro mouse B cell survival assay results (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Data are represented as the mean ± standard deviation of 4–5 mice per group. Statistics are with unpaired <i>t</i> test with Welch’s correction (GraphPad Prism software): (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01, (∗∗∗) <i>p</i> < 0.001, (∗∗∗∗) <i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>R</i>)-3-Ethynyl-3-hydroxy-1-methylpyrrolidin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Boc<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 0°C to rt; (b) HOBT, EDCI, methanol 0 °C to rt; (c) TBSCl, imidazole, CH<sub>2</sub>Cl<sub>2,</sub> 0 °C to rt; (d) MeI, NaH, DMF, 0 °C to rt; (e) TBAF, THF, 0 °C to rt (40% yield over 5 steps); (f) DMP (1.4 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C – rt (87% yield); (g) ethynylmagnesium bromide (0.5 M in THF), THF, −70 °C (76% yield); (h) TFA, CH<sub>2</sub>Cl<sub>2</sub> followed by Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (i) Chiral SFC, CHIRALPAK IC, 20% yield over two steps.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>2c</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 2-Chloro-4-iodopyridine, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (b) NH<sub>4</sub>Cl, HATU, DIPEA, THF, rt; (c) compound (<i>R</i>)-<b>8</b> (2–3 equiv), CuI (0.05 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.05–0.1 equiv), TEA, DMF, MeCN, 80°C [90% yield of <b>2c</b>, 66% yield of <b>2d</b>, 67% yield of <b>2e</b>, 37% yield of <b>2f</b>].</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>3d</b> and <b>3e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 3-Bromophenylboronic acid, Cu(OAc)<sub>2</sub>, pyridine, THF, oxygen atmosphere, 50–90 °C (43% of <b>14a</b>, 14% of <b>14b</b>); (b) compound (<i>R</i>)-<b>8</b> (2 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.3 equiv), TEA, DMSO, microwave at 90 °C (74% of <b>15a</b>, 60% of <b>15b</b>); (c) NH<sub>3</sub>, MeOH, 40 °C (40% of <b>3d</b>, 47% of <b>3e</b>).</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/medium/jm-2018-00678y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>4b</b> and <b>4f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-15/acs.jmedchem.8b00678/20180802/images/large/jm-2018-00678y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00678&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) KHF<sub>2</sub>, water, rt; (b) compound (<i>R</i>)-<b>8</b> (1.10 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv), CuI (0.1 equiv) TEA, DMF, 40 °C (90%); (c) compound <b>18</b> (1–2 equiv), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv), Na<sub>2</sub>CO<sub>3</sub>, water, 90 °C (52% yield of <b>20</b>, 57% yield of <b>4f</b>); (d) NH<sub>3</sub>, methanol, 40 °C (50% yield of <b>4b</b>).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 18 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="note"><p class="first last">For leading references see the following:</p></div><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.+C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0lgENH_AuybCrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, A.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase: a key regulator in the immune system and in cancer</span>. <i>Cytokine Growth Factor Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.cytogfr.2010.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.cytogfr.2010.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=20685151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGjsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=213-226&author=Y.+M.+Thuauthor=A.+Richmond&title=NF-%CE%BAB+inducing+kinase%3A+a+key+regulator+in+the+immune+system+and+in+cancer&doi=10.1016%2Fj.cytogfr.2010.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase: A key regulator in the immune system and in cancer</span></div><div class="casAuthors">Thu, Yee Mon; Richmond, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">213-226</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NF-κB inducing kinase (NIK) is a kinase that activates the canonical and non-canonical NF-κB pathways to control transcriptional expression of certain proteins such as cytokines, chemokines and NF-κB signaling mols.  Many advances have been made in understanding the mol. mechanisms by which the stability of NIK is regulated to affect downstream signaling.  Genetic mouse models suggest that NIK plays an essential role in the regulation of the immune system as well as in the bone microenvironment.  Increasing evidence links NIK to the tumorigenesis of hematol. cancers, such as multiple myeloma, and solid tumors, such as pancreatic carcinoma and melanoma.  Understanding the mechanism by which NIK is de-regulated will potentially provide therapeutic options for certain diseases such as autoimmunity and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMtga85N1_7LVg90H21EOLACvtfcHk0ljQ0Hal7_gW7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGjsbbL&md5=5a8cebc7e8423336295544bcc4aab2d8</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2010.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2010.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DY.%2BM.%26aulast%3DRichmond%26aufirst%3DA.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%253A%2520a%2520key%2520regulator%2520in%2520the%2520immune%2520system%2520and%2520in%2520cancer%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2010%26volume%3D21%26spage%3D213%26epage%3D226%26doi%3D10.1016%2Fj.cytogfr.2010.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cildir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-κB signaling in health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.molmed.2016.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=414-429&author=G.+Cildirauthor=K.+C.+Lowauthor=V.+Tergaonkar&title=Noncanonical+NF-%CE%BAB+signaling+in+health+and+disease&doi=10.1016%2Fj.molmed.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DCildir%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DK.%2BC.%26aulast%3DTergaonkar%26aufirst%3DV.%26atitle%3DNoncanonical%2520NF-%25CE%25BAB%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D414%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Regulation and function of NF-kappaB transcription factors in the immune system</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1146%2Fannurev.immunol.021908.132641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=19302050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=693-733&author=S.+Vallabhapurapuauthor=M.+Karin&title=Regulation+and+function+of+NF-kappaB+transcription+factors+in+the+immune+system&doi=10.1146%2Fannurev.immunol.021908.132641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of NF-κB transcription factors in the immune system</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">693-733</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The mammalian Rel/NF-κB family of transcription factors, including RelA, c-Rel, RelB, NF-κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100), plays a central role in the immune system by regulating several processes ranging from the development and survival of lymphocytes and lymphoid organs to the control of immune responses and malignant transformation.  The 5 members of the NF-κB family are normally kept inactive in the cytoplasm by interaction with inhibitors called IκBs or the unprocessed forms of NF-κB1 and NF-κB2.  A wide variety of signals emanating from antigen receptors, pattern-recognition receptors, receptors for the members of TNF and IL-1 cytokine families, and others induce differential activation of NF-κB heterodimers.  Although work over the past two decades has shed significant light on the regulation of NF-κB transcription factors and their functions, much progress has been made in the past two years revealing new insights into the regulation and functions of NF-κB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAbeMOsSfPT7Vg90H21EOLACvtfcHk0ljQ0Hal7_gW7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSlt7o%253D&md5=9353fabd1673c6191220ef4acaf95c32</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132641%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRegulation%2520and%2520function%2520of%2520NF-kappaB%2520transcription%2520factors%2520in%2520the%2520immune%2520system%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D693%26epage%3D733%26doi%3D10.1146%2Fannurev.immunol.021908.132641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">The noncanonical NF-kappaB pathway</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">125</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2011.01088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1111%2Fj.1600-065X.2011.01088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22435551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVyku73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=125&author=S.+C.+Sun&title=The+noncanonical+NF-kappaB+pathway&doi=10.1111%2Fj.1600-065X.2011.01088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1e</span><div class="casTitle"><span class="NLM_cas:atitle">The noncanonical NF-κB pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-140, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The noncanonical nuclear factor-κB (NF-κB) signaling pathway mediates activation of the p52/RelB NF-κB complex and, thereby, regulates specific immunol. processes.  This NF-κB pathway relies on the inducible processing of NF-κB2 precursor protein, p100, as opposed to the degrdn. of IκBα in the canonical NF-κB pathway.  A central signaling component of the noncanonical NF-κB pathway is NF-κB-inducing kinase (NIK), which functions together with a downstream kinase, IKKα (inhibitor of NF-κB kinase α), to induce phosphorylation-dependent ubiquitination and processing of p100.  Under normal conditions, NIK is targeted for continuous degrdn. by a tumor necrosis factor (TNF) receptor-assocd. factor-3 (TRAF3)-dependent E3 ubiquitin ligase.  In response to signals mediated by a subset of TNF receptor superfamily members, NIK becomes stabilized as a result of TRAF3 degrdn., leading to the activation of noncanonical NF-κB.  This review discusses both the historical perspectives and the recent progress in the regulation and biol. function of the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqjkgMTubiLVg90H21EOLACvtfcHk0ljEaiyciFJyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVyku73K&md5=f857e411ec0f648f6d6171a984dcc394</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01088.x%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DThe%2520noncanonical%2520NF-kappaB%2520pathway%26jtitle%3DImmunol%2520Rev.%26date%3D2012%26volume%3D246%26spage%3D125%26doi%3D10.1111%2Fj.1600-065X.2011.01088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Razani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichardt, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives</span>. <i>Immunol Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2011.01059.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1111%2Fj.1600-065X.2011.01059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22017430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFagsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2011&pages=44-54&author=B.+Razaniauthor=A.+D.+Reichardtauthor=G.+Cheng&title=Non-canonical+NF-kappaB+signaling+activation+and+regulation%3A+principles+and+perspectives&doi=10.1111%2Fj.1600-065X.2011.01059.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1fR"><div class="casContent"><span class="casTitleNuber">1f</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling activation and regulation: principles and perspectives</span></div><div class="casAuthors">Razani, Bahram; Reichardt, Anna Devi; Cheng, Genhong</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-54</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Nuclear-factor κB (NF-κB) transcription factors are activated by a wide variety of stimuli in diverse cell types and control key aspects of immune function and development.  Receptor-mediated activation of NF-κB appears to occur through two distinct signaling pathways termed as the canonical and non-canonical NF-κB pathways.  Although much work has demonstrated the physiol. importance of non-canonical NF-κB signaling to immunity and its involvement in diverse pathologies, such as cancers and autoimmune disease, the architecture and regulation of the pathway is only beginning to be understood.  The non-canonical pathway appears to be activated by a select set of receptors within the tumor necrosis factor superfamily, and we discuss the mol. mechanisms that connect ligation of these receptors to pathway activation.  It has become increasingly clear that the key regulatory step of the pathway involves modulation of the post-translational degrdn. of NF-κB-inducing kinase (NIK), the central activating kinase of non-canonical NF-κB signaling.  How NIK post-translational stability is controlled before and after receptor ligation is an important aspect of understanding non-canonical NF-κB signaling.  Furthermore, how release of NF-κB dimers downstream of the pathway's activation is actually connected to its identified physiol. and pathol. roles is a key remaining question in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxjtZ3BYUJjrVg90H21EOLACvtfcHk0ljEaiyciFJyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFagsL%252FK&md5=b4b7e40a5437602ea0a61aaa5577e1f3</span></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2011.01059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2011.01059.x%26sid%3Dliteratum%253Aachs%26aulast%3DRazani%26aufirst%3DB.%26aulast%3DReichardt%26aufirst%3DA.%2BD.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DNon-canonical%2520NF-kappaB%2520signaling%2520activation%2520and%2520regulation%253A%2520principles%2520and%2520perspectives%26jtitle%3DImmunol%2520Rev.%26date%3D2011%26volume%3D244%26spage%3D44%26epage%3D54%26doi%3D10.1111%2Fj.1600-065X.2011.01059.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. J.</span></span> <span> </span><span class="NLM_article-title">Active and inactive protein kinases: structural basis for regulation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81092-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2FS0092-8674%2800%2981092-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=8612268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADyaK28XisFejs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1996&pages=149-158&author=L.+N.+Johnsonauthor=M.+E.+M.+Nobleauthor=D.+J.+Owen&title=Active+and+inactive+protein+kinases%3A+structural+basis+for+regulation&doi=10.1016%2FS0092-8674%2800%2981092-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Active and inactive protein kinases: structural basis for regulation</span></div><div class="casAuthors">Johnson, Louise N.; Noble, Martin E. M.; Owen, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-58</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 37 refs., examg. structural information available for active and inactive forms of various protein kinases and relating the information to regulation of enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWyGfpacKLdrVg90H21EOLACvtfcHk0ljEaiyciFJyGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFejs7o%253D&md5=aa92e06eb2c5f80208a2f2ff5243e2a6</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981092-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981092-2%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BJ.%26atitle%3DActive%2520and%2520inactive%2520protein%2520kinases%253A%2520structural%2520basis%2520for%2520regulation%26jtitle%3DCell%26date%3D1996%26volume%3D85%26spage%3D149%26epage%3D158%26doi%3D10.1016%2FS0092-8674%2800%2981092-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Krupa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, N.</span></span> <span> </span><span class="NLM_article-title">Structural modes of stablilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1039</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.04.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.jmb.2004.04.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2004&pages=1025-1039&author=A.+Krupaauthor=G.+Preethiauthor=N.+Srinivasan&title=Structural+modes+of+stablilization+of+permissive+phosphorylation+sites+in+protein+kinases%3A+distinct+strategies+in+Ser%2FThr+and+Tyr+kinases&doi=10.1016%2Fj.jmb.2004.04.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.04.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.04.043%26sid%3Dliteratum%253Aachs%26aulast%3DKrupa%26aufirst%3DA.%26aulast%3DPreethi%26aufirst%3DG.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DStructural%2520modes%2520of%2520stablilization%2520of%2520permissive%2520phosphorylation%2520sites%2520in%2520protein%2520kinases%253A%2520distinct%2520strategies%2520in%2520Ser%252FThr%2520and%2520Tyr%2520kinases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D339%26spage%3D1025%26epage%3D1039%26doi%3D10.1016%2Fj.jmb.2004.04.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harhaj, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">26243</span>– <span class="NLM_lpage">26250</span>, <span class="refDoi"> DOI: 10.1074/jbc.M403286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1074%2Fjbc.M403286200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=26243-26250&author=G.+Liaoauthor=M.+Zhangauthor=E.+W.+Harhajauthor=S.+C.+Sun&title=Regulation+of+the+NF-kappaB-inducing+kinase+by+tumor+necrosis+factor+receptor-associated+factor+3-induced+degradation&doi=10.1074%2Fjbc.M403286200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403286200%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHarhaj%26aufirst%3DE.%2BW.%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DRegulation%2520of%2520the%2520NF-kappaB-inducing%2520kinase%2520by%2520tumor%2520necrosis%2520factor%2520receptor-associated%2520factor%25203-induced%2520degradation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D26243%26epage%3D26250%26doi%3D10.1074%2Fjbc.M403286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignali, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1038/ni.1678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fni.1678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=18997792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1364-1370&author=S.+Vallabhapurapuauthor=A.+Matsuzawaauthor=W.+Zhangauthor=P.+H.+Tsengauthor=J.+J.+Keatsauthor=H.+Wangauthor=D.+A.+Vignaliauthor=P.+L.+Bergsagelauthor=M.+Karin&title=Nonredundant+and+complementary+functions+of+TRAF2+and+TRAF3+in+a+ubiquitination+cascade+that+activates+NIK-dependent+alternative+NF-kappaB+signaling&doi=10.1038%2Fni.1678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Keats, Jonathan J.; Wang, Haopeng; Vignali, Dario A. A.; Bergsagel, P. Leif; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1364-1370</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB-inducing kinase (NIK) for ubiquitin-dependent degrdn., thus preventing processing of the NF-κB2 precursor protein p100 to release p52.  However, the resp. functions of TRAF2 and TRAF3 in NIK degrdn. and activation of alternative NF-κB signaling have remained elusive.  We now show that CD40 or BAFF receptor activation result in TRAF3 degrdn. in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity.  Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2.  Degrdn. of TRAF3 prevented assocn. of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-κB2-p100 processing.  Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohqDvmlMG8NrVg90H21EOLACvtfcHk0ljZ7D2-OQAW1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K&md5=37793636ab6dd59cfc73a923b5f22702</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fni.1678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1678%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTseng%26aufirst%3DP.%2BH.%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DVignali%26aufirst%3DD.%2BA.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNonredundant%2520and%2520complementary%2520functions%2520of%2520TRAF2%2520and%2520TRAF3%2520in%2520a%2520ubiquitination%2520cascade%2520that%2520activates%2520NIK-dependent%2520alternative%2520NF-kappaB%2520signaling%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1364%26epage%3D1370%26doi%3D10.1038%2Fni.1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zarnegar, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dempsey, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korneluk, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1378</span>, <span class="refDoi"> DOI: 10.1038/ni.1676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fni.1676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=18997794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1371-1378&author=B.+J.+Zarnegarauthor=Y.+Wangauthor=D.+J.+Mahoneyauthor=P.+W.+Dempseyauthor=H.+H.+Cheungauthor=J.+Heauthor=T.+Shibaauthor=X.+Yangauthor=W.+C.+Yehauthor=T.+W.+Makauthor=R.+G.+Kornelukauthor=G.+Cheng&title=Noncanonical+NF-kappaB+activation+requires+coordinated+assembly+of+a+regulatory+complex+of+the+adaptors+cIAP1%2C+cIAP2%2C+TRAF2+and+TRAF3+and+the+kinase+NIK&doi=10.1038%2Fni.1676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK</span></div><div class="casAuthors">Zarnegar, Brian J.; Wang, Yaya; Mahoney, Douglas J.; Dempsey, Paul W.; Cheung, Herman H.; He, Jeannie; Shiba, Travis; Yang, Xiaolu; Yeh, Wen-chen; Mak, Tak W.; Korneluk, Robert G.; Cheng, Genhong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1371-1378</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent studies suggest that nuclear factor κB-inducing kinase (NIK) is suppressed via constitutive proteasome-mediated degrdn. regulated by TRAF2, TRAF3 and cIAP1 or cIAP2.  Here the authors demonstrated that the degrdn. of NIK occurs upon assembly of a regulatory complex via TRAF3 recruitment of NIK and TRAF2 recruitment of cIAP1 and cIAP2.  In contrast to TRAF2 and TRAF3, cIAP1 and cIAP2 seem to play redundant roles in the degrdn. of NIK, as inhibition of both cIAPs was required for noncanonical NF-κB activation and increased survival and proliferation of primary B lymphocytes.  Furthermore, the lethality of TRAF3 deficiency in mice could be rescued by a single NIK gene, highlighting the importance of tightly regulated NIK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLV9SGYvOx7Vg90H21EOLACvtfcHk0ljZ7D2-OQAW1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsbrM&md5=66f315dca2be3608590b5d8bb9801f85</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fni.1676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1676%26sid%3Dliteratum%253Aachs%26aulast%3DZarnegar%26aufirst%3DB.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMahoney%26aufirst%3DD.%2BJ.%26aulast%3DDempsey%26aufirst%3DP.%2BW.%26aulast%3DCheung%26aufirst%3DH.%2BH.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYeh%26aufirst%3DW.%2BC.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DKorneluk%26aufirst%3DR.%2BG.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DNoncanonical%2520NF-kappaB%2520activation%2520requires%2520coordinated%2520assembly%2520of%2520a%2520regulatory%2520complex%2520of%2520the%2520adaptors%2520cIAP1%252C%2520cIAP2%252C%2520TRAF2%2520and%2520TRAF3%2520and%2520the%2520kinase%2520NIK%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1371%26epage%3D1378%26doi%3D10.1038%2Fni.1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Varfolomeev, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blankenship, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dynek, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flygare, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshayes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span> <span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation and TNFα-dependent apoptosis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">681</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2007.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=W.+V.+Fedorovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-%CE%BAB+activation+and+TNF%CE%B1-dependent+apoptosis&doi=10.1016%2Fj.cell.2007.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFedorova%26aufirst%3DW.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-%25CE%25BAB%2520activation%2520and%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681%26doi%3D10.1016%2Fj.cell.2007.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Senftleben, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krähn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonizzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1126/science.1062677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1126%2Fscience.1062677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=11520989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1495-1499&author=U.+Senftlebenauthor=Y.+Caoauthor=G.+Xiaoauthor=F.+R.+Gretenauthor=G.+Kr%C3%A4hnauthor=G.+Bonizziauthor=Y.+Chenauthor=Y.+Huauthor=A.+Fongauthor=S.-C.+Sunauthor=M.+Karin&title=Activation+by+IKK%CE%B1+of+a+second%2C+evolutionary+conserved%2C+NF-%CE%BAB+signaling+pathway&doi=10.1126%2Fscience.1062677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span></div><div class="casAuthors">Senftleben, Uwe; Cao, Yixue; Xiao, Gutian; Greten, Florian R.; Kraehn, Gertraud; Bonizzi, Giuseppina; Chen, Yi; Hu, Yinling; Fong, Abraham; Sun, Shao-Cong; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5534</span>),
    <span class="NLM_cas:pages">1495-1499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In mammals, the canonical nuclear factor κB (NF-κB) signaling pathway activated in response to infections is based on degrdn. of IκB inhibitors.  This pathway depends on the IκB kinase (IKK), which contains two catalytic subunits, IKKα and IKKβ.  IKKβ is essential for inducible IκB phosphorylation and degrdn., whereas IKKα is not.  Here the authors show that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-κB2 (p100) precursor.  IKKα preferentially phosphorylates NF-κB2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-κB-inducing kinase (NIK).  IKKα is therefore a pivotal component of a second NF-κB activation pathway based on regulated NF-κB2 processing rather than IκB degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL1TLJXkDAYrVg90H21EOLACvtfcHk0lhhvXLj9sonEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D&md5=fbd1395649a813a75e82a154543a7396</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062677%26sid%3Dliteratum%253Aachs%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKr%25C3%25A4hn%26aufirst%3DG.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DActivation%2520by%2520IKK%25CE%25B1%2520of%2520a%2520second%252C%2520evolutionary%2520conserved%252C%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1495%26epage%3D1499%26doi%3D10.1126%2Fscience.1062677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.+C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0lhhvXLj9sonEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BC.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roschke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alarcón, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fessler, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimberly, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.166.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.4049%2Fjimmunol.166.1.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=6-10&author=J.+Zhangauthor=V.+Roschkeauthor=K.+P.+Bakerauthor=Z.+Wangauthor=G.+S.+Alarc%C3%B3nauthor=B.+J.+Fesslerauthor=H.+Bastianauthor=R.+P.+Kimberlyauthor=T.+Zhou&title=Cutting+edge%3A+a+role+for+B+lymphocyte+stimulator+in+systemic+lupus+erythematosus&doi=10.4049%2Fjimmunol.166.1.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.166.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.166.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRoschke%26aufirst%3DV.%26aulast%3DBaker%26aufirst%3DK.%2BP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAlarc%25C3%25B3n%26aufirst%3DG.%2BS.%26aulast%3DFessler%26aufirst%3DB.%2BJ.%26aulast%3DBastian%26aufirst%3DH.%26aulast%3DKimberly%26aufirst%3DR.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DCutting%2520edge%253A%2520a%2520role%2520for%2520B%2520lymphocyte%2520stimulator%2520in%2520systemic%2520lupus%2520erythematosus%26jtitle%3DJ.%2520Immunol.%26date%3D2001%26volume%3D166%26spage%3D6%26epage%3D10%26doi%3D10.4049%2Fjimmunol.166.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheema, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roschke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilbert, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stohl, W.</span></span> <span> </span><span class="NLM_article-title">Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=11407690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsFQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1319&author=G.+S.+Cheemaauthor=V.+Roschkeauthor=D.+M.+Hilbertauthor=W.+Stohl&title=Elevated+serum+B+lymphocyte+stimulator+levels+in+patients+with+systemic+immune-based+rheumatic+diseases&doi=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases</span></div><div class="casAuthors">Cheema, Gurtej S.; Roschke, Viktor; Hilbert, David M.; Stohl, William</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1313-1319</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective. to det. whether serum levels of B lymphocyte stimulator (BLyS) are elevated in patients with systemic immune-based rheumatic diseases and correlate with serum Ig levels and/or autoantibody titers.  Methods. Sera from 185 patients with various systemic immune-based rheumatic diseases (95 with systemic lupus erythematosus [SLE], 67 with rheumatoid arthritis [RA], 23 with other diagnoses) were assayed for BLyS and Ig.  In 7 patients who required arthrocentesis of a swollen knee, coincident serum and synovial fluid samples were assayed for BLyS.  Medical charts were retrospectively reviewed for elevated autoantibody titers and proteinuria within a 1-mo period before or after collection of sera for BLyS and Ig detn.  Sera concurrently collected from 48 normal healthy subjects served as controls.  Results. Serum BLyS levels were elevated in 38 of 185 patients (21%) and correlated significantly with serum IgG levels.  Serum BLyS levels did not correlate with the patients' age, sex, race, or medications, but correlated pos. with anti-double-stranded DNA antibody titers among SLE patients and with rheumatoid factor titers among seropos. RA patients.  In contrast, serum BLyS levels correlated inversely with nephrotic-range proteinuria among SLE patients.  In every case tested, BLyS levels in clin. inflamed synovial fluids were greater than those in simultaneously obtained sera.  Conclusion. BLyS may be an important factor in driving polyclonal hypergammaglobulinemia and elevated autoantibody titers in patients with systemic immune-based rheumatic diseases.  Local prodn. of BLyS in the joints may contribute to joint pathol.  Patients with elevated serum BLyS levels may be ideal candidates for therapeutic targeting of BLyS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryThicWY4tN7Vg90H21EOLACvtfcHk0lhhvXLj9sonEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsFQ%253D&md5=6a72a4e2531f86c693797c6225a4099b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200106%252944%253A6%253C1313%253A%253AAID-ART223%253E3.0.CO%253B2-S%26sid%3Dliteratum%253Aachs%26aulast%3DCheema%26aufirst%3DG.%2BS.%26aulast%3DRoschke%26aufirst%3DV.%26aulast%3DHilbert%26aufirst%3DD.%2BM.%26aulast%3DStohl%26aufirst%3DW.%26atitle%3DElevated%2520serum%2520B%2520lymphocyte%2520stimulator%2520levels%2520in%2520patients%2520with%2520systemic%2520immune-based%2520rheumatic%2520diseases%26jtitle%3DArthritis%2520Rheum.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1319%26doi%3D10.1002%2F1529-0131%28200106%2944%3A6%3C1313%3A%3AAID-ART223%3E3.0.CO%3B2-S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croft, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eun, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madireddi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span> <span> </span><span class="NLM_article-title">TNF superfamily in inflammatory disease: translating basic insights</span>. <i>Trends Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.it.2011.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.it.2011.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22169337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1yitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=144-152&author=M.+Croftauthor=W.+Duanauthor=H.+Choiauthor=S.+Y.+Eunauthor=S.+Madireddiauthor=A.+Mehta&title=TNF+superfamily+in+inflammatory+disease%3A+translating+basic+insights&doi=10.1016%2Fj.it.2011.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">TNF superfamily in inflammatory disease: translating basic insights</span></div><div class="casAuthors">Croft, Michael; Duan, Wei; Choi, Heonsik; Eun, So-Young; Madireddi, Shravan; Mehta, Amit</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">144-152</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The tumor necrosis factor (TNF) and TNF receptor superfamilies (TNFSF and TNFRSF) consist of approx. 50 membrane and sol. proteins that can modulate cellular function.  Most of these mols. are expressed by or can target cells of the immune system, and they have a wide range of actions including promoting cellular differentiation, survival, and prodn. of inflammatory cytokines and chemokines.  Emerging data show that TNFSF ligand-receptor signaling pathways are active in inflammatory and autoimmune disease.  Furthermore, several genetic polymorphisms in TNFSF and TNFRSF assoc. with susceptibility to developing disease.  Here, we examine recent data regarding the potential of these mols. as targets for therapy of autoimmune and inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRh8nycH5RH7Vg90H21EOLACvtfcHk0lhrAjOWVqsn3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1yitLo%253D&md5=2695b879fef1f6d4b20286e9c4274db9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2011.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2011.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCroft%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DEun%26aufirst%3DS.%2BY.%26aulast%3DMadireddi%26aufirst%3DS.%26aulast%3DMehta%26aufirst%3DA.%26atitle%3DTNF%2520superfamily%2520in%2520inflammatory%2520disease%253A%2520translating%2520basic%2520insights%26jtitle%3DTrends%2520Immunol.%26date%3D2012%26volume%3D33%26spage%3D144%26epage%3D152%26doi%3D10.1016%2Fj.it.2011.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Looney, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anolik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, I.</span></span> <span> </span><span class="NLM_article-title">A perspective on B-cell-targeting therapy for SLE</span>. <i>Mod. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.3109/s10165-009-0213-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.3109%2Fs10165-009-0213-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=19669389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FovFGlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1-10&author=R.+J.+Looneyauthor=J.+Anolikauthor=I.+Sanz&title=A+perspective+on+B-cell-targeting+therapy+for+SLE&doi=10.3109%2Fs10165-009-0213-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A perspective on B-cell-targeting therapy for SLE</span></div><div class="casAuthors">Looney R John; Anolik Jennifer; Sanz Inaki</div><div class="citationInfo"><span class="NLM_cas:title">Modern rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In recent years, large controlled trials have tested several new agents for systemic lupus erythematosus (SLE).  Unfortunately, none of these trials has met its primary outcome.  This does not mean progress has not been made.  In fact, a great deal has been learned about doing clinical trials in lupus and about the biological and clinical effects of the drugs being tested.  Many of these drugs were designed to target B cells directly, e.g., rituximab, belimumab, epratuzumab, and transmembrane activator and calcium modulator and cyclophilin ligand interactor-immunoglobulin (TACI-Ig).  The enthusiasm for targeting B cells derives from substantial evidence showing the critical role of B cells in murine models of SLE, as well promising results from multiple open trials with rituximab, a chimeric anti-CD20 monoclonal antibody that specifically depletes B cells (Martin and Chan in Immunity 20(5):517-527, 2004; Sobel et al. in J Exp Med 173:1441-1449, 1991; Silverman and Weisman in Arthritis Rheum 48:1484-1492, 2003; Silverman in Arthritis Rheum 52(4):1342, 2005; Shlomchik et al. in Nat Rev Immunol 1:147-153, 2001; Looney et al. in Arthritis Rheum 50:2580-2589, 2004; Lu et al. in Arthritis Rheum 61(4):482-487, 2009; Saito et al. in Lupus 12(10):798-800, 2003; van Vollenhoven et al. in Scand J Rheumatol 33(6):423-427, 2004; Sfikakis et al.  Arthritis Rheum 52(2):501-513, 2005).  Why have the controlled trials of B-cell-targeting therapies failed to demonstrate efficacy? Were there flaws in design or execution of these trials? Or, were promising animal studies and open trials misleading, as so often happens? This perspective discusses the current state of B-cell-targeting therapies for human lupus and the future development of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSFLEl7jX-CDAwxfk_AGB-EfW6udTcc2eaS_9LXQi1zirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FovFGlsg%253D%253D&md5=c9b565d7d1d494c0931f0ae1c25a2d08</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3109%2Fs10165-009-0213-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-009-0213-x%26sid%3Dliteratum%253Aachs%26aulast%3DLooney%26aufirst%3DR.%2BJ.%26aulast%3DAnolik%26aufirst%3DJ.%26aulast%3DSanz%26aufirst%3DI.%26atitle%3DA%2520perspective%2520on%2520B-cell-targeting%2520therapy%2520for%2520SLE%26jtitle%3DMod.%2520Rheumatol.%26date%3D2010%26volume%3D20%26spage%3D1%26epage%3D10%26doi%3D10.3109%2Fs10165-009-0213-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mortier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remouchamps, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4515</span>– <span class="NLM_lpage">4520</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2010.06.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4515-4520&author=J.+Mortierauthor=B.+Masereelauthor=C.+Remouchampsauthor=C.+Ganeffauthor=J.+Pietteauthor=R.+Frederick&title=NF-%CE%BAB+inducing+kinase+%28NIK%29+inhibitors%3A+Identification+of+new+scaffolds+using+virtual+screening&doi=10.1016%2Fj.bmcl.2010.06.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.027%26sid%3Dliteratum%253Aachs%26aulast%3DMortier%26aufirst%3DJ.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DRemouchamps%26aufirst%3DC.%26aulast%3DGaneff%26aufirst%3DC.%26aulast%3DPiette%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DR.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%253A%2520Identification%2520of%2520new%2520scaffolds%2520using%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4515%26epage%3D4520%26doi%3D10.1016%2Fj.bmcl.2010.06.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span>; <span class="NLM_string-name">Sagara, T.</span>; <span class="NLM_string-name">Fan, W.</span>; <span class="NLM_string-name">Haxell, T. F. N.</span>; <span class="NLM_string-name">Jenks, M. G.</span>; <span class="NLM_string-name">Malaska, M. J.</span>; <span class="NLM_string-name">Moore, J. A.</span>; <span class="NLM_string-name">Ouvry, G.</span>; <span class="NLM_string-name">Pandi, B.</span>; <span class="NLM_string-name">Peel, M. R.</span>; <span class="NLM_string-name">Steward, K. M.</span></span> <span> </span><span class="NLM_article-title">Novel 6-Azaindole Aminopyrimidine Derivatives Having NIK Inhibitory Activity</span>. <span class="NLM_patent">WO2010042337</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Goto&author=T.+Sagara&author=W.+Fan&author=T.+F.+N.+Haxell&author=M.+G.+Jenks&author=M.+J.+Malaska&author=J.+A.+Moore&author=G.+Ouvry&author=B.+Pandi&author=M.+R.+Peel&author=K.+M.+Steward&title=Novel+6-Azaindole+Aminopyrimidine+Derivatives+Having+NIK+Inhibitory+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DY.%26atitle%3DNovel%25206-Azaindole%2520Aminopyrimidine%2520Derivatives%2520Having%2520NIK%2520Inhibitory%2520Activity%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstein, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2013.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1238-1244&author=K.+Liauthor=L.+R.+McGeeauthor=B.+Fisherauthor=A.+Sudomauthor=J.+Liuauthor=S.+M.+Rubensteinauthor=M.+K.+Anwerauthor=T.+D.+Cushingauthor=Y.+Shinauthor=M.+Ayresauthor=F.+Leeauthor=J.+Eksterowiczauthor=P.+Faulderauthor=B.+Waszkowyczauthor=O.+Plotnikovaauthor=E.+Farrellyauthor=S.-H.+Xiaoauthor=G.+Chenauthor=Z.+Wang&title=Inhibiting+NF-%CE%BAB-inducing+kinase+%28NIK%29%3A+Discovery%2C+structure-based+design%2C+synthesis%2C+structure-activity+relationship%2C+and+co-crystal+structures&doi=10.1016%2Fj.bmcl.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRubenstein%26aufirst%3DS.%2BM.%26aulast%3DAnwer%26aufirst%3DM.%2BK.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DF.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DInhibiting%2520NF-%25CE%25BAB-inducing%2520kinase%2520%2528NIK%2529%253A%2520Discovery%252C%2520structure-based%2520design%252C%2520synthesis%252C%2520structure-activity%2520relationship%252C%2520and%2520co-crystal%2520structures%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1238%26epage%3D1244%26doi%3D10.1016%2Fj.bmcl.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span>; <span class="NLM_string-name">Cushing, T. D.</span>; <span class="NLM_string-name">Fisher, B.</span>; <span class="NLM_string-name">He, X.</span>; <span class="NLM_string-name">Li, K.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">McGee, L. R.</span>; <span class="NLM_string-name">Pattaropong, V.</span>; <span class="NLM_string-name">Faulder, P.</span>; <span class="NLM_string-name">Seganish, J. L.</span>; <span class="NLM_string-name">Shin, Y.</span>; <span class="NLM_string-name">Wang, Z.</span>; <span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols as Kinase Inhibitors</span>. <span class="NLM_patent">WO2009158011</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Chen&author=T.+D.+Cushing&author=B.+Fisher&author=X.+He&author=K.+Li&author=Z.+Li&author=L.+R.+McGee&author=V.+Pattaropong&author=P.+Faulder&author=J.+L.+Seganish&author=Y.+Shin&author=Z.+Wang&author=W.+Liu&title=Alkynyl+Alcohols+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26atitle%3DAlkynyl%2520Alcohols%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of tricyclic NF-κB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.-F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-based+design+of+tricyclic+NF-%CE%BAB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)</span></div><div class="casAuthors">Castanedo, Georgette M.; Blaquiere, Nicole; Beresini, Maureen; Bravo, Brandon; Brightbill, Hans; Chen, Jacob; Cui, Hai-Feng; Eigenbrot, Charles; Everett, Christine; Feng, Jianwen; Godemann, Robert; Gogol, Emily; Hymowitz, Sarah; Johnson, Adam; Kayagaki, Nobuhiko; Kohli, Pawan Bir; Knuppel, Kathleen; Kraemer, Joachim; Kruger, Susan; Loke, Pui; McEwan, Paul; Montalbetti, Christian; Roberts, David A.; Smith, Myron; Steinbacher, Stefan; Sujatha-Bhaskar, Swathi; Takahashi, Ryan; Wang, Xiaolu; Wu, Lawren C.; Zhang, Yamin; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a structure-guided optimization of a novel series of NF-κB inducing kinase (NIK) inhibitors.  Starting from a modestly potent, low mol. wt. lead, activity was improved by designing a type I1/2 binding mode that accessed a back pocket past the methionine-471 gatekeeper.  Divergent binding modes in NIK and PI3K were used to dampen PI3K-inhibition while maintaining NIK inhibition within these series.  Potent compds. were discovered that selectively inhibit the nuclear translocation of NF-kB2 (p52/REL-B) but not canonical NF-kB1 (REL-A/p50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-sPXJiSfLVg90H21EOLACvtfcHk0lgknnt8K0KZOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK&md5=316b70f51a5b800ba810082d0b3862da</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.-F.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-based%2520design%2520of%2520tricyclic%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpfe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in scaffold hopping</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01437</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01437" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSks7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1238&author=Y.+Huauthor=D.+Stumpfeauthor=J.+Bajorath&title=Recent+advances+in+scaffold+hopping&doi=10.1021%2Facs.jmedchem.6b01437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in Scaffold Hopping</span></div><div class="casAuthors">Hu, Ye; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1238-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Scaffold hopping refers to the computer-aided search for active compds. contg. different core structures, which is a topic of high interest in medicinal chem.  Herein foundations and caveats of scaffold hopping approaches are discussed and recent methodol. developments analyzed.  Despite the conceptual prevalence of pharmacophore methods for scaffold hopping, a variety of computational approaches have been successfully applied.  In recent years, scaffold hopping calcns. are increasingly carried out at the level of scaffolds rather than compds., and scaffold queries increasingly from chem. structures.  In addn., relationships between compds., scaffolds, and biol. activities are beginning to be globally explored, beyond individual applications.  Going forward, computational scaffold hopping is thought to benefit from the consideration of new scaffold concepts and the development of methods capable of guiding search calcns. toward scaffolds that are likely to represent potent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreklFOuNfjw7Vg90H21EOLACvtfcHk0lgknnt8K0KZOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSks7%252FM&md5=a845ab13a7af0e397eedc94f7adcf870</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01437%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520scaffold%2520hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1238%26doi%3D10.1021%2Facs.jmedchem.6b01437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N.</span></span> <i>Scaffold Hopping in Medicinal Chemistry</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2F9783527665143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=N.+Brown&title=Scaffold+Hopping+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2F9783527665143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527665143%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%26btitle%3DScaffold%2520Hopping%2520in%2520Medicinal%2520Chemistry%26pub%3DWiley-VCH%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.str.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=22921830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1704-1714&author=G.+de%0ALeon-Boenigauthor=K.+K.+Bowmanauthor=J.+A.+Fengauthor=T.+Crawfordauthor=C.+Everettauthor=Y.+Frankeauthor=A.+Ohauthor=M.+Stanleyauthor=S.+T.+Stabenauthor=M.+A.+Starovasnikauthor=H.+J.+A.+Wallweberauthor=J.+Wuauthor=L.+C.+Wuauthor=A.+R.+Johnsonauthor=S.+G.+Hymowitz&title=The+crystal+structure+of+the+catalytic+domain+of+the+NF-%CE%BAB+inducing+kinase+reveals+a+narrow+but+flexible+active+site&doi=10.1016%2Fj.str.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site</span></div><div class="casAuthors">de Leon-Boenig, Gladys; Bowman, Krista K.; Feng, Jianwen A.; Crawford, Terry; Everett, Christine; Franke, Yvonne; Oh, Angela; Stanley, Mark; Staben, Steven T.; Starovasnik, Melissa A.; Wallweber, Heidi J. A.; Wu, Jiansheng; Wu, Lawren C.; Johnson, Adam R.; Hymowitz, Sarah G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The NF-κB inducing kinase (NIP) regulates the non-canonical NF-κB pathway downstream of important clin. targets including BAFF, RANKL, and LTβ.  Despite numerous genetic studies assocg. dysregulation of this pathway with autoimmune diseases and hematol. cancers, detailed mol. characterization of this central signaling node has been lacking.  We undertook a systematic cloning and expression effort to generate sol., well-behaved proteins encompassing the kinase domains of human and murine NIK.  Structures of the apo NIK kinase domain from both species reveal an active-like conformation in the absence of phosphorylation.  ATP consumption and peptide phosphorylation assays confirm that phosphorylation of NIK does not increase enzymic activity.  Structures of murine NIK bound to inhibitors possessing two different chemotypes reveal conformational flexibility in the gatekeeper residue controlling access to a hydrophobic pocket.  Finally, a single amino acid difference affects the ability of some inhibitors to bind murine and human NIK with the same affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkN2Wi64mVzLVg90H21EOLACvtfcHk0lgCP-lTCyISFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P&md5=3f7d5bbd95066eb9d660ba810aba6e54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Boenig%26aufirst%3DG.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520reveals%2520a%2520narrow%2520but%2520flexible%2520active%2520site%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1704%26epage%3D1714%26doi%3D10.1016%2Fj.str.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angiolini, M.</span></span> <span> </span><span class="NLM_article-title">Through the ‘gatekeeper door’: Exploiting the active kinase conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2681</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/jm901443h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%98gatekeeper+door%E2%80%99%3A+Exploiting+the+active+kinase+conformation&doi=10.1021%2Fjm901443h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%2598gatekeeper%2520door%25E2%2580%2599%253A%2520Exploiting%2520the%2520active%2520kinase%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2681%26epage%3D2694%26doi%3D10.1021%2Fjm901443h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Angiolini, M.</span></span> <span> </span><span class="NLM_article-title">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.4155%2Ffmc.10.294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=21446845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=309-337&author=M.+Angiolini&title=Targeting+the+DFG-in+kinase+conformation%3A+a+new+trend+emerging+from+a+patent+analysis&doi=10.4155%2Ffmc.10.294"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis</span></div><div class="casAuthors">Angiolini, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">309-337</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Aberrant kinase signaling leads to a multitude of disease states.  The clin. and com. success of agents typified by imatinib or dasatinib in the treatment of hematol. malignancies has further validated kinase inhibition as a useful clin. strategy.  This increased interest in kinases as therapeutic targets is evidenced by the rapidly increasing no. of patent applications and peer-reviewed articles.  This article discusses recent Patent that describe small mols. targeting the DFG-in active kinase conformation, by the so-called type I1/21/2'' inhibitor, against a small set of clin. relevant targets such as B-Raf, p38αα, Jak2 and EphB4.  Preclin. and clin. data are also highlighted for the most promising new mol. entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGWPNwqVr3XrVg90H21EOLACvtfcHk0lgCP-lTCyISFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVCltb8%253D&md5=7c6cbe986141be40b6ae2109170fc41b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.294%26sid%3Dliteratum%253Aachs%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520DFG-in%2520kinase%2520conformation%253A%2520a%2520new%2520trend%2520emerging%2520from%2520a%2520patent%2520analysis%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D309%26epage%3D337%26doi%3D10.4155%2Ffmc.10.294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roskoski, R.</span></span> <span> </span><span class="NLM_article-title">Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.phrs.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=26529477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKksL%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2016&pages=26-48&author=R.+Roskoski&title=Classification+of+small+molecule+protein+kinase+inhibitors+based+upon+the+structures+of+their+drug-enzyme+complexes&doi=10.1016%2Fj.phrs.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes</span></div><div class="casAuthors">Roskoski, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-48</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Because dysregulation and mutations of protein kinases play causal roles in human disease, this family of enzymes has become one of the most important drug targets over the past two decades.  The X-ray crystal structures of 21 of the 27 FDA-approved small mol. inhibitors bound to their target protein kinases are depicted in this paper.  The structure of the enzyme-bound antagonist complex is used in the classification of these inhibitors.  Type I inhibitors bind to the active protein kinase conformation (DFG-Asp in, αC-helix in).  Type I1/2 inhibitors bind to a DFG-Asp in inactive conformation while Type II inhibitors bind to a DFG-Asp out inactive conformation.  Type I, I1/2, and type II inhibitors occupy part of the adenine binding pocket and form hydrogen bonds with the hinge region connecting the small and large lobes of the enzyme.  Type III inhibitors bind next to the ATP-binding pocket and type IV inhibitors do not bind to the ATP or peptide substrate binding sites.  Type III and IV inhibitors are allosteric in nature.  Type V inhibitors bind to two different regions of the protein kinase domain and are therefore bivalent inhibitors.  The type I-V inhibitors are reversible.  In contrast, type VI inhibitors bind covalently to their target enzyme.  Type I, I1/2, and II inhibitors are divided into A and B subtypes.  The type A inhibitors bind in the front cleft, the back cleft, and near the gatekeeper residue, all of which occur within the region sepg. the small and large lobes of the protein kinase.  The type B inhibitors bind in the front cleft and gate area but do not extend into the back cleft.  An anal. of the limited available data indicates that type A inhibitors have a long residence time (minutes to hours) while the type B inhibitors have a short residence time (seconds to minutes).  The catalytic spine includes residues from the small and large lobes and interacts with the adenine ring of ATP.  Nearly all of the approved protein kinase inhibitors occupy the adenine-binding pocket; thus it is not surprising that these inhibitors interact with nearby catalytic spine (CS) residues.  Moreover, a significant no. of approved drugs also interact with regulatory spine (RS) residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0COwqC0CabVg90H21EOLACvtfcHk0lh3r8JckjFJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKksL%252FN&md5=e6b45c8644e322f30f898e763780c64b</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DRoskoski%26aufirst%3DR.%26atitle%3DClassification%2520of%2520small%2520molecule%2520protein%2520kinase%2520inhibitors%2520based%2520upon%2520the%2520structures%2520of%2520their%2520drug-enzyme%2520complexes%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D103%26spage%3D26%26epage%3D48%26doi%3D10.1016%2Fj.phrs.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">LLE = lipophilic ligand efficiency = p<i>K</i><sub>i</sub> – log <i>D</i>.</p></div><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lh3r8JckjFJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span> <span> </span><span class="NLM_article-title">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5980</span>– <span class="NLM_lpage">5991</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.bmcl.2013.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=24018190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5980-5991&author=M.+D.+Shultz&title=Setting+expectations+in+molecular+optimizations%3A+Strengths+and+limitations+of+commonly+used+composite+parameters&doi=10.1016%2Fj.bmcl.2013.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters</span></div><div class="casAuthors">Shultz, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5980-5991</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Over the past 15 years there have been extensive efforts to understand and reduce the high attrition rates of drug candidates with an increased focus on physicochem. properties.  The fruits of this labor have been the generation of numerous efficiency indexes, metric-based rules and visualization tools to help guide medicinal chemists in the design of new compds. with more favorable properties.  This deluge of information may have had the unintended consequence of further obfuscating mol. optimizations by the inability of these scoring functions, rules and guides to reach a consensus on when a particular transformation is identified as beneficial.  In this manuscript, several composite parameters, or efficiency indexes, are examd. utilizing theor. and exptl. matched mol. pair analyses in order to understand the basis for how each will perform under varying scenarios of mol. optimizations.  In contrast to empirically derived composite parameters based on heavy atom count, lipophilic efficiency (LipE) sets consistent expectations regardless of mol. wt. or relative potency and can be used to generate consistent expectations for any matched mol. pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJeTISXSJyLbVg90H21EOLACvtfcHk0lh3r8JckjFJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSrs7rI&md5=3b766e26254f482b75b8973888c13aec</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26atitle%3DSetting%2520expectations%2520in%2520molecular%2520optimizations%253A%2520Strengths%2520and%2520limitations%2520of%2520commonly%2520used%2520composite%2520parameters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5980%26epage%3D5991%26doi%3D10.1016%2Fj.bmcl.2013.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffen, E. J.</span></span> <span> </span><span class="NLM_article-title">Fragment screening: an introduction</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1039/b610069b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1039%2Fb610069b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCks7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=429-446&author=A.+R.+Leachauthor=M.+M.+Hannauthor=J.+N.+Burrowsauthor=E.+J.+Griffen&title=Fragment+screening%3A+an+introduction&doi=10.1039%2Fb610069b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment screening: an introduction</span></div><div class="casAuthors">Leach, Andrew R.; Hann, Michael M.; Burrows, Jeremy N.; Griffen, Ed J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">429-446</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpttvt8xGGyL7Vg90H21EOLACvtfcHk0lh3r8JckjFJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCks7vE&md5=66d60d107405d7e87e90f5d2d29355ed</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1039%2Fb610069b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610069b%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DHann%26aufirst%3DM.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGriffen%26aufirst%3DE.%2BJ.%26atitle%3DFragment%2520screening%253A%2520an%2520introduction%26jtitle%3DMol.%2520BioSyst.%26date%3D2006%26volume%3D2%26spage%3D429%26epage%3D446%26doi%3D10.1039%2Fb610069b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span> For a related mechanism,
see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degnan, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span> <span> </span><span class="NLM_article-title">Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1124/dmd.114.061879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1124%2Fdmd.114.061879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=25633841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFSjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=578-589&author=X.+Zhuoauthor=X.+S.+Huangauthor=A.+P.+Degnanauthor=L.+B.+Snyderauthor=F.+Yangauthor=H.+Huangauthor=Y.+Z.+Shuauthor=B.+M.+Johnson&title=Identification+of+glutathione+conjugates+of+acetylene-containing+positive+allosteric+modulators+of+metabotropic+glutamate+receptor+subtype+5&doi=10.1124%2Fdmd.114.061879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5</span></div><div class="casAuthors">Zhuo, Xiaoliang; Huang, Xiaohua Stella; Degnan, Andrew P.; Snyder, Lawrence B.; Yang, Fukang; Huang, Hong; Shu, Yue-Zhong; Johnson, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">578-589</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A recent medicinal chem. campaign to identify pos. allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) led to the discovery of potent compds. featuring an oxazolidinone structural core flanked by biaryl acetylene and haloaryl moieties.  However, biotransformation studies of some of these mGluR5 PAMs demonstrated the formation of glutathione (GSH) conjugates.  The conjugates in question were formed independently of NADPH as the main products in liver microsomes and liver cytosol (rat and human) and exhibited masses that were 307 u greater than their resp. substrates, indicating the involvement of a reductive step in the formation of these metabolites.  To further characterize the relevant metabolic sequences, GSH conjugates of (4R,5R)-5-(3-fluorophenyl)-4-(5-(pyrazin-2-ylethynyl)pyridin-3-yl)oxazolidin-2-one and (4R,5R)-5-(4-fluorophenyl)-4-(6-((3-fluoropyridin-2-yl)ethynyl) pyridin-2-yl)oxazolidin-2-one were biosynthesized and isolated.  Subsequent anal. by NMR showed that GSH had reacted with the acetylene carbon atoms of these mGluR5 PAMs, suggesting a conjugate addn. mechanism and implicating cytosolic and microsomal GSH S-transferases (GSTs) in catalysis.  Interestingly, five closely related mGluR5 PAMs were not similarly prone to the formation of GSH conjugates in vitro.  These compds. also featured acetylenes, but were flanked by either Ph or cyclohexyl rings, which indicated that the formation of GSH conjugates was influenced by proximal functional groups that modulated the electron d. of the triple bond and/or differences in enzyme-substrate specificity.  These results informed an ongoing drug-discovery effort to identify mGluR5 PAMs with drug-like properties and a low risk of reactivity with endogenous thiols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHBHWhrex97Vg90H21EOLACvtfcHk0liRmZr4UT1Ntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFSjsbY%253D&md5=fca55e910eac73eebdf2e67242b13718</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.114.061879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.114.061879%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%2BS.%26aulast%3DDegnan%26aufirst%3DA.%2BP.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DShu%26aufirst%3DY.%2BZ.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26atitle%3DIdentification%2520of%2520glutathione%2520conjugates%2520of%2520acetylene-containing%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2015%26volume%3D43%26spage%3D578%26epage%3D589%26doi%3D10.1124%2Fdmd.114.061879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Laizure, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herring, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witbrodt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. B.</span></span> <span> </span><span class="NLM_article-title">The role of human carboxylesterases in drug metabolism: Have we overlooked their importance?</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1002/phar.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1002%2Fphar.1194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=23386599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVOltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=210-222&author=S.+C.+Laizureauthor=V.+Herringauthor=Z.+Huauthor=K.+Witbrodtauthor=R.+B.+Parker&title=The+role+of+human+carboxylesterases+in+drug+metabolism%3A+Have+we+overlooked+their+importance%3F&doi=10.1002%2Fphar.1194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of human carboxylesterases in drug metabolism: have we overlooked their importance?</span></div><div class="casAuthors">Laizure, S. Casey; Herring, Vanessa; Hu, Zheyi; Witbrodt, Kevin; Parker, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-222</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Carboxylesterases are a multigene family of mammalian enzymes widely distributed throughout the body that catalyze the hydrolysis of esters, amides, thioesters, and carbamates.  In humans, two carboxylesterases, hCE1 and hCE2, are important mediators of drug metab.  Both are expressed in the liver, but hCE1 greatly exceeds hCE2.  In the intestine, only hCE2 is present and highly expressed.  The most common drug substrates of these enzymes are ester prodrugs specifically designed to enhance oral bioavailability by hydrolysis to the active carboxylic acid after absorption from the gastrointestinal tract.  Carboxylesterases also play an important role in the hydrolysis of some drugs to inactive metabolites.  It has been widely believed that drugs undergoing hydrolysis by hCE1 and hCE2 are not subject to clin. significant alterations in their disposition, but evidence exists that genetic polymorphisms, drug-drug interactions, drug-disease interactions and other factors are important determinants of the variability in the therapeutic response to carboxylesterase-substrate drugs.  The implications for drug therapy are far-reaching, as substrate drugs include numerous examples from widely prescribed therapeutic classes.  Representative drugs include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, antiplatelet drugs, statins, antivirals, and central nervous system agents.  As research interest increases in the carboxylesterases, evidence is accumulating of their important role in drug metab. and, therefore, the outcomes of pharmacotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Icv81r0ebVg90H21EOLACvtfcHk0liRmZr4UT1Ntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVOltrs%253D&md5=6a68263c68e92bba8bbcb64e0e30ae92</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fphar.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1194%26sid%3Dliteratum%253Aachs%26aulast%3DLaizure%26aufirst%3DS.%2BC.%26aulast%3DHerring%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DWitbrodt%26aufirst%3DK.%26aulast%3DParker%26aufirst%3DR.%2BB.%26atitle%3DThe%2520role%2520of%2520human%2520carboxylesterases%2520in%2520drug%2520metabolism%253A%2520Have%2520we%2520overlooked%2520their%2520importance%253F%26jtitle%3DPharmacotherapy%26date%3D2013%26volume%3D33%26spage%3D210%26epage%3D222%26doi%3D10.1002%2Fphar.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span>; <span class="NLM_string-name">Mayer, J.
M.</span></span> <span> </span><span class="NLM_article-title">Hydrolysis in Drug and Prodrug Metabolism: Chemistry</span>.  <i>Biochemistry and Enzymology</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=B.+Testa&author=J.%0AM.+Mayer&title=Biochemistry+and+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DHydrolysis%2520in%2520Drug%2520and%2520Prodrug%2520Metabolism%253A%2520Chemistry%26btitle%3DBiochemistry%2520and%2520Enzymology%26pub%3DWiley-VCH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Uetrecht, J. P.</span>; <span class="NLM_string-name">Trager, W.</span></span> <i>Drug Metabolism: Chemical and Enzymatic Aspects</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.3109%2F9780849375965" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+P.+Uetrecht&author=W.+Trager&title=Drug+Metabolism%3A+Chemical+and+Enzymatic+Aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.3109%2F9780849375965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.3109%252F9780849375965%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%2BP.%26btitle%3DDrug%2520Metabolism%253A%2520Chemical%2520and%2520Enzymatic%2520Aspects%26pub%3DInforma%2520Healthcare%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taketani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterase in the liver and small intestine of experimental animals and human</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">924</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2007.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1016%2Fj.lfs.2007.07.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=924-932&author=M.+Taketaniauthor=M.+Shiiauthor=K.+Ohuraauthor=S.+Ninomiyaauthor=T.+Imai&title=Carboxylesterase+in+the+liver+and+small+intestine+of+experimental+animals+and+human&doi=10.1016%2Fj.lfs.2007.07.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2007.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2007.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DOhura%26aufirst%3DK.%26aulast%3DNinomiya%26aufirst%3DS.%26aulast%3DImai%26aufirst%3DT.%26atitle%3DCarboxylesterase%2520in%2520the%2520liver%2520and%2520small%2520intestine%2520of%2520experimental%2520animals%2520and%2520human%26jtitle%3DLife%2520Sci.%26date%3D2007%26volume%3D81%26spage%3D924%26epage%3D932%26doi%3D10.1016%2Fj.lfs.2007.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Burch, J.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Staben, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2015025025</span>, Feb 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Blaquiere&author=J.+Burch&author=G.+M.+Castanedo&author=J.+A.+Feng&author=B.+Hu&author=S.+Staben&author=G.+Wu&author=P.-W.+Yuen&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Burch, J.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>, <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Staben, S.</span>; <span class="NLM_string-name">Wu, G.</span>; <span class="NLM_string-name">Yuen, P.-W.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2015025026</span>, Feb 26, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Blaquiere&author=J.+Burch&author=G.+M.+Castanedo&author=J.+A.+Feng&author=B.+Hu&author=X.+Lin&author=S.+Staben&author=G.+Wu&author=P.-W.+Yuen&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span>; <span class="NLM_string-name">Castanedo, G. M.</span>; <span class="NLM_string-name">Feng, J. A.</span>; <span class="NLM_string-name">Crawford, J. J.</span>; <span class="NLM_string-name">Lee, W.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Hu, B.</span>; <span class="NLM_string-name">Wu, G.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Alcohols and Methods of Use</span>. <span class="NLM_patent">WO 2016135163</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Blaquiere&author=G.+M.+Castanedo&author=J.+A.+Feng&author=J.+J.+Crawford&author=W.+Lee&author=X.+Lin&author=B.+Hu&author=G.+Wu&title=Alkynyl+Alcohols+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26atitle%3DAlkynyl%2520Alcohols%2520and%2520Methods%2520of%2520Use%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bents, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaochico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span> <span> </span><span class="NLM_article-title">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">179</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02672-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=10.1038%2Fs41467-017-02672-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=29330524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=179&author=H.+D.+Brightbillauthor=E.+Sutoauthor=N.+Blaquiereauthor=N.+Ramamoorthiauthor=S.+Sujatha-Bhaskarauthor=E.+B.+Gogolauthor=G.+M.+Castanedoauthor=B.+T.+Jacksonauthor=Y.+C.+Kwonauthor=S.+Hallerauthor=J.+Leschauthor=K.+Bentsauthor=C.+Everettauthor=P.+Bir+Kohliauthor=S.+Lingeauthor=L.+Christianauthor=K.+Barrettauthor=A.+Jaochicoauthor=L.+M.+Berezhkovskiyauthor=P.+W.+Fanauthor=Z.+Modrusanauthor=K.+Velizauthor=M.+J.+Townsendauthor=J.+DeVossauthor=A.+R.+Johnsonauthor=R.+Godemannauthor=W.+P.+Leeauthor=C.+D.+Austinauthor=B.+S.+McKenzieauthor=J.+A.+Hackneyauthor=J.+J.+Crawfordauthor=S.+T.+Stabenauthor=M.+H.+Alaoui+Ismailiauthor=L.+C.+Wuauthor=N.+Ghilardi&title=NF-%CE%BAB+inducing+kinase+is+a+therapeutic+target+for+systemic+lupus+erythematosus&doi=10.1038%2Fs41467-017-02672-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span></div><div class="casAuthors">Brightbill Hans D; Sujatha-Bhaskar Swathi; Gogol Emily B; Jackson Benjamin T; Christian Laura; Wu Lawren C; Ghilardi Nico; Suto Eric; Kwon Youngsu C; Lesch Justin; DeVoss Jason; Lee Wyne P; McKenzie Brent S; Blaquiere Nicole; Castanedo Georgette M; Crawford James J; Staben Steven T; Ramamoorthi Nandhini; Townsend Michael J; Haller Susan; Austin Cary D; Bents Karin; Linge Sandra; Godemann Robert; Everett Christine; Kohli Pawan Bir; Barrett Kathy; Johnson Adam R; Alaoui Ismaili Moulay H; Jaochico Allan; Berezhkovskiy Leonid M; Fan Peter W; Modrusan Zora; Veliz Kelli; Hackney Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NF-κB-inducing kinase (NIK) mediates non-canonical NF-κB signaling downstream of multiple TNF family members, including BAFF, TWEAK, CD40, and OX40, which are implicated in the pathogenesis of systemic lupus erythematosus (SLE).  Here, we show that experimental lupus in NZB/W F1 mice can be treated with a highly selective and potent NIK small molecule inhibitor.  Both in vitro as well as in vivo, NIK inhibition recapitulates the pharmacological effects of BAFF blockade, which is clinically efficacious in SLE.  Furthermore, NIK inhibition also affects T cell parameters in the spleen and proinflammatory gene expression in the kidney, which may be attributable to inhibition of OX40 and TWEAK signaling, respectively.  As a consequence, NIK inhibition results in improved survival, reduced renal pathology, and lower proteinuria scores.  Collectively, our data suggest that NIK inhibition is a potential therapeutic approach for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSowPmlnIWxaqcneEtCi92fW6udTcc2eZcQlFBpLe1Qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D&md5=41a91514e1f4e8b2b44912ba6d6a4788</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02672-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02672-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrightbill%26aufirst%3DH.%2BD.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DRamamoorthi%26aufirst%3DN.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DGogol%26aufirst%3DE.%2BB.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BT.%26aulast%3DKwon%26aufirst%3DY.%2BC.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DBents%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DChristian%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DJaochico%26aufirst%3DA.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DFan%26aufirst%3DP.%2BW.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DVeliz%26aufirst%3DK.%26aulast%3DTownsend%26aufirst%3DM.%2BJ.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DAustin%26aufirst%3DC.%2BD.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DHackney%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DGhilardi%26aufirst%3DN.%26atitle%3DNF-%25CE%25BAB%2520inducing%2520kinase%2520is%2520a%2520therapeutic%2520target%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D179%26doi%3D10.1038%2Fs41467-017-02672-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y','PDB','6G4Y'); return false;">PDB: 6G4Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z','PDB','6G4Z'); return false;">PDB: 6G4Z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00678">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_22164"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00678">10.1021/acs.jmedchem.8b00678</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Biochemical and cellular assay conditions, metabolic stability assay conditions, kinase selectivity data, crystallography details, pharmacokinetic study conditions, metabolite identification assays, and human B cell survival data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_001.pdf">jm8b00678_si_001.pdf (567.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00678/suppl_file/jm8b00678_si_002.csv">jm8b00678_si_002.csv (2.47 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Protein Data Bank codes are the following: <b>1a</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Y">6G4Y</a>; <b>2f</b>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6G4Z">6G4Z</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00678%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-15%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00678" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991902f9cb3da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
